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Pathologic biomechanical stresses cause cardiac hypertrophy, which is associated with 
QT prolongation and increased risk of life-threatening ventricular arrhythmias. Previous 
studies demonstrated that repolarizing K+ current densities are decreased in pressure 
overload-induced left ventricular hypertrophy, resulting in action potential and QT 
prolongation. Cardiac hypertrophy also occurs with exercise training, but this 
“physiological hypertrophy” is not associated with electrical abnormalities or increased 
arrhythmia risk, suggesting that repolarizing K+ currents are upregulated, in parallel with 
the increase in myocyte size, to maintain normal cardiac function. To explore this 
hypothesis directly, two mouse models of physiological hypertrophy, one produced by 
chronic exercise (swim-) training of wild type mice and the other by cardiac-specific 
expression of constitutively active phosphoinositide-3-kinase-p110α (caPI3Kα), were 
utilized. Electrophysiological experiments revealed that repolarizing K+ current 
amplitudes were increased and K+ current densities were normalized in hypertrophied 
ventricular myocytes from swim-trained or caPI3Kα animals. Molecular analyses 
revealed that increases in K+ currents reflect the upregulation of the transcripts encoding 
iii 
the underlying K+ channel subunits. Importantly, additional experiments demonstrated 
that the transcriptional upregulation of myocardial K+ channel expression in response to 
exercise or augmented PI3Kα signaling is independent of cellular hypertrophy and Akt 
signaling.  
The hypothesis that increased PI3Kα signaling can counteract the adverse 
electrophysiological remodeling, including decreased K+ current densities and impaired 
repolarization associated with pathological hypertrophy and heart failure was also 
explored. These experiments revealed that increased PI3Kα signaling, but not renin-
angiotensin system blockade, results in transcriptional upregulation of repolarizing K+ 
channel subunits and normalization of K+ current densities in transverse aortic 
constriction (TAC)-induced pathological hypertrophy, as well as in a transgenic mouse 
model of dilated cardiomyopathy/heart failure. Increased PI3Kα signaling, therefore, 
normalizes ventricular action potential durations, QT intervals and cardiac electrical 
functioning in the hypertrophied and failing heart.   
Additional studies here applied a combined miRNA- and RNA-sequencing approach to 
define the impact of enhanced PI3Kα signaling on myocardial transcriptome structure in 
the setting of pressure overload-induced pathological left ventricular hypertrophy. These 
analyses revealed that enhanced PI3Kα signaling normalized miRNAs and mRNAs that 
were aberrantly expressed in pathological hypertrophy and that increased PI3Kα 
signaling reduces cardiac fibrosis in pathological hypertrophy through the modulation of 
TGF-β signaling and miR-21 expression.  
In conclusion, enhanced PI3Kα signaling results in the transcriptional upregulation of K+ 
channel subunits and the maintenance of cardiac excitability in physiological 
hypertrophy, and the impact of increased PI3Kα signaling on K+ channel regulation is 
independent of cellular hypertrophy and Akt. In addition, enhancing PI3Kα signaling 
iv 
increases repolarizing K+ currents and K+ channel subunit expression in mouse models 
of pathological hypertrophy and heart failure, ameliorating arrhythmogenic electrical 
remodeling. Augmentation of PI3Kα signaling, therefore, may be a useful and unique 
strategy to protect against the increased risk of ventricular arrhythmias and sudden 
death associated with cardiomyopathy. The results here also demonstrate the power 
and robustness of next-generation sequencing in efforts to define the cardiac 
transcriptome architecture and dynamics in physiological and pathological contexts, as 
well as to identify novel molecular mechanisms important in cardiovascular 
pathophysiology. 
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Chapter 1: Introduction 
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1.1 Ionic basis of cardiac excitability and contractile function 
The normal contractile function of the mammalian heart depends on proper myocardial 
electrical activity, including the sequential activation of cells in specialized conducting 
system, the normal propagation of electrical activity through the myocardium, and the 
generation of action potentials in individual cardiomyocytes (Fozzard, 1991; Roden et 
al., 2002). The normal cardiac cycle begins with the action potential originating in the 
sinoatrial node, propagating through the atria to the atrioventriular node; the electrical 
activity then spreads through the His bundle and conducting Purkinje fibers to the 
cardiac apex and excites the working ventricular myocardium (Figure 1.1) (Nerbonne & 
Kass, 2005). The propagation of myocardial electrical activity also depends on electrical 
coupling mediated by gap junctions, ensuring the coordination of the electromechanical 
functioning of the atrial and ventricular myocardium (Kanno & Saffitz, 2001). Myocardial 
action potentials are generated by the sequential activation and inactivation of ion 
channels conducting depolarizing, Na+ and Ca2+, and repolarizing, K+, currents (Fozzard, 
1991; Roden et al., 2002). During the action potential, Ca2+ influx through voltage-gated 
Ca2+ channels trigger the release of Ca2+ ions from the sarcoplasmic reticulum into the 
cytosol, where Ca2+ binds to the protein troponin-C of the troponin-tropomyosin complex, 
leading to cardiomyocyte longitudinal shortening. The synchronous shortening of the 
ventricular myocytes results in the contraction of the heart and the systolic ejection of 
blood (ter Keurs, 2011).  
 
The subsequent diastolic relaxation of the myocytes depends on the repolarization of 
membrane potential and the removal of Ca2+ from the sarcomere (ter Keurs, 2011). 
Myocardial action potential repolarization is determined by multiple outward K+ currents 
through voltage-gated K+ (Kv) and inwardly rectifying K+ (Kir) channels. The relative  
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Figure 1.1 Electrical activity in the myocardium 
Top: Schematic of a human heart with action potential waveforms recorded in different regions illustrated. Bottom: 
Schematic of a surface electrocardiogram; four sequential beats are displayed. Reprinted from (Nerbonne & Kass, 2005) 
with permission from the American Physiological Society. 
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expression levels of Kv channels vary in myocytes from different regions (eg. atrial vs 
ventricle, epicardium vs endocardium), resulting in the distinct action potential 
waveforms in atrial and ventricular myocytes, as well as the gradient of repolarization 
through the ventricular myocardium (Figure 1.1) (Nerbonne & Guo, 2002; Nerbonne & 
Kass, 2005). The transmural ventricular repolarization gradient plays a critical role in the 
propagation of myocardial electrical activity and the maintenance of normal contractile 
function (Akar et al., 2000).  
 
1.2 Multiple K+ currents determine myocardial action potential repolarization 
Multiple voltage-gated K+ (Kv) channels, as well as non-voltage-gated Kir channels, 
have been identified and demonstrated to contribute to myocardial action potential 
repolarization (Roden et al., 2002; Nerbonne & Kass, 2005). Based on differences in 
time- and voltage-dependent properties and pharmacological sensitivities, two types of 
Kv channels have been distinguished: transient outward Kv (Ito) and delayed rectifier Kv 
(IK) currents. Currents classified as Ito activate and inactivate rapidly upon membrane 
depolarization and underlie early (phase I) repolarization, whereas IK currents activate on 
depolarization with variable kinetics and underlie late (phase III) repolarization 
(Nerbonne & Kass, 2005). The heterogeneities in the biophysical properties and 
expression levels of various K+ currents contribute to the inter-species and inter-regional 
differences in action potential waveforms (Schram et al., 2002; Nerbonne & Kass, 2005). 
The Ito densities, for example, are high in murine ventricular myocytes, dominating the 
early repolarization and contributing to the short action potential durations (APD) in 
mouse cardiomyocytes (Figure 1.2, right panel). In contrast, Ito in human ventricular 
myocytes (Figure 1.2, left panel) partially repolarizes the membrane potential,  
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Figure 1. 2 Schematic of action potential waveforms and underlying ionic currents in adult human 
(left) and mouse (right) ventricular myocytes. 
As illustrated, the diversity of outward K+ currents in myocardial cells is greater than that for the inward Na+ and 
Ca2+ currents, and the various K+ currents play distinct roles in action potential repolarization in human and mouse 
ventricular cells. Reprinted from (Nerbonne, 2004) with permission from Elsevier. 
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determining phase 1 repolarization and the early plateau potential, yet only influencing 
APD indirectly (van der Heyden et al., 2006).  
 
Action potential waveforms are typically shorter in the mammalian epicardium (Figure 
1.1) than in endocardium, reflecting regional differences in Ito and/or IK densities 
(Litovsky & Antzelevitch, 1988; Furukawa et al., 1992; Bryant et al., 1998; Nerbonne & 
Guo, 2002; Costantini et al., 2005). Importantly, while the expression of individual Ito and 
IK components varies in different cardiac regions and in different species, the biophysical 
properties and pharmacological sensitivities of the individual current types are similar, 
suggesting that each is encoded by a unique molecular entity, and that the regional 
differences in action potential waveforms reflect largely the differences in the expression 
levels of the various channel types (Nerbonne & Kass, 2005). In the adult mouse 
ventricular myocardium, two different types of Ito (Ito,f and Ito,s) are expressed, along with 
two distinct slowly inactivating Kv current components, IK,slow1 and IK,slow2, and a non-
inactivating, steady-state current, Iss (Figure 1.3) (Guo et al., 1999). While the densities 
of IK,slow and Iss are expressed at similar levels throughout the ventricles, the expression 
of Ito,f and Ito,s varies in different regions (Guo et al., 1999). The expression of Ito,f, for 
example, is highest in the right ventricle (RV), intermediate in the left ventricle (LV) 
(Brunet et al., 2004), lower in ~80% of the interventricular septum (IVS) cells, and 
undetectable in ~20% of IVS cells (Guo et al., 1999). In addition, Ito,s is expressed in all 
IVS cells, but not detectable in LV or RV myocytes (Brunet et al., 2004). 
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Figure 1.3 Regional differences in Ca2+-independent, depolarization-activated K+ currents in isolated 
adult mouse left ventricular myocytes.  
Outward K+ currents were recorded during 4.5-s depolarizing voltage steps to potentials between −40 and +60 mV from a 
holding potential of −70 mV. The records displayed were from three different cells: one isolated from the apex (A) of the 
left ventricle (LV) and the other two from the interventricular septum (B and C). The Kv current components, Ito,f, Ito,s, IK,slow 
and Iss are indicated. Ito,f, which is prominent in cells isolated from the LV apex (A), is expressed at a significantly lower 
level or is absent in cells isolated from the interventricular septum (B and C). Reprinted and adapted from (Xu et al., 
1999b) with permission from  the Rockefeller University Press. 
8 
While Kv currents contribute importantly to the repolarization of action potentials in 
mammalian ventricular myocardium, the inwardly rectifying (Kir) currents also contribute 
to shaping the resting and active membrane properties of cardiomyocytes. Among the 
several types of Kir currents expressed in adult mouse heart, IK1 contributes to the 
terminal phase of repolarization and the maintenance of resting membrane potentials in 
mouse ventricular cells (Figure 1.2) (Nichols & Lopatin, 1997; Lopatin & Nichols, 2001; 
Nerbonne & Kass, 2005) 
 
1.3 Molecular determinants of repolarizing K+ currents in ventricular myocytes 
 
Functional K+ channels are integral membrane protein complexes consisting of pore-
forming (α) subunits, multiple accessory (β) subunits and regulatory proteins (Roden et 
al., 2002; Nerbonne & Kass, 2005). The α subunits of Kv channels are six-
transmembrane-spanning domain (S1-S6) proteins, and functional Kv channels are 
composed of four α-subunits. A large number of Kv α subunit genes have been identified 
(Nerbonne & Kass, 2005), and heterologous expression of the various Kv α subunits 
reveals functional Kv currents with distinct time- and voltage-dependent properties (Po et 
al., 1993; Snyders, 1999; Nerbonne & Kass, 2005). In heterologous expression systems, 
Kv α subunits of the same subfamily have been shown to form heteromeric channels, 
contributing to the diversity of Kv channels (Covarrubias et al., 1991; Po et al., 1993). In 
addition, a number of different types of Kv channel accessory subunits have been 
identified and shown to interact with Kv α subunits to modulate channel biophysical 
properties and cell surface expression (Nerbonne & Kass, 2005; Abbott et al., 2007), 
further increasing Kv channel diversity.  
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Using transgenic and targeted gene knock out strategies and biochemical approaches, it 
has been demonstrated that in adult mouse ventricles, the pore forming (α) subunit 
Kv4.2 underlies Ito,f (Barry et al., 1998; Guo et al., 2000; Kuo et al., 2001) and that Kv1.4 
encodes Ito,s (Guo et al., 1999; Guo et al., 2000). Biochemical studies have revealed that 
the Kv channel accessory (β) subunit, KChIP2, associates with Kv4.2 α subunits in 
mouse ventricular tissues, modulating the cell surface expression and gating properties 
of Kv4 channels (Kuo et al., 2001; Guo et al., 2002; Li et al., 2005; Foeger et al., 2012). 
Exploiting similar strategies, it has been shown that the two components of IK,slow, IK,slow1 
and IK,slow2, are encoded by Kv1.5 and Kv2.1, respectively (Xu et al., 1999a; London et 
al., 2001a; Kodirov et al., 2004; Li et al., 2004). Recent studies in rat ventricular 
myocytes have also suggested that the two-pore domain K+ (K2P) channel subunit, 
KCNK3 (TASK1), underlies Iss currents (Putzke et al., 2007; Wang et al., 2012). 
 
Similar to the Kv channels, multiple functionally distinct types of Kir channel pore-forming 
α-subunits (Kir1-6) have been identified. The Kir α-subunits, like Kv channels, assemble 
as tetramers to form functional Kir channels (Nichols & Lopatin, 1997; Lopatin & Nichols, 
2001; Nerbonne & Kass, 2005), although Kir α-subunits have only two, instead of six, 
transmembrane domains. It has been shown that murine cardiac IK1 channels appear to 
reflect the heteromeric assembly of the Kir α-subunits, Kir 2.1 and Kir 2.2 (Nichols et al., 
1996; Zaritsky et al., 2000; Zaritsky et al., 2001; McLerie & Lopatin, 2003; Zobel et al., 
2003). 
 
Accumulating evidence suggests that myocardial repolarizing K+ channels function as 
components of macromolecular protein complexes, comprising different pore-forming 
and accessory channel subunits and other regulatory proteins that mediate interactions 
10 
with the actin cytoskeleton, extracellular matrix and/or signaling proteins (Nerbonne & 
Kass, 2005), each of which likely plays a role in determining repolarizing K+ channel 
properties and functional K+ channel cell surface expression.  
 
1.4 Repolarizing K+ current remodeling in cardiac hypertrophy and heart failure 
 
Cardiac hypertrophy, defined as thickening of the myocardial wall along with 
enlargement of the heart, is associated with increased cardiomyocyte size secondary to 
pathological stresses (valvular heart diseases, hypertensioin, myocardial infarction etc.), 
physiological loading (exercise training or pregnancy) or intrinsic sarcomeric protein 
mutations (Lorell & Carabello, 2000). Cardiac hypertrophy induced by pathological 
stresses (pathological hypertrophy), although initially a compensatory response to 
increased load, results in impaired, deteriorating cardiac function. In addition, 
decompensated cardiac hypertrophy leads to left ventricular (LV) dilatation, increased 
interstitial fibrosis, and ultimately heart failure (Levy et al., 1990). By contrast, exercise 
training-induced physiological hypertrophy is associated with maintained (or enhanced) 
cardiac function, normal histological features with no evidence of interstitial fibrosis, and 
does not progress to failure (Kaplan et al., 1994; Pluim et al., 2000). 
 
At the molecular level, pathological hypertrophy is associated with upregulation of the 
fetal gene program, including atrial natriuretic peptide (ANP), B-type natriuretic peptide 
(BNP), and fetal forms of contractile proteins, such as skeletal α-actin and β-myosin 
heavy chain (β-MHC). These changes are accompanied by downregulation of adult 
cardiac proteins, such as α-MHC and sarcoplasmic reticulum Ca2+-ATPase (McMullen & 
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Jennings, 2007). In contrast, this molecular remodeling is not observed in physiological 
hypertrophy induced by exercise training (McMullen et al., 2003). 
 
Pathological hypertrophy is also associated with increased risk of cardiac arrhythmias 
and sudden cardiac death. Large-scaled epidemiological studies have revealed higher 
rates of ventricular arrhythmias and atrial fibrillation in individuals (patients) with 
pathological hypertrophy (Messerli et al., 1984; Levy et al., 1987; McLenachan et al., 
1987). The Framingham Heart Study, for example, reported that pathological 
hypertrophy is associated with >2 fold increase in risk for sudden cardiac death, 
independent of the development of heart failure. Several mechanisms have been 
proposed to account for the increased arrhythmogenicity associated with pathological 
hypertrophy, including impaired myocardial perfusion (Harrison et al., 1991; Houghton et 
al., 1992), fibrosis-related pro-arrhythmic substrates (Mammarella et al., 2000), and 
abnormal electrophysiological properties of the hypertrophied cardiomyocytes (Nordin et 
al., 1989; Rials et al., 1997; Swynghedauw et al., 1997). Consistent with the latter 
hypothesis, pathological hypertrophy results in prolonged ventricular action potential 
durations (APD) and increased APD dispersion, changes that are reflected (prolonged 
QT internal and increased QT dispersion) in surface ECG recordings (Gillis et al., 2000), 
and that appear to reflect impaired myocardial repolarization secondary to the reduction 
in repolarizing K+ current densities (Volk et al., 2001a; Wang et al., 2007). The impaired 
repolarization and increased APD dispersion result in increased electrical heterogeneity 
in the myocardium and increased arrhythmia susceptibility (Volk et al., 2001a; 
Marionneau et al., 2008b).  
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Recent studies in a mouse model of pressure overload-induced left ventricular 
hypertrophy (LVH) produced by transverse aortic constriction (TAC) revealed that the 
observed reductions in the densities of repolarizing K+ currents are not associated with 
K+ channel subunit gene/protein downregulation (Marionneau et al., 2008b). Rather, in 
TAC LV myocytes, increased myocyte size is the main factor in determining the 
reductions in K+ current densities. The observed decreases in functional K+ current 
densities, therefore, result directly from the failure to upregulate K+ channel subunit 
expression levels in proportion to the increase in myocyte size (Marionneau et al., 
2008b). 
 
Heart failure, irrespective of the underlying etiology, is associated with increased risk of 
life-threatening arrhythmias (Tomaselli et al., 1994; Haider et al., 1998). Sudden cardiac 
death, presumably due to lethal ventricular arrhythmias, accounts for approximately 50% 
of deaths in individuals with heart failure (Tomaselli et al., 1994). The increased 
incidence of life-threatening ventricular arrhythmias in heart failure patients is a 
consequence of complex pathological remodeling in cardiac structural (Akar et al., 
2004), neurohumoral (Vaseghi & Shivkumar, 2008) and electrophysiological properties 
(Beuckelmann et al., 1993; Marionneau et al., 2008b). Electrical remodeling in heart 
failure (Beuckelmann et al., 1993) results, at least in part, from reductions in the 
densities of repolarizing K+ currents, Ito (Beuckelmann et al., 1993; Kaab et al., 1998; 
Tomaselli & Marban, 1999; Li et al., 2002; Akar et al., 2005), delayed rectifier (Tsuji et 
al., 2000; Li et al., 2002)  and IK1 (Beuckelmann et al., 1993; Li et al., 2002; Akar et al., 
2005), which can lead to action potential prolongation and increased dispersion of 
repolarization, both of which are arrhythmogenic. Molecular studies have revealed that 
the decreases in many of the repolarizing K+ currents in failing hearts reflect the 
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downregulation of the subunits encoding the underlying channels/currents (Nattel et al., 
2007; Nass et al., 2008). 
 
In contrast to pathological hypertrophy or heart failure, exercise training-induced 
physiological hypertrophy, regardless of the magnitude of hypertrophic growth, is not 
associated with impaired repolarization, increased QT intervals/dispersion (Mayet et al., 
1999), life-threatening arrhythmias, or sudden cardiac death (Pelliccia et al., 2000; 
Serra-Grima et al., 2000; Biffi et al., 2008). The absence of electrical abnormalities and 
the immunity against ventricular arrhythmias in physiological hypertrophy suggest that 
there are fundamental differences in the electrophysiological properties of myocytes in 
pathological and physiological hypertrophy. Delineating the mechanism(s) underlying the 
differences in the electrophysiological responses of the myocardium in physiological and 
pathological hypertrophy is key to advancing our understanding and to developing 
therapeutic strategies to prevent arrhythmias associated with pathological hypertrophy. 
These topics are the focus of the studies presented in Chapter 3 and 4.  
 
1.5 Physiological cardiac hypertrophy and PI3Kα signaling 
 
Chronic exercise training activates the insulin-like growth factor 1 (IGF1)- 
phosphoinositide-3-kinase p110α (PI3Kα)-Akt signaling pathway, and accumulating 
evidences have shown that IGF1-PI3Kα-Akt signaling axis is essential in mediating 
exercise training-induced physiological hypertrophy (DeBosch et al., 2006b; McMullen & 
Jennings, 2007; Weeks & McMullen, 2011). Studies focused on defining the effects of 
growth factors on cardiac hypertrophy revealed that cardiac IGF1, but not endothelin-1 
or angiotensin II, was elevated in the hearts of athletes, compared with healthy 
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sedentary controls (Neri Serneri et al., 2001), and that serum levels of IGF1 were 
increased in humans and animals with chronic exercise training (Yeh et al., 1994; Koziris 
et al., 1999). It has also been shown that cardiac IGF1 levels correlated positively with 
LV mass and size in the hearts of athletes as well as controls (Neri Serneri et al., 2001). 
These results suggest a pivotal role for IGF1 in mediating exercise-induced physiological 
cardiac hypertrophy. Consistent with this suggestion, transgenic mice with cardiac-
specific overexpression of IGF1 receptor (α-MHC IGF1R) develop physiological 
hypertrophy, with 35-40% increase in cardiac size and normal cardiac function 
(McMullen et al., 2004), whereas mice lacking IGF1R (IGF1R-/-) were resistant to chronic 
exercise-induced cardiac hypertrophy (Kim et al., 2008). Taken together, these 
observations demonstrate that IGF1-mediated signaling plays a critical role in the 
development of physiological hypertrophy. 
 
IGF1 acts through IGF1R, a receptor tyrosine kinase on the cell surface, and activates 
phosphoinositide-3-kinase p110α (PI3Kα). PI3Kα, the Class IA component of the PI3K 
enzyme family, converts the plasma membrane lipid phosphatidylinositol-4,5-
bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate (PIP3), which initiates 
the activation of downstream signaling constituents at the plasma membrane such as 
phosphatidylinositol-dependent kinase 1 (PDK1) and Akt (Cantley, 2002). Transgenic 
mice with enhanced cardiac PI3Kα signaling develop cardiac hypertrophy similar to 
exercise-induced physiological hypertrophy (Shioi et al., 2000). In contrast, mice with 
reduced PI3Kα activity, either transgenic mice expressing dominant negative PI3Kα 
(dnPI3Kα) or knock-out mice lacking both p85α and p85β, the regulatory subunits of 
PI3Kα, display a blunted hypertrophic response to exercise training, but not to 
pathological stimuli,  such as pressure overload (McMullen et al., 2003; Luo et al., 2005). 
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In addition, crossbreeding dnPI3Kα with α-MHC IGF1R transgenic mice blunted the 
development of cardiac hypertrophy that was normally observed in IGF1R transgenic 
animals (McMullen et al., 2004). These observations suggest that PI3Kα, acting 
downstream of IGF1, plays a critical role in regulating physiological hypertrophy induced 
by exercise training. 
 
Akt is a well-characterized serine threonine kinase downstream of PI3Kα, and is 
activated (hyperphosphorylated) in animal models of physiological hypertrophy 
(McMullen et al., 2003; McMullen et al., 2004; Kemi et al., 2008). There are three Akt 
isoforms, Akt1, 2 and 3, although only Akt1 and Akt2 are highly expressed in the heart 
(Nakatani et al., 1999). Akt1 has been shown to regulate normal cardiac growth (Cho et 
al., 2001b) and is absolutely required for the development of physiological hypertrophy 
induced by chronic exercise training (DeBosch et al., 2006b). The hypertrophic response 
normally observed in wild-type animals with chronic exercise training is completed 
abrogated in mice (Akt1-/-) lacking Akt1 (DeBosch et al., 2006b). Akt2, on the other hand, 
plays a critical role in insulin-regulated glucose homeostasis, as well as in cardiomyocyte 
survival (Cho et al., 2001a; Garofalo et al., 2003; Etzion et al., 2010). Mice (Akt2-/-) 
lacking Akt2 display a severe diabetic phenotype, but the hypertrophic response to IGF1 
stimulation is preserved (DeBosch et al., 2006a).   
 
In addition to acting through Akt, PI3K-mediated signaling has been shown to regulate 
various cellular processes by modulating the cell surface expression and the functioning 
of membrane ion channels. PIP2 and PIP3, lipid products of the PI3Ks, for example, 
reportedly affect the activity of the cystic fibrosis transmembrane conductance regulator 
(CFTR) (Himmel & Nagel, 2004), Kv channels (Loussouarn et al., 2003) and Kir 
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channels (Hilgemann et al., 2001; Lopes et al., 2002). PI3Ks also mediate the activation 
of L-type Ca2+ channels in vascular smooth muscle cells upon stimulation of M2-
muscarinic (Callaghan et al., 2004), α2-adrenergic (Roberts, 2003) and angiotensin II 
receptors (Le Blanc et al., 2004). In addition, PI3Ks have been shown to enhance the 
cell surface expression of voltage-dependent Ca2+ currents in neurons by promoting 
channel subunit trafficking (Viard et al., 2004). Because the activation of PI3Kα signaling 
is necessary and sufficient to induce physiological hypertrophy, it is possible that the 
maintenance of normal electrical functioning and the immunity against 
arrhythmogenecity observed in physiological hypertrophy is also attributed to the 
activation of PI3Kα signaling. 
 
As described above, the impaired repolarization and increased arrhythmogenecity 
associated with pathological hypertrophy are attributed to the failure to upregulate K+ 
currents and K+ channel subunits in parallel with the hypertrophic growth. The absence 
of electrical abnormalities or arrhythmia risk observed in physiological hypertrophy, in 
contrast, suggests that repolarizing K+ currents are upregulated in parallel with the 
increase in myocyte size with physiological hypertrophy to maintain normal myocardial 
electrical functioning. The studies presented in Chapter 3 were designed to test this 
hypothesis directly.  Additional studies were carried out to determine the role of PI3Kα-
Akt signaling in the regulation of repolarizing K+ currents and K+ channel subunit 
expression in physiological hypertrophy (Chapter 3). In addition, the hypothesis that 
enhanced PI3Kα signaling can protect against the effects of pathological hypertrophy 
and heart failure to maintain K+ channel expression, was also tested (Chapter 4). Finally, 
using the molecular and bioinformatic pipeline optimized for transcriptomal profiling with 
next-generation high-throughput sequencing technologies, the hypothesis that increased 
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PI3Kα signaling provides protective effects in pathological hypertrophy by reversing 
aberrant myocardial miRNA and mRNA expression, secondary to pathological stress, 
was tested (Chapter 5). 
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Chapter 2: Materials and Methods
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2.1 Experimental animals 
Animals were handled in accordance with the Guide for the Care and Use of Laboratory 
Animals (NIH). All protocols involving animals were approved by the Animal Studies 
Committee at Washington University Medical School.  
 
For data presented in Chapter 3, initial experiments were performed on adult (8-10 
week) male wild type (WT) FVB/N mice subjected to chronic swim-training (McMullen et 
al., 2003), as well as on adult (8-12 week) male mice with cardiac-specific expression of 
constitutively active phosphoinositide-3-kinase p110α (caPI3Kα) (n=25) (Shioi et al., 
2000) and WT littermate controls (n=35). Additional experiments were carried out on 
adult (8-10 week) Akt1-/- mice (C57Bl/6) (Cho et al., 2001b; DeBosch et al., 2006b)  
subjected to chronic swim-training (trained n=14, untrained control n=15) (McMullen et 
al., 2003) and on a mouse model of cardiac-specific expression of caPI3Kα transgene 
driven by a tet-responsive (tet-off) α-MHC promoter (in FVB/N background) (icaPI3Kα 
n=30, WT control n=15) (Yano et al., 2008). Double transgenic animals carrying both tTA 
and caPI3Kα transgenes (icaPI3Kα) were maintained with doxycycline-containing (Dox; 
200mg doxycycline/kg) diet to repress transgene expression. The expression of caPI3Kα 
transgene was induced by removing Dox diet for 4 weeks in adult (8-10 weeks) icaPI3Kα 
animals and the activation of PI3Kα signaling in these animals was confirmed by 
Western blot.  
 
For data presented in Chapter 4, initial experiments were carried out on eight to twelve-
week-old male caPI3Kα and WT mice subjected to transverse aortic constriction (TAC) 
to produce pressure overload-induced LVH (Marionneau et al., 2008b). In addition, 
experiments were also performed in a transgenic mouse model (TG9) of heart failure 
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(Buerger et al., 2006). Electrophysiological studies were conducted on 10 week male 
WT, TG9, double transgenic (caPI3KαxTG9) mice as well as on TG9 mice following 
chronic 4 weeks swim training. Additional experiments were carried out on 10 week TG9 
animals treated with the angiotensin-converting enzyme (ACE) inhibitor, captopril 
(50mg/L in the drinking water for 4 weeks). 
 
For data presented in Chapter 5, experiments were conducted in eight to twelve-week-
old male WT FVB/N and caPI3Kα mice subjected to TAC or sham operation.  
 
2.2 Chronic swim training and citrate synthase activity measurement  
Animals (WT FVB/N, Akt1-/-, or TG9) were placed in a small tank (surface area of 225 
cm2) filled with water maintained at 30-32ºC to avoid thermal stress. Initial swim time 
was 20 min, increasing by 10 min per day until 90 min sessions were reached.  Once 
attained, the 90 min training schedule was continued twice a day (separated by 4-5 hr), 
7 days a week, for 4 weeks. Citrate synthase (CS) activity was measured in 
gastrocnemius muscles dissected from swim-trained and untrained experimental 
animals (Harrison et al., 2002), weighed and frozen in liquid nitrogen. Frozen samples 
were homogenized on ice in 100 mM Tris-HCl, and protein concentrations were 
determined using the BCA protein Assay Kit (Pierce). Individual tissue homogenates 
(5µl) were then added to a (1 ml) reaction mix containing: 100 mM Tris-HCl, 1.0 mM 
dithio-bis(2-nitrobenzoic acid), 10 mM oxaloacetate and 0.2 mM acetyl CoA. The 
absorbance of each sample at 412 nm was recorded at 25 °C every 30 seconds for 5 
minutes. Mean absorbance change per minute was recorded and citrate synthase 
activity (in µmol*mg protein-1*min-1) was calculated using the extinction coefficient (13.6 
mM-1*cm-1) of 5-thio-2-nitrobenzoic acid at 412 nm (Harrison et al., 2002). 
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2.3 Induction of pressure overload-induced pathological left ventricular 
hypertrophy  
Eight to twelve-week-old male caPI3Kα and WT mice were subjected to transverse 
aortic constriction (TAC) to produce pressure overload-induced LVH (Zhang et al., 2003; 
Marionneau et al., 2008b). Animals were anesthetized with a mixture of xylazine (16 
mg/kg, intraperitoneally[i.p.]) and ketamine (80 mg/kg, i.p.). Once deep anesthesia was 
confirmed by the absence of toe pinch reflex, the chest was opened and the thoracic 
aorta was identified. A 7-0 silk suture was placed around the transverse aorta and tied 
around a 26-gauge needle, which was then removed. Seven days after surgery, 
caPI3Kα and WT animals, with and without TAC, were analyzed.  
 
2.4 Electrophysiological recordings  
Surface electrocardiograms (ECG) were recorded from anesthetized (Tribromoethanol, 
0.25 mg/kg, i.p.) swim-trained WT, control WT, swim-trained and untrained Akt1-/-,  
caPI3Kα control, caPI3Kα+TAC, WT+TAC, TG9 and caPI3KαxTG9 animals, using 
needle electrodes connected to a dual bioamplifier (AD Instrument, PowerLab 26T). 
Lead II recordings were analyzed (Yang et al., 2010). QT intervals were measured as 
the time interval between the initiation of the QRS complex and the end of the T wave, 
and corrected for heart rate using the formula QTc=QT/(√RR/100) (Mitchell et al., 1998).  
 
Body weights, tibia lengths and LV weights were measured and recorded at the time of 
tissue harvesting. Hearts were removed from anesthetized animals, mounted on a 
Langendorf-apparatus and perfused retrogradely through the aorta with 25 ml of (0.8 
mg/ml) collagenase-containing (type II, Worthington) solution (Marionneau et al., 2008b; 
Yang et al., 2010). Following perfusion, the LV apex was separated, mechanically 
22 
dispersed, plated on laminin-coated coverslips and maintained in a 95% air-5% CO2 
incubator. Whole-cell current- and voltage-clamp recordings were obtained from LV apex 
myocytes within 24 hr of isolation at room temperature (22-24°C). All voltage- and 
current-clamp experiments were performed using an Axopatch 1B patch clamp amplifier 
(Molecular Devices) interfaced to a microcomputer with a Digidata 1332 analog/digital 
interface and the pCLAMP9 software package (Molecular Devices); Data were filtered at 
5kHz before storage.  
 
For recordings of whole-cell K+ currents, pipettes contained (in mM): KCl 135; EGTA 10; 
HEPES 10; K2ATP 5 and glucose 5 (pH 7.2; 310 mOsm). The bath solution contained (in 
mM): NaCl 136; KCl 4; MgCl2 2; CaCl2 1; CoCl2 5; tetrodotoxin (TTX) 0.02; HEPES 10 
and glucose 10 (pH 7.4; 300 mOsm). For recordings of whole-cell voltage-gated Ca2+ 
(ICa) currents, the CoCl2 was omitted from the bath and the KCl in the pipette and bath 
solutions was replaced with CsCl (140 mM) and TEACl (4mM), respectively. The TTX 
and the CoCl2 were omitted from the bath solution for current-clamp recordings.  
 
Whole-cell voltage-gated outward K+ (Kv) currents were recorded in response to 4.5 s 
voltage steps to test potentials between -60 and +40 mV from a holding potential (HP) of 
-70 mV. Currents (IK1) through inward rectifier K+ (Kir) channels, evoked in response to 
hyperpolarization to -120 mV from the same HP, were also recorded in each cell. Whole-
cell voltage-gated inward Ca2+ currents (ICa), evoked in response to 250 ms voltage 
steps to test potentials between -30 and +50 mV from a prepulse to -40 mV, presented 
from the holding potential (-70 mV) to inactivate the voltage-gated Na+ currents; the 
paradigm is illustrated in the legend to Figure 3.9. Action potentials were elicited in 
response to brief (<5 ms) depolarizing current injections of varying amplitudes, delivered 
at 1 Hz. 
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Voltage-clamp data were compiled and analyzed using Clampfit (Version 9.2, Molecular 
Devices) and Excel (Microsoft). Integration of the capacitative transients recorded during 
brief ± 10 mV voltage steps from the holding potential (-70 mV) provided the whole-cell 
membrane capacitance (Cm). Leak currents were always <100 pA, and were not 
corrected. Series resistances (<9 MΩ) were routinely compensated electronically 
(>80%). Voltage errors resulting from the uncompensated series resistance were ≤8 mV 
and were not corrected. Peak Kv current and IK1 amplitudes were measured as the 
maximal amplitudes of the outward and inward currents, respectively, evoked at each 
test potential under the recording conditions described above. Peak ICa amplitudes were 
measured as the differences between the peak inward current and the current at the end 
of the depolarizing voltage step. Current amplitudes were normalized to whole-cell 
membrane capacitances (in the same cell) to provide current densities (in pA/pF). The 
time constants of inactivation (decay) and the amplitudes of the individual Kv current 
components, Ito,f, IK,slow and Iss were determined from double exponential fits to the decay 
phase of the outward K+ currents, as described previously (Brunet et al., 2004). Resting 
membrane potentials, action potential amplitudes and action potential durations at 25%, 
50% and 90% repolarization were also measured.  
 
2.5 Histology  
Swim-trained and WT mice were anesthetized with intraperitoneal injection of ketamine 
(86 mg/kg) and xylazine (13 mg/kg) and perfused with 4% paraformaldehyde in 0.1 
mol/L phosphate buffer. Isolated ventricular tissue was embedded in paraffin, sectioned 
and stained with Masson trichrome (DeBosch et al., 2006b). Ventricular myocyte cross-
sectional area was measured using an Axioskop microscope (Carl Zeiss, Inc, Chester, 
VA) and the Axiovision 4.0 software (DeBosch et al., 2006b).   
24 
2.6 Quantitative transcript analyses  
Total RNA from the LV of experimental animals was isolated and DNase treated using 
described methods (Marionneau et al., 2005). RNA concentrations were determined by 
optical density measurements. For experiments in Chapter 3 and 4, equal amounts of 
mRNA were used for each sample for transcript analyses of genes encoding ion channel 
pore-forming (α) and accessory subunits, markers of pathological hypertrophy, as well 
as of control genes, including glyceraldehyde 3-phosphate dehydrogenase (Gapdh), 
hypoxanthine guanine phosphoribosyl transferase (Hprt), and the nuclear membrane 
protein lamin A/C (Lmna) (Table 2.1) using SYBR green RT-PCR in a two-step process 
(Marionneau et al., 2005; Marionneau et al., 2008b). All data were analyzed using the 
threshold cycle (CT) relative quantification method. These data were normalized to the 
value measured (in the same sample) for Lmna, which encodes the nuclear membrane 
protein lamin A/C, to reference the transcript expression data to the number of nuclei 
(i.e. the number of myocytes) in the sample. Because only myocyte size (not number) is 
increased in cardiac hypertrophy (Hannan et al., 2003), this method provided relative 
differences in transcript expression levels on a per myocyte basis. For each transcript, 
these normalized values were then expressed relative to the mean value determined for 
the control LV samples, and mean ± SEM normalized values are presented. Expression 
of each channel subunit transcript was also normalized to the total cellular RNA in the 
same sample, which increases with cardiac hypertrophy (Hannan et al., 2003). This 
method allows direct comparisons of the observed changes in channel subunit 
expression levels relative to the overall increase in RNA.  
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Table2. 1 Sequence specific primers used in SYBR Green RT-PCR 
Gene 
 
Forward Primer Reverse Primer 
Kv4.2 (Kcnd2) 5'-TGAATCACGTTTGTGTCATTAGTGA 5'-TTCAACTTGCGCTCATCTTAGG 
Kv4.3 (Kcnd3) 5'-GCCGCAGCACCTAGTCGTT 5'-CACCACGTCGATGATACTCATGA 
KChIP2 (Kcnip2) 5'-GGCTGTATCACGAAGGAGGAA 5'-CCGTCCTTGTTTCTGTCCATC 
Kvβ1 (Kcnab1) 5'-AAATACCCAGAAAGGCAAGTGT 5'-ATCTAGCATGTGCCGAGGAA 
Kv1.5 (Kcna5) 5'-CCTGCGAAGGTCTCTGTATGC 5'-TGCCTCGATCTCTCTTTACAAATCT 
Kv2.1 (Kcnb1) 5'-CACACAGCAATAGCGTTCAACTT 5'-AGGCGTAGACACAGTTCGGC 
TASK1 (Kcnk3) 5'-GCTTCCGCAACGTCTATGC 5'-GGGATGGAGTACTGCAGCTTCT 
Kir2.1 (Kcnj2) 5'-AAGAGCCACCTTGTGGAAGCT 5'-CTTCTGAAGTGATCCTAGATTTGAGA 
Kir2.2 (Kcnj12) 5'-AGCACCACCCTGACCACAAT 5'-CTGAGCAACCCTACCCCAA 
KvLQT1 (Kcnq1) 5'-ACCATCGCCTCCTGTTTCTCT 5'-CCCGCTGGGAGTGCAA 
mERG (Kcnh2) 5'-CCGGGTGCGGGAGTTTAT 5'-CGAGGCGCTGGCGTAAT 
Mink (Kcne1) 5'-CCCAATTCCACGACTGTTCTG 5'-CCGCCCTGTTCAGCTGTCT 
MiRP2 (Kcne3) 5'-TGCTGTGCTGAAGGCTCTGA 5'-CAGGCCGGCAGAGCAA 
Nav1.5 (Scn5a) 5'-AGTGCCACCAATGCCTTGTAC 5'-GCGGAGGGTCGTGTTGTG 
Navβ1 (Scn1b) 5'-TGGCAGAGATGGTGTACTGC 5'-TCCACTGCAGAACTGTGAGG 
Cav1.2 (Cacna1c) 5'-CCCTTCTTGTGCTCTTCGTC 5'-ACACCCAGGGCAACTCATAG 
Cavβ2 (Cacnb2) 5'-GTACCTTCCATGCGACCAGT 5'-ATTGTATCCGCGTCAAGGAC 
Cavα2δ1 (Cacna2d1) 5'-CACTGCTGTGGCAAGTGTTT 5'-TTACATCCTGAGCGTTGCTG 
ANF (Nppa ) 5'-CACTGTGGCGTGGTGAACA 5'-TCGTGATAGATGAAGGCAGGAA 
Cx43 (Gja1) 5’-ACAAGTCCTTCCCCATCTCTCA 5’-GTGTGGGCACAGACACGAAT 
Cx40 (Gja5) 5’-CCAAACCAGGAGCAGATTCC 5’-GCGTACTCTGGCTTCTGGCTAT 
HPRT (Hprt) 5'-TGAATCACGTTTGTGTCATTAGTGA 5'-TTCAACTTGCGCTCATCTTAGG 
GAPDH (Gapdh) 5'-ACTCCACTCACGGCAAATTC 5'-TCTCCATGGTGGTGAAGACA 
Lamin A/C (Lmna) 5'-GGCTACAGACGCTGAAGGAG 5'-CTGTTCCACCTGGTCCTCAT 
   
In Chapter 5, total RNA isolated from the LV of individual animals (as described above) 
was reserve transcribed into cDNA using NCode VILO miRNA cDNA synthesis Kit (Life 
Technologies). Quantitative real-time PCR (RT-PCR) for mmu-miR-21, mmu-miR-127, 
mmu-miR-146b, mmu-miR-199-5p, mmu-miR-411, mmu-miR-541, mmu-miR-34c, mmu-
miR-214, mmu-miR-410, mmu-miR-300 and endogenous control 5S rRNA for each 
sample was carried out using EXPRESS SYBR GreenER miRNA qRT-PCR Kit (Life 
Technologies) with NCode universal reverse primer and forward primers designed 
specifically for each of the miRNAs (Table 2.2). All data, analyzed using the threshold 
cycle relative quantification (∆∆CT) method, were normalized to the value measured (in 
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the same sample) for 5S rRNA. For each miRNA, the normalized values were then 
expressed relative to the mean of the control (WT Sham) LV samples. 
Table2. 2 Primer sequences for miRNA-specific RT-PCR 
Gene Mature sequence Forward primer sequence 
mmu-miR-21 Uagcuuaucagacugauguuga 5’ CTAGCTTATCAGACTGATGTTGAA 
mmu-miR-127 Cugaagcucagagggcucugau 5’TGAAGCTCAGAGGGCTCTGAT 
mmu-miR-146b Ugagaacugaauuccauaggcu 5’GCTGAGAACTGAATTCCATAGGCT 
mmu-miR-199a-5p Cccaguguucagacuaccuguuc 5’ CCAGTGTTCAGACTACCTGTTCAA 
mmu-miR-411 Uaguagaccguauagcguacg 5’ GGTAGTAGACCGTATAGCGTACGAA 
mmu-miR-541 Aagggauucugauguuggucacacu 5’ GGGATTCTGATGTTGGTCACACTA 
mmu-miR-34c Aggcaguguaguuagcugauugc 5’ GAGGCAGTGTAGTTAGCTGATTGC 
mmu-miR-214 Ugccugucuacacuugcugugc 5’ GCCTGTCTACACTTGCTGTGC 
mmu-miR-410 Agguugucugugaugaguucg 5’ GAGGTTGTCTGTGATGAGTTCGA 
mmu-miR-300 Uugaagagagguuauccuuugu 5’ GCTTGAAGAGAGGTTATCCTTTGTAA 
5S rRNA  5’AATACCGGGTGCTGTAGGCTTT 
miR-cluster 16 Cacggcggcuggaauuccc 5’ GGCGGCTGGAATTCCC 
miR-cluster 4 Accaucugugggauuaugacugaacg 5’ CATCTGTGGGATTATGACTGAACG 
miR-cluster 54 Gggggcguggaauuaucgggu 5’ GGCGTGGAATTATCGGGT 
 
2.7 Quantitative protein analyses  
Protein lysates were prepared from the LV of experimental animals using described 
methods (Guo et al., 2005). Protein concentrations were determined using the BCA 
protein Assay Kit (Pierce). For Western blot analyses, equal amounts of total proteins 
prepared from individual control and experimental animals were loaded on SDS-PAGE 
gels. The following commercially available antibodies were used: rabbit polyclonal anti-
Kv4.2, anti-Kir2.2 (Millipore, Billerica, MA, USA); rabbit polyclonal anti-TASK1 (Alomone 
labs, Jerusalem, Israel); mouse monoclonal anti-GAPDH (Abcam, Cambridge, MA, 
USA); rabbit polyclonal anti-phospho-Akt(S473), anti-total Akt, anti-phospho-ribosomal 
protein S6(S235/236), and anti-phospho-GSK3β(S9) (Cell Signaling Technology, 
Danvers, MA); goat polyclonal anti-Sprouty 1 and rabbit polyclonal anti-lamin A/C (Santa 
Cruz Biotechnology, Santa Cruz, CA). The mouse monoclonal anti-KChIP2 and anti-
Kv2.1 antibodies were developed by and obtained from the UC Davis/NIH NeuroMab 
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Facility, supported by NIH grant U24NS050606 and maintained by the University of 
California, Davis, CA 95616. The specificities of the anti-Kv4.2, anti-KChIP2, anti-Kv2.1, 
and anti-TASK1 antibodies have all been tested on protein extracts from mice in which 
the genes encoding these subunits have been eliminated by homologous recombination. 
In each case, no signals corresponding to the targeted channel subunit were detected.  
 
After washing, the membrane strips were incubated for 2 hr at room temperature with 
alkaline phosphatase-conjugated secondary antibody diluted in blocking buffer, and 
bound antibodies were detected using a chemiluminescent alkaline phosphatase 
substrate. Protein band intensities were quantified by densitometry (Quantity One Basic 
Software, Bio-Rad Laboratory, Hercules, CA), and the measured abundances were 
normalized to the expression of lamin A/C (evident as a doublet at 62- and 69-kD) in the 
same sample on the same blot. For each protein, these values were then expressed 
relative to the mean control LV value; mean ± SEM normalized values are presented. 
Channel subunit protein expression levels were also normalized to the total cellular 
protein (in the same sample) to allow direct comparison of observed changes relative to 
the global increases in cellular protein associated with cardiac hypertrophy (Hannan et 
al., 2003).  
 
2.8 Construction of barcoded short-read RNA libraries and sequencing 
2.8.1 Small RNA library construction and sequencing 
Total RNA from the LV of individual animals was isolated with Trizol (Life Technologies) 
using described protocols (Marionneau et al., 2008b; Yang et al., 2010), and the quality 
and integrity of total RNA samples were confirmed using Agilent 2100 bioanalyzer 
(Agilent Technologies). Small RNA libraries were prepared using TrueSeq Small RNA 
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Sample Prep Kits (Illumina) in accordance with the manufacturer’s instructions. In short, 
3’ and 5’ adapters were sequentially ligated to small RNAs (from 1 µg total RNA), 
followed by a reverse transcription reaction to create single stranded cDNA.  The cDNA 
samples were then PCR amplified and barcoded using a common primer and a primer 
containing unique six-base index sequence. The amplified libraries were size-
selected/gel-purified and quantified using Qubit dsDNA HS Assay kit (Life 
Technologies). Six to eight barcoded libraies were pooled in equimolar (10 nmol/L) 
amounts and diluted to 8 pmol/L for cluster formation on a single flow cell lane, followed 
by single-end sequencing on an Illumina HiSeq 2000 sequencer.  
 
2.8.2 Messenger RNA library preparation and sequencing 
Messenger RNA libraries were prepared using TrueSeq RNA Sample Prep Kits 
(Illumina) in accordance with the manufacturer’s recommendations. In brief, 3µg of total 
LV RNA was twice oligo(dT) selected using poly-T oligo-attached magnetic beads. The 
poly-A(+) RNA was then eluted, fragmented and reverse transcribed into first strand 
cDNA using random hexamers, followed by second-strand cDNA synthesis. Double-
stranded (ds) cDNAs were end-repaired and single-adenylated at 3’ ends. Barcoded 
adapters containing unique six-base index sequences and T-overhangs were ligated to 
the cDNA samples from individual mouse LV. Individual cDNA libraries was PCR 
amplified and purified; six barcoded libraries were pooled in equimolar (10 nmol/L) 
amounts and diluted to 4 pmol/L for cluster formation on a single flow cell lane, followed 
by single-end sequencing on an Illumina HiSeq 2000 sequencer.   
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2.9 Analyses of miRNA and mRNA sequencing data 
 
2.9.1 Small RNA sequencing data analyses 
Sequencing data from samples pooled in the same flow cell lane were separated 
(demultiplexed) using CASAVA 1.6 software (Illumina). A total of 165.5 million reads 
were obtained from sequencing 15 small RNA libraries (Table 1). The sequence reads 
were analyzed using the miRanalyzer program (Hackenberg et al.; Hackenberg et al., 
2009), where the raw sequencing data were transformed and filtered to keep only 
sequences containing 17-26 bases. Filtered reads were then successively mapped 
(using Bowtie) (Langmead et al., 2009) to: (1) miRBase (Griffiths-Jones, 2006) v.16 
mouse database (allowing up to two mismatches), to detect known miRNAs; (2) the 
RefSeq and Rfam database, to detect contamination from other RNA species; and (3) 
the mouse genome to detect potential novel miRNAs.  The sequences matching known 
miRNAs were clustered and counted; the read counts of each known miRNAs were then 
normalized to the total counts of sequences mapped to the miRbase v.16 database and 
presented as PMMR (sequences per million mapped reads).  
 
2.9.2 Novel miRNA discovery 
Sequence reads that are counterparts of known mature miRNAs, but that have not been 
previously reported in the miRBase database, were identified and defined as novel 
miRNA-star (miRNA*). Sequence reads that did not match known miRNAs or known 
transcripts from the RefSeq and Rfam database were mapped against the mouse 
genome (M37). Once aligned, sequence reads that share characteristics of miRNAs 
were identified and clustered using the computational algorithms provided by 
miRAnalyzer (Hackenberg et al., 2009). These clusters were further filtered to exclude 
contamination from repetitive sequences and from mRNA or noncoding RNA 
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degradation products. Only clusters with a read depth ≥100 reads were chosen for 
further analyses. The filtered candidate miRNAs and their precursors were further 
examined using the following criteria (Griffiths-Jones et al., 2006; Fehniger et al., 2010): 
(1)non-homologous to any known non-coding RNAs; (2)predicted with stem-loop hairpin 
structure with a -∆G ≤15; (3)mature miRNA length of 17-26 bases mapped to the stem of 
the predicted hairpin structure without extension into the loop or outside of the stem-loop 
fold; and (4) lack of a bulged secondary structure larger than 50% of the mature 
sequence within the stem of the hairpin. The structures of putative miRNA precursors 
were examined using the RNA-folding prediction software, RNAfold WebServer 
(http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi). Candidate miRNAs (and their precursors), 
fulfilling the described criteria, were grouped as putative novel miRNAs. The putative 
novel miRNAs were first checked against the latest miRBase v.18 database (released in 
Nov 2011); candidate miRNAs not found in the miRBase v.16, but reported in the 
miRBase v.18 were reassigned to the group of known miRNAs.   
 
2.9.3 mRNA sequencing data processing  
After demultiplexing sequencing data, adapter sequences were removed and individual 
libraries were converted to FASTQ format. Sequence reads were mapped to the mouse 
genome (mm9) with Bowtie (Langmead et al., 2009), allowing up to two mismatches. 
Sequence reads aligned to the mouse genome were imported into Partek Genomics 
Suite version 6.5 (Partek, St Louis, MO) for sequencing read clustering, counting and 
annotation. The RefSeq transcript database was chosen as the annotation reference 
and subsequent data analyses were focused on sequence reads mapping to coding 
exons. The read counts of each known transcript were normalized to the length of 
individual transcript and the total mapped read counts in a given sample and expressed 
as RPKM (reads per kilobase of exon per million mapped reads). Sequence reads 
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mapped to different isoforms of individual genes were pooled together for subsequent 
comparative analyses. 
2.9.4 Methods for sequencing data compiling and presentation 
Gene symbols and PMMR/RPKM values were imported into MultiExperiment Viewer 
(MeV v4.7.4) for comparison of miRNA and mRNA expression values, computation of 
significant levels/false discovery rates, preparation of heat-map, hierarchical clustering 
and self-organizing trees analyses. Gene ontology analyses were performed using 
g:Profiler (http://biit.cs.ut.ee/gprofiler/) (Reimand et al., 2007). Correlation coefficients 
and linear regression for comparison of miRNA/mRNA expression between biological 
replicates were calculated using Excel (Microsoft).  
 
2.10 Statistical analyses  
All averaged electrophysiological, transcript, sequencing and Western blot data are 
presented as means ± SEM. The statistical significance of differences among 
experimental groups was evaluated by one-way analysis of variance (ANOVA), followed 
by post-hoc Tukey’s multiple comparison correction. In some cases, Student’s t test or 
Mann-Whitney U test were used to evaluate the differences between groups. A two-
tailed P value <0.05 was considered statistically significant. 
 
2.11 Principal contributions to the work as a whole  
Kai-Chien Yang in collaboration with Jeanne Nerbonne contributed to the design of 
these studies and Kai-Chien Yang carried out the experiments presented here. Expert 
technical assistance was received from Rick Wilson in the maintenance and screening of 
the mouse lines used in this study.  
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Chapter 3: Enhanced PI3Kα Signaling 
Mediates Electrical Remodeling in 
Physiological Hypertrophy through an Akt-
independent Mechanism 
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3.1 Abstract 
Pathologic biomechanical stresses cause cardiac hypertrophy, which is associated with 
QT prolongation and arrhythmias. Previous studies have demonstrated that repolarizing 
K+ current densities are decreased in pressure overload-induced left ventricular 
hypertrophy, resulting in action potential and QT prolongation. Cardiac hypertrophy also 
occurs with exercise training, but this physiological hypertrophy is not associated with 
electrical abnormalities or increased arrhythmia risk, suggesting that repolarizing K+ 
currents are upregulated, in parallel with the increase in myocyte size, to maintain 
normal cardiac function. To explore this hypothesis directly, electrophysiological 
recordings were obtained from ventricular myocytes isolated from two mouse models of 
physiological hypertrophy, one produced by swim-training of wild type mice and the 
other by cardiac-specific expression of constitutively active phosphoinositide-3-kinase-
p110α (caPI3Kα). Whole-cell voltage-clamp recordings revealed that repolarizing K+ 
current amplitudes were higher in ventricular myocytes isolated from swim-trained and 
caPI3Kα, compared with wild type, animals. The increases in K+ current amplitudes 
paralleled the observed cellular hypertrophy, resulting in normalized or increased K+ 
current densities. Electrocardiographic parameters, including QT intervals, as well as 
ventricular action potential waveforms in swim-trained animals/myocytes were 
indistinguishable from controls, demonstrating preserved electrical function. Additional 
experiments revealed that inward Ca2+ current amplitudes/densities were also increased 
in caPI3Kα, compared with WT, LV myocytes. The expression of transcripts encoding 
K+, Ca2+ and other ion channel subunits was increased in swim-trained and caPI3Kα 
ventricles, in parallel with the increase in myocyte size and with the global increases in 
total cellular RNA expression. In contrast to pathological hypertrophy, therefore, the 
functional expression of repolarizing K+ (and depolarizing Ca2+) channels is increased 
with physiological hypertrophy, reflecting upregulation of the underlying ion channel 
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subunit transcripts and resulting in increased current amplitudes and the normalization of 
current densities and action potential waveforms. These results suggest that activation 
of PI3Kα signaling preserves normal myocardial electrical functioning and could be 
protective against the increased risk of arrhythmias and sudden death that are prevalent 
in pathological cardiac hypertrophy. 
 
Additional experiments were undertaken to test the hypothesis that Akt1, which underlies 
PI3Kα-induced cellular hypertrophy, also mediates the effects of augmented PI3Kα 
signaling on the transcriptional regulation of cardiac ion channels. In contrast to wild-type 
animals, chronic exercise (swim) training of mice (Akt1-/-) lacking Akt1 did not result in 
ventricular myocyte hypertrophy. Ventricular K+ current amplitudes and the expression of 
K+ channel subunits, however, were increased markedly in Akt1-/- animals with exercise 
training. Expression of the transcripts encoding inward (Na+ and Ca2+) channel subunits 
were also increased in Akt1-/- ventricles following swim training. Using a transgenic 
mouse model of inducible cardiac-specific expression of constitutively active PI3Kα 
(icaPI3Kα), further experiments revealed that short-term activation of PI3Kα signaling in 
the myocardium also led to the transcriptional upregulation of ion channel subunits. 
Inhibition of cardiac Akt activation with triciribine in the context of enhanced PI3Kα 
signaling did not prevent the upregulation of myocardial ion channel subunits. The 
results here demonstrate that chronic exercise training and enhanced PI3Kα 
expression/activity result in transcriptional upregulation of myocardial ion channel 
subunits independent of cellular hypertrophy and Akt signaling.   
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3.2 Introduction 
Cardiac hypertrophy, an adaptive response of the myocardium to increased load, occurs 
in a variety of disease states, including hypertension and myocardial infarction, and is 
associated with an increased risk of life-threatening ventricular arrhythmias (Haider et 
al., 1998). Abnormal electrical function in cardiac hypertrophy (Mayet et al., 1996; 
McIntyre & Fry, 1997) reflects at least in part reductions in repolarizing K+ current 
densities (Nabauer et al., 1996; Marionneau et al., 2008b). Reduced K+ currents can 
prolong the action potential and increase repolarization dispersion. Both effects are 
arrhythmogenic and predispose individuals to life-threatening arrhythmias (McIntyre & 
Fry, 1997; Oikarinen et al., 2004).  
 
Recent studies in a mouse model of pressure overload-induced left ventricular 
hypertrophy (LVH) produced by transverse aortic constriction (TAC) revealed that the 
observed reductions in the densities of repolarizing K+ currents are not associated with 
K+ channel subunit gene/protein downregulation (Marionneau et al., 2008b). Rather, in 
TAC LV myocytes, increased myocyte size is the main factor in determining the 
reductions in K+ current densities. The observed decreases in functional K+ current 
densities, therefore, result directly from the failure to upregulate K+ channel subunit 
expression levels in proportion to the increase in myocyte size (Marionneau et al., 
2008b). Interestingly, exercise also causes cardiac hypertrophy, especially in trained 
athletes, although this physiological hypertrophy is not associated with electrical 
abnormalities or increased arrhythmia risk (Mayet et al., 1999; Biffi et al., 2008). These 
observations suggest that repolarizing K+ currents are upregulated in parallel with the 
increase in myocyte size in physiological hypertrophy to maintain normal myocardial 
function.  The studies presented here tested this hypothesis directly.  
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Initial experiments here were carried out in mice subjected to 4 weeks of exercise 
(swimming) training (McMullen et al., 2003). QT intervals, a reflection of ventricular 
depolarization and repolarization, in swim-trained mice were indistinguishable from 
controls, as determined from surface electrocardiograms. Ventricular action potential 
waveforms were also not significantly different in swim-trained and control LV myocytes. 
In addition, whole-cell voltage-clamp experiments revealed that amplitudes of the 
repolarizing K+ currents were higher in swim-trained LV myocytes, and that repolarizing 
K+ current densities were maintained (or increased) in spite of marked increases in LV 
myocyte size.   
 
Chronic exercise training activates the insulin-like growth factor 1 (IGF-1)- 
phosphoinositide-3-kinase p110α (PI3Kα) signaling pathway, and PI3Kα is the key 
signaling molecule mediating exercise training-induced physiological hypertrophy 
(McMullen et al., 2003). Marked upregulation of repolarizing K+ currents was also 
evident in a transgenic mouse model (caPI3Kα) of physiological hypertrophy produced 
by cardiac-specific expression of constitutively active PI3Kα (Shioi et al., 2000).  
 
Molecular and biochemical analyses in both models of physiological hypertrophy 
revealed increases in the transcript and protein expression levels of the subunits 
encoding myocardial ion channels, in parallel with the increase in myocyte size and 
global increases in cellular protein/RNA expression, suggesting that increased 
myocardial ion channel subunit expression underlies the upregulated ionic currents and 
the maintenance of normal electrical function in physiological hypertrophy.  
 
PI3Kα, the Class IA component of the PI3K enzyme family, converts the plasma 
membrane lipid phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-
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3,4,5-trisphosphate (PIP3), which initiates the activation of downstream signaling 
constituents at the plasma membrane such as phosphatidylinositol-dependent kinase 1 
(PDK1) and Akt (Cantley, 2002). Akt is a well-characterized serine threonine kinase 
downstream of PI3Kα, and consists of three different isoforms, Akt1, 2 and 3; of the 
three Akt isoforms, only Akt1 and Akt2 are highly expressed in the heart (Nakatani et al., 
1999). Akt1 has been shown to regulate normal cardiac growth (Cho et al., 2001b) and 
is absolutely required for the development of physiological hypertrophy induced by 
chronic exercise training (DeBosch et al., 2006b). Akt2, on the other hand, plays a 
critical role in insulin-regulated glucose homeostasis, as well as in cardiomyocyte 
survival (Cho et al., 2001a; Garofalo et al., 2003; Etzion et al., 2010). Because of the 
pivotal role of PI3Kα-Akt1 signaling axis in mediating physiological hypertrophy, we 
hypothesized that electrical remodeling upon enhanced PI3Kα signaling also depends 
on Akt1. 
 
Genetic and pharmacological approaches were utilized in experiments designed to 
explore this hypothesis directly. Unexpectedly, these experiments revealed that PI3Kα-
mediated electrical remodeling, reflecting transcriptional upregulation of ion channel 
subunits, is independent of cellular hypertrophy and Akt signaling.  
 
3.3 Results 
3.3.1 Exercise-induced ventricular myocyte hypertrophy and K+ current 
upregulation 
As previously reported (McMullen et al., 2003), the experiments here revealed that 
chronic swim-training in mice results in marked ventricular hypertrophy. The mean ± 
SEM left ventricular mass to tibia length ratio (LVM/TL), for example, is significantly  
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Figure 3. 1 Chronic (4 week) 
swim-training results in LV 
myocyte hypertrophy and 
increased phosphorylation of 
the downstream targets of the 
PI3Kα, Akt, ribosomal protein 
S6 and GSK3β. 
A, LV mass/tibia length 
(LVM/TL) ratios were 
determined in control (n= 6) and 
swim-trained (n= 9) animals; 
individual and mean 
±s.e.m. values are plotted. B, 
representative transverse LV 
sections from control and swim-
trained animals, stained with 
Masson Trichrome, are shown. 
The black dashed lines outline 
individual myocytes; scale bar = 
20 μm. C, mean ± s.e.m. cross-
sectioned area of LV myocytes in control (n= 50) and swim-trained (n= 50) LV. Mean values in A and C are significantly 
different (*P < 0.001). D, representative Western blots of fractionated LV proteins from control (n= 4) and swim-trained (n= 
4) animals probed for phospho-Akt (pAkt), total Akt, phospho-GSK3β (pGSK3β), phospho-ribosomal protein S6 (pS6), 
and the nuclear membrane protein lamin A/C; equal amounts of proteins were loaded in each lane. E, the expression 
levels of each of these proteins were determined. pAkt levels were normalized to total Akt, whereas pS6 and pGSK3β 
levels were normalized to lamin A/C in the same sample. The mean ±s.e.m. relative expression levels of pAkt, pS6 and 
pGSK3β are significantly (#P < 0.01, *P < 0.001) higher in swim-trained, compared with control, LV. 
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(P<0.001) higher (by 27 ± 4 %) in swim-trained, compared with untrained (Figure 3.1A), 
animals. Histological measurements in trichrome-stained transverse LV sections 
revealed that mean ± SEM LV myocyte cross-sectional area is significantly (P<0.001) 
larger in swim-trained, compared with control, hearts (Figure 3.1B and 3.1C). Also 
consistent with previous reports (Hannan et al., 2003; McMullen et al., 2003), therefore, 
swim-training induced physiological hypertrophy is associated with increased LV 
myocyte size without an increase in myocyte number.  
 
Biochemical experiments were also conducted to examine the extent of phosphorylation 
of Akt, ribosomal protein S6 and glycogen synthase kinase 3β (GSK3β), previously 
shown to be increased with swim training induced-hypertrophy (McMullen et al., 2003). 
As illustrated in Figure 3.1D, Western blot analyses revealed increased phosphorylation 
of Akt, ribosomal protein S6 and GSK3β in swim-trained, compared with control, LV, 
consistent with the activation of PI3Kα signaling with exercise (McMullen et al., 2003). 
As also shown in Figure 3.1D, however, the relative expression of the nuclear 
membrane protein lamin A/C was lower in the samples from swim-trained, compared 
with control, animals. This observation is consistent with the suggestion (see above) that 
cardiac hypertrophy reflects an increase in myocyte size, but not in the numbers of 
(nuclei) myocytes (Hannan et al., 2003) and suggests that normalizing protein 
expression data to lamin A/C (see methods) will allow comparison of protein expression 
levels based on the numbers of cells (nuclei) in each sample.  
 
Whole-cell voltage-clamp recordings from LV myocytes isolated from control and swim-
trained mice revealed that the amplitudes of the peak outward Kv (IK,peak) and the 
inwardly rectifying Kir (IK1) currents are significantly (P<0.01) higher in LV myocytes from 
the swim-trained animals (Figure 3.2A and 3.2B). Kinetic analyses of the decay phases  
40 
 
 
 
Figure 3. 2 Repolarizing K+ current amplitudes are increased in ventricular myocytes from swim-trained mice. 
(A) Representative whole-cell K+ currents recorded from myocytes isolated from the apex of the left ventricles (LV) of 
control and swim-trained mice. Currents were evoked in response to (4.5 s) voltage steps to test potentials between -120 
and +40 mV from a holding potential (HP) of -70mV; the paradigm is illustrated below the records. Mean ± SEM K+ current 
amplitudes in LV myocytes from swim-trained animals are larger than in control LV myocytes (B). Mean ± SEM Cm is also 
significantly higher in cells from swim-trained animals (C), reflecting the increase in myocyte size. Normalizing current 
amplitudes for differences in cell size provided K+ current densities (D, E). Mean ± SEM K+ current densities in LV 
myocytes following swim-training are similar to (or higher than) control LV myocytes (see text). Values indicated are 
significantly (‡P<0.05, #P<0.01, *P<0.001) different in LV myocytes from control and swim-trained animals. 
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of the outward currents (Brunet et al., 2004) provided the amplitudes of the individual 
components (Ito,f, IK,slow and Iss) of the peak Kv currents, each of which is significantly 
higher in LV myocytes from swim-trained animals (Figure 3.2B). In contrast, there are 
no measurable differences in the time (Table 3.1) or the voltage- (data not shown) 
dependent properties of the Kv currents in cells from control and swim-trained mice. 
Consistent with the hypertrophic growth of the LV, however, whole-cell membrane 
capacitances (Cm) are significantly (P<0.01) higher in myocytes from swim-trained, 
compared with control, animals with mean ± SEM Cm values of 183 ± 4 pF (n=32) and 
156 ± 5 pF (n=20), respectively (Figure 3.2C). The observed increases in current 
amplitudes (Figure 3.2B), however, are sufficient to offset the cellular hypertrophy 
(Figure 3.2C) to maintain repolarizing K+ current densities similar to control levels 
(Figure 3.2D and 3.2E). Indeed, Iss and IK1 densities are actually higher in LV myocytes 
from swim-trained, compared with control, animals (see 3.4 Discussion). 
 
3.3.2 Functional consequences of exercise training-induced physiological 
hypertrophy 
To examine the functional consequences of exercise-induced ventricular hypertrophy, 
paired surface ECG recordings were obtained from animals before and after the 4-week 
training protocol. Analyses of these records revealed that the morphologies of the QRS 
complexes, P and T waves (Figure 3.3A), as well as the durations of the RR, PR, QRS 
and QT (and QTc) intervals (Figure 3.3B), measured before and after training, are 
indistinguishable. In addition, action potential waveforms in control and swim-trained LV 
myocytes are similar (Figure 3.3C), and mean ± SEM action potential durations at 25 
(APD25), 50 (APD50) and 90 (APD90) percent repolarization in control and swim-trained 
LV myocytes are not significantly different (Figure 3.3D). 
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Table 3. 1 Kv and Kir Currents in WT Control, Swim-Trained and caPI3Kα LV Myocytes. 
 
  WT Control Swim-trained caPI3K ANOVA 
N  20 32 25  
Cm (pF)  
 
156 ± 5 183 ± 4# 202 ± 7* 
P<0.000
1 
Ipeak d (ms) — — —  
 
Amplitude (pA) 
 
8535 ± 462 11561 ± 519# 14941 ± 827* P<0.000
1 
 
Density (pA/pF) 
 
55.0 ± 3.4 66.5 ± 3.5‡ 77.6 ± 5.2# P<0.000
1 
Ito,f d (ms) 88 ± 10 93 ± 10 90 ± 8 N.S. 
 Amplitude (pA)  
4042 ± 321 5016 ± 384‡ 6052 ± 597# P<0.01 
 
Density (pA/pF) 
 
26.5 ± 2.5 27.3 ± 2.4 32.1 ± 3.5 N.S. 
IK,slow d (ms) 981 ± 40 1168 ± 72 1093 ± 44 N.S. 
 Amplitude (pA)  
3615 ± 226 4612 ± 288‡ 7027 ± 512* P<0.000
1 
 Density (pA/pF) 
 
23.4 ± 1.4 25.4 ± 1.6 36.1 ± 2.7* P<0.05 
Iss d (ms) — — —  
 
Amplitude (pA) 
 
868 ± 35 2471 ± 169* 1862 ± 145* P<0.000
1 
 Density (pA/pF) 
 
5.7 ± 0.3 13.8 ± 0.8* 9.4 ± 0.6* P<0.000
1 
IK1 d (ms) — — —  
 
Amplitude (pA) 
 
-1811 ± 106 -2946 ± 156* -2694 ± 150* P<0.000
1 
 
Density (pA/pF) 
 
-11.7 ± 0.7 -15.4 ± 1.6‡ -13.8 ± 0.9‡ P<0.05 
* All values are means ± SEM. Kv and Kir current amplitudes/densities were determined at +40 mV and -120mV, 
respectively. The ANOVA column refers to the statistical significance of a one-way ANOVA test across each row.  
Values in caPI3Kα, or in swim-trained LV myocytes that were compared are significantly (‡ P<0.05, #P<0.01 , 
*P<0.001) different from the values in control WT cells in the post-hoc Tukey’s multiple comparison  test are indicated. 
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Figure 3. 3 ECG and action potential waveforms in swim-trained and control animals are indistinguishable. 
 (A) Representative ECG (lead II) waveforms from an anesthetized adult WT mouse before and 4 weeks after swim-
training are illustrated. (B) Mean ± SEM RR, PR, QRS, QT and QTc intervals in animals before and after swim-training are 
not significantly different. (C) Mean ± SEM action potential amplitudes (APA) and action potential durations at 25% 
(APD25), 50% (APD50) and 90% (APD90) repolarization in swim-trained and control LV myocytes are not significantly 
different (D). 
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3.3.3 Molecular basis of K+ current upregulation in swim-trained LV 
Physiological hypertrophy has been shown to be associated with global increases in 
total LV protein and RNA content (Hannan et al., 2003), suggesting that the observed 
increases in K+ current amplitudes in LV myocytes from swim-trained animals (Figure 
3.2A) reflect increased expression of the subunits encoding the underlying K+ channels. 
To explore this hypothesis directly, Western blot analyses, using K+ channel subunit-
specific antibodies, were performed on protein lysates prepared from the LV of swim-
trained and control animals. Equal amounts of proteins from individual animals were 
fractionated, probed and quantified. Expression of lamin A/C was also probed (Figure 
3.4A) and used for normalization (see Methods). Representative blots are presented in 
Figure 3.4A. 
 
Quantitative analyses of these blots revealed that the mean ± SEM normalized (to lamin 
A/C) expression levels of each of the K+ channel proteins examined (Figure 3.4B) were 
increased in swim-trained, compared with control, LV.  Specifically, the mean ± SEM 
relative expression levels of Kv4.2, the Kv pore-forming subunit that underlies mouse 
ventricular Ito,f (Guo et al., 2005), and of the Ito,f channel accessory subunit KChIP2 (Kuo 
et al., 2001; Guo et al., 2002), are increased significantly (P<0.05) in swim-trained, 
compared with control, LV (Figure 3.4B). Marked increases in the expression of Kv2.1 
(P<0.05), which underlies one component of IK,slow, IK,slow2 (Xu et al., 1999a), and of the 
IK1 channel subunit, Kir2.2 (P<0.01) (Zaritsky et al., 2001),  as well as of the two-pore 
domain subunit (K2P), TASK1 (P<0.05),  suggested to encode  ventricular Iss channels 
(Putzke et al., 2007), are also evident in swim-trained, compared with control, LV 
(Figure 3.4B).  Consistent with previous reports (Hannan et al., 2003), total protein is 
also increased significantly (P<0.001) in swim-trained (compared to control) LV (Figure 
3.4C).  
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Figure 3. 4 Expression of K+ channel subunits is increased in the LV of swim-trained animals in parallel with the 
increase in total protein. 
 (A) Representative Western blots of fractionated LV proteins from control (n=6) and swim-trained (n=6) animals probed 
with anti-K+ channel subunit-specific antibodies, as well as anti-GAPDH and anti-nuclear membrane protein lamin A/C 
antibodies. (B) The expression of each protein on each blot was measured and normalized to the expression of lamin A/C 
(evident as a doublet at 62- and 69-kD) in the same sample on the same blot. Protein expression data were expressed 
relative to the mean value of the control LV samples. The mean ± SEM relative expression levels of several K+ channel 
subunits, as well as GAPDH, are significantly (‡P<0.05) higher in swim-trained, compared with control, LV. (C) Individual 
and mean ± SEM total protein content are significantly (*P<0.001) higher in swim-trained (n=8), than in control (n=6), LV 
(left). (D) The individual and mean ± SEM relative (to total protein) lamin A/C protein expression levels are significantly 
(#P<0.01) lower in the LV from swim-trained (n=6),  compared with control (n=6), animals (see text). 
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Normalization of the individual channel subunit protein expression levels to the total 
protein measured in the same sample revealed that each of the channel subunit proteins 
is increased in swim-trained LV in parallel with the overall increase in protein expression 
(Supplemental Figure 3.1A), thereby maintaining relative (compared to total protein) 
ion channel subunit expression levels similar to WT control levels. In contrast, when 
compared to total protein, the relative expression level of lamin A/C is lower in swim-
trained, compared with control, LV  (Figure 3.4D). The fact that the expression of lamin 
A/C is not increased in parallel with the global increase in protein expression is 
consistent with previous reports demonstrating increased myocyte size, but not myocyte 
number, in the hypertrophied heart (Hannan et al., 2003) and with the suggestion above 
that lamin A/C expression can be exploited to normalize protein expression data to cell 
(nuclei) number.  
 
Further experiments revealed that the expression levels of the transcripts encoding Ito,f 
channel subunits, Kcnd2 (Kv4.2) and Kcnip2 (KChIP2), normalized to lamin A/C, are 
also increased (P<0.01) in swim-trained, compared with control, LV (Figure 3.5A), as is 
Kcnd3 (Kv4.3) (P<0.01), the primary determinant of Ito,f in large mammals (Kaab et al., 
1998; Kong et al., 1998; Wang et al., 1999). The expression level of the Kcnb1 
transcript, which encodes the IK,slow,2 channel subunit, Kv2.1, but not of Kcna5,which 
encodes the IK,slow,1 channel subunit, Kv1.5, (Xu et al., 1999a; London et al., 2001b),  is 
also increased significantly (P<0.01) with exercise (Figure 3.5A). Similarly, expression of 
the IK1 channel transcripts, Kcnj12 (Kir2.2) and Kcnj2 (Kir2.1) (Zaritsky et al., 2001), as 
well as of the putative Iss encoding, K2P channel subunit, Kcnk3 (TASK1) (Putzke et al., 
2007), are higher (P<0.05) in swim-trained, compared with control, LV (Figure 3.5A).   
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Figure 3. 5 Expression levels of K+ channel subunit transcripts are also increased with swim-training. 
 (A) Individual and mean ± SEM total RNA levels are higher in swim-trained (n=6), compared with control (n=6), LV. 
Expression levels of K+ channel subunit transcript expression levels were measured and normalized to lmna in the same 
sample. Transcript expression data were expressed relative to the mean value of control LV samples. The mean ± SEM 
relative expression levels of the transcripts encoding GAPDH (B) and several K+ channel subunits (C) are significantly 
(‡P<0.05, #P<0.01, *P<0.001) higher in swim-trained LV, whereas expression of ANF (B), a marker of pathological 
hypertrophy,  is similar in LV samples from control and swim-trained animals.  
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Expression of GAPDH is also increased with swim training, whereas atrial natriuretic 
factor (ANF), considered a marker of pathological hypertrophy (McMullen & Jennings, 
2007), is not affected (Figure 3.5B). In parallel with the global increase in protein 
(Figure 3.4C), total RNA is also significantly (P<0.001) higher (1.4-fold on average) in 
swim-trained, than in control, LV (Figure 3.5C). Normalization of channel subunit 
transcript expression levels to the total cellular RNA measured in the same sample 
revealed that the increases in channel subunit transcript expression levels in swim-
trained LV parallel the global increases in cellular RNA, maintaining relative (compared 
to total RNA) ion channel subunit expression levels at or near control levels 
(Supplemental Figure 3.1B).  
 
Supplemental Figure 3. 1 Myocardial K+ channel subunit protein and transcript expression levels in LV samples 
from swim-trained and control animals increase in parallel with total cellular protein/RNA.  
Protein (A) and transcript (B) expression levels of each of the K+ channel subunits were measured in LV samples from 
swim-trained and control LV, and normalized to the total protein or total RNA respectively determined in the same sample. 
Values determined in swim-trained LV were then expressed relative to the controls. Mean ± SEM normalized protein (A) 
and transcript (B) expression levels are plotted. 
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The expression levels of transcripts encoding several other ion channel subunits 
(normalized to lamin A/C) are also increased in the LV of animals following exercise 
(Figure 3.5E). For example, expression of Kcnh2 (mERG) and Kcnq1 (KvLQT1), the 
subunits which underlie the rapid and slow components of cardiac delayed rectification, 
IKr and IKs (Sanguinetti et al., 1995; Sanguinetti et al., 1996) in large mammals including 
humans, as well as voltage-gated Na+ and Ca2+ channel and gap junction channel 
subunit transcripts, are also increased with swim-training (Figure 3.5E) 
 
3.3.4 Activation of cardiac PI3Kα signaling also results in K+ current upregulation 
Chronic exercise training results in activation of PI3Kα and downstream signaling targets 
(Figure 3.1), as previously demonstrated (McMullen et al., 2003; DeBosch et al., 2006b; 
O'Neill et al., 2007). It has also been reported that cardiac specific transgenic 
overexpression of constitutively active PI3Kα (caPI3Kα) produces ventricular 
hypertrophy with normal cardiac function (Shioi et al., 2000). Subsequent experiments 
here, therefore, were aimed at determining if increasing cardiac PI3Kα signaling directly 
also results in the upregulation of repolarizing ventricular K+ currents.  
 
Similar to the results obtained in the experiments conducted on myocytes from animals 
following chronic swim training (Figure 3.2), IK,peak (P<0.001) and IK1 (P<0.001) 
amplitudes are significantly larger in caPI3K, compared with WT, LV myocytes (Figure 
3.6A and 3.6B). Analysis of the currents revealed that the amplitudes of Ito,f, IK,slow and Iss 
are all significantly (P<0.01) higher in caPI3Kα, than in WT, LV myocytes (Figure 3.6B), 
whereas the time- and voltage-dependent properties of the currents in caPI3Kα and WT 
cells are similar (Table 3.1). Consistent with the hypertrophic growth of caPI3Kα hearts, 
however, caPI3Kα LV myocytes are larger than WT cells. The mean ± SEM Cm 
determined for caPI3Kα (202 ± 7 pF, n=25) LV cells is significantly (P<0.001) higher than  
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Figure 3. 6 Repolarizing K+ currents are also upregulated in ventricular myocytes from adult caPI3Kα mice. 
 (A) Whole-cell K+ currents were recorded as described in the legend to Figure 2 from myocytes isolated from the LV apex 
of caPI3Kα and WT mice. Mean ± SEM K+ current amplitudes (B) and whole-cell Cm (C) are higher in caPI3Kα, than in WT, 
LV myocytes. After normalization for differences in cell size, K+ current densities (D, E) in caPI3Kα LV myocytes are 
similar to, or higher than, the densities in WT cells. Values indicated are significantly (‡P<0.05, #P<0.01, and *P<0.001) 
higher in caPI3Kα LV myocytes compared with WT myoyctes. 
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the mean in WT (156 ± 5 pF, n=20) cells (Figure 3.6C). Normalization of the  measured 
K+ current amplitudes (Figure 3.6B) for differences in myocyte size (Figure 3.6C) 
revealed that repolarizing K+ current densities in caPI3Kα LV myocytes are similar to, or 
actually higher than, the densities in WT LV cells (Figure 3.6D and 6E). 
 
 
 
Figure 3. 7 Expression levels of K+ channel subunit proteins are also increased in caPI3Kα LV. 
 (A) Individual and mean ± SEM (*P<0.001) protein content are higher in caPI3Kα (n=8), than in WT (n=8), LV. (B) 
Representative Western blots of fractionated ventricular proteins probed with anti-K+ channel subunit-specific antibodies, 
as well as with anti-GAPDH and anti-lamin A/C. (C) Mean ± SEM (n=8) K+ channel subunit (and GAPDH) expression 
levels are significantly (‡P<0.05, #P<0.01) higher in caPI3Kα, than in WT, LV.  
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Additional electrophysiological experiments revealed no significant differences in resting 
membrane potentials, action potential waveforms, or ECG parameters in WT and 
caPI3Kα cells/animals (data not illustrated). Exploiting the same strategy as used in the 
analyses of the LV of swim-trained mice, biochemical experiments were conducted to 
examine K+ channel subunit protein expression levels in the LV of caPI3Kα, compared 
with WT, mice. As illustrated in Figure 3.7, these experiments revealed that the protein 
expression levels of the Ito,f channel subunits (Kv4.2 and KChIP2), the IK,slow2 channel 
subunit (Kv2.1), the IK1 channel subunit (Kir2.2), and the putative Iss K2P channel subunit 
(TASK1) (normalized to lamin A/C) are all increased significantly (P<0.05) in caPI3Kα, 
compared with WT, LV (Figure 3.7A and 3.7B). Consistent with the marked hypertrophy 
in caPI3Kα hearts, total LV protein content is  higher than in control LV (P<0.001; Figure 
3.7C). Normalization of the channel subunit protein expression levels to the total protein 
measured in the same sample revealed that the observed increases in ion channel 
subunit protein expression are proportional to the global increase in total protein 
expression in caPI3Kα LV (Supplemental Figure 3.2A).  Similar to the observations in 
swim-trained animals, cardiac specific expression of caPI3Kα is also associated with 
marked increases in the expression levels of the transcripts encoding repolarizing K+ (as 
well as a number of other ion) channel subunits (Figure 3.8A and 3.8E) and in total 
RNA (Figure 3.8C), whereas ANF expression is unaffected in the caPI3Kα LV (Figure 
3.8B). The observed increases in channel subunit transcript expression levels in 
caPI3Kα LV also parallel the increase in total cellular RNA (Supplemental Figure 3.2B). 
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Figure 3. 8 Expression levels of transcripts encoding channel subunits are also increased in caPI3Kα LV. 
 (A) Individual and mean ± SEM (P<0.001) total RNA levels are higher in caPI3Kα (n=6), compared with WT (n=6), LV. 
The mean ± SEM relative transcript expression level of GAPDH, but not ANF, is higher in caPI3Kα than in WT LV (B). 
Expression levels of several K+ channel subunits (C,D), as well as other voltage-gated and gap junction channel subunits 
(E) are significantly (‡P<0.05, #P<0.01 ) higher in caPI3Kα,  compared with WT, LV. 
  
54 
 
Supplemental Figure 3. 2 Myocardial K+ channel subunit protein and transcript expression levels in LV samples 
from caPI3Kα and WT animals increases in parallel  with total cellular protein/RNA.  
Protein (A) and transcript (B) expression levels of K+ channel subunits were measured in LV samples from caPI3Kα and 
WT LV, and normalized to the total protein or total RNA respectively determined in the same sample. Values measured in 
caPI3Kα LV were then expressed relative to WT. Mean ± SEM protein (A) and transcript (B) expression levels are plotted. 
3.3.5 Voltage-gated Ca2+ currents are also upregulated with physiological 
hypertrophy 
The observation that the expression of repolarizing K+ currents is upregulated in 
physiological hypertrophy without altering action potential waveform and ECG 
parameters suggests that the amplitudes of (depolarizing) inward currents likely are also  
upregulated to maintain ventricular myocyte excitability. As noted above, RT-PCR 
analysis revealed that the transcripts encoding voltage-gated Na+ and Ca2+ channel 
pore-forming and accessory subunits are increased in caPI3Kα (Figure 3.8E), as well as 
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Figure 3. 9 Depolarizing Ca2+ (ICa) 
current amplitudes are increased in 
LV myocytes from adult caPI3Kα 
mice. 
 (A) Representative whole-cell Ca2+ 
currents recorded from myocytes 
isolated from the LV apex of WT and 
caPI3Kα mice. Currents were evoked in 
response to (250 ms) voltage steps to 
test potentials between -30 and +50 mV 
from a prepulse potential of -40 mV 
(used to inactivate Na+ currents); the 
paradigm is illustrated below the 
records. Mean ± SEM Ca2+ current 
amplitudes (at +10 mV) are significantly 
higher in caPI3Kα, compared with WT, 
LV myocytes (B).  Current amplitudes 
were normalized for differences in cell 
size, and representative (C) and mean 
± SEM (D) ICa densities are illustrated. 
Values indicated are significantly 
(‡P<0.05, #P<0.01) different in caPI3Kα 
and WT LV myocytes. 
in swim-trained LV (Figure 3.5E). Additional voltage-clamp experiments revealed that 
the peak voltage-gated inward Ca2+ current (ICa) amplitudes are significantly (P<0.01) 
higher in caPI3Kα, than in WT, LV myocytes (Figure 3.9 A,B). Normalization of ICa 
amplitudes to myocyte size (Cm) revealed that inward Ca2+ current densities are also 
significantly (P<0.05) increased in caPI3Kα, compared with WT, LV myocytes (Figure 
3.9 C,D). 
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3.3.6 Repolarizing K+ currents are upregulated in Akt1-/- LV with chronic swim 
training 
The results here demonstrate that chronic exercise (swim training)-induced physiological 
hypertrophy, which results in increased PI3Kα activation, leads to the upregulation of 
repolarizing ventricular K+ and Ca2+ currents in parallel with the increase in myocyte size. 
The critical downstream effector of PI3Kα-mediated physiological hypertrophy in 
response to exercise training has been demonstrated to be the serine-threonine kinase 
Akt1 (DeBosch et al., 2006b). Indeed, animals lacking Akt1 (Akt1-/-)(Cho et al., 2001b; 
DeBosch et al., 2006b) failed to display ventricular hypertrophy with exercise training 
(DeBosch et al., 2006b).  
 
To test the hypothesis that Akt1 is also required for exercise (PI3Kα)-induced electrical 
remodeling, adult (8-10 week) Akt1-/- mice were subjected to chronic swim training for 4 
weeks. Previous studies have demonstrated that Akt1-/- mice are fertile and have a 
normal life span (Cho et al., 2001a) and that Akt2 and Akt3 expression levels in adult 
Akt1-/- mouse hearts (DeBosch et al., 2006b) are indistinguishable from WT hearts. 
Following swim training, mean ± SEM citrate synthase activity in the gastrocnemius 
muscles was increased significantly (P<0.01) to 1.01±0.12 µmol/mg protein/min (n=4), 
compared with 0.53±0.07 µmol/mg protein/min (n=4) in muscles from untrained Akt1-/-  
animals (Figure 3.10A), indicating the adequacy of exercise training (Allen et al., 2001). 
Consistent with previous suggestions that Akt1 is required for exercise training-induced 
physiological hypertrophy (DeBosch et al., 2006b), however, the LVW/TL ratio (Figure 
3.10B), as well as the mean ± SEM whole-cell membrane capacitance (Cm), a 
measurement of cell size, of isolated LV myocytes (Figure 1C), were similar in swim-
trained and untrained Akt1-/-  animals.  
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Figure 3. 10 Chronic swim training did not result in cardiac hypertrophy in Akt1-/-  animals 
 (A) Citrate synthase activity was increased significantly (P<0.01) in gastrocnemius muscles from swim-trained, compared 
with untrained,  Akt1-/- animals (n=4 in each group), indicating the adequacy of exercise training.(Allen et al., 2001)  (B) LV 
mass/tibia length (LVM/TL) ratios were determined in swim trained and untrained Akt1-/- animals (n=6 in each group); 
individual and mean ± SEM values are plotted. (C) Mean ± SEM whole-cell membrane capacitances (Cm) were similar in 
LV myocytes isolated from swim-trained and untrained Akt1-/- animals, consistent with the absence of hypertrophic growth 
in response to exercise training. 
Whole-cell voltage-clamp experiments were performed on LV myocytes isolated from 
swim-trained and untrained Akt1-/- mice. As illustrated in Figure 3.11, these experiments 
revealed that the amplitudes of the peak (IK,peak) outward voltage-gated (Kv) and inwardly 
rectifying (Kir) K+ currents were significantly higher in the LV myocytes from swim-
trained, compared with untrained, Akt1-/-  animals (P<0.05; Figure 3.11A,B,D). Kinetic 
analyses of the decay phases of the outward K+ currents revealed that the amplitudes of 
the individual Kv current components, Ito,f and Iss, were higher in swim-trained Akt1-/- LV 
myocytes (Figure 3.11D). The amplitudes of IK,slow were also increased in Akt1-/- LV 
myocytes with swim training, although the increase did not reach statistical significance. 
There were no measurable differences in the time- or the voltage-dependent properties 
of the Kv currents in LV cells from Akt1-/- mice with and without swim training (Figure 
3.11B and Table 3.2). 
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Figure 3. 11 Repolarizing K+ current amplitudes and densities were increased in LV myocytes isolated from 
swim-trained Akt1-/- animals 
 (A) Representative whole-cell K+ currents recorded from myocytes isolated from the LV apex of swim-trained and 
untrained Akt1-/- mice. Currents were evoked in response to (4.5 s) voltage steps to test potentials between -120 and +40 
mV from a holding potential (HP) of -70 mV. (B) The mean ± SEM amplitudes of the peak outward K+ currents (IK,peak) 
were significantly (‡P<0.05, #P<0.01,*P<0.001) higher in swim-trained, compared with untrained, Akt1-/-  LV myocytes. (D) 
Normalizing current amplitudes to cell size (Cm) revealed that mean ± SEM IK,peak densities were also significantly higher in 
LV myocytes from swim-trained, compared with untrained, Akt1-/- LV myocytes. The amplitudes of the individual Kv current 
components, Ito,f, IK,slow, and Iss, as well as IK1, were also measured (see Methods). Mean ± SEM Ito,f and Iss (at +40 mV) 
and IK1 (at -120 mV) current amplitudes (D) and densities (E) were significantly (‡P<0.05, #P<0.01, *P<0.001) higher in LV 
apex myocytes from swim-trained, compared with untrained, Akt1-/- animals. 
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Normalization of the measured K+ current amplitudes in individual cells to the whole cell 
capacitance (myocyte size) in the same cell revealed that similar to the current 
amplitudes, mean ± SEM repolarizing K+ current (IK,peak, Ito,f, Iss and IK1) densities were 
significantly (P<0.05) higher in Akt1-/- LV myocytes following swim training (Figure 
3.11C,E). 
Table 3. 2 Kv and Kir Currents in Swim-trained and Untrained Akt1-/-, WT+Vehicle, icaPI3Kα+Vehicle and 
icaPI3Kα+TCN LV Myocytes.* 
LV Cells  Cm  (pF) IK,peak Ito,f IK,slow Iss IK1 
Akt1-/-  untrained  141 ± 6      
(n=23) τ  (ms)  — 89 ± 6 1597 ± 112 — — 
 Amplitude (pA)  5289 ± 436 2103 ± 225 2118 ± 194 1067 ± 68 -1276 ± 80
 Density (pA/pF)  37.2 ± 2.5 14.7 ± 1.4 14.9 ± 1.1 7.6 ± 0.5 -8.4 ± 0.9 
Akt1-/-  trained  141 ±7      
(n=20)   — 75 ± 6 1303 ± 61 — — 
 Amplitude (pA)  7235 ± 523# 3387 ± 385# 2557 ± 198 1291 ± 91‡ -2471 ± 139*
 Density (pA/pF)  54.3 ± 5.4# 25.9 ± 3.4# 19.2 ± 2.1 9.3 ± 0.6‡ -12.5 ± 0.6*
WT+Vehicle  181 ± 9      
(n=33) τ  (ms)  — 121 ± 9 1097 ± 95 — — 
 Amplitude (pA)  11485 ± 659 4159 ± 314 5399 ± 391 1599 ± 91 -2677 ± 173
 Density (pA/pF)  67.2 ± 4.0 24.8 ± 2.1 31.1 ± 2.0 9.1 ± 0.4 -14.9 ± 1.0
icaPI3Kα+Vehicle  177 ± 9      
(n=24) τ  (ms)  — 109 ± 55 981 ± 55 — — 
 Amplitude (pA)  16087 ± 1139* 6424 ± 734# 6780 ± 471‡ 1837 ± 104 -3457 ± 284‡
 Density (pA/pF)  92.2 ± 5.9# 38.8 ± 4.4# 41.2 ± 3.1‡ 11.2 ± 0.7 -19.1 ± 1.4‡
icaPI3Kα+TCN  171 ± 6      
(n=21) τ  (ms)  — 90 ± 36 949 ± 30 — — 
 Amplitude (pA)  15394 ± 903* 6199 ± 493* 6563 ± 367‡ 1751 ± 94 -3077 ± 188‡
 Density (pA/pF)  96.1 ± 6.0* 35.0 ± 2.5# 37.4 ± 2.1‡ 10.0 ± 0.5 -18.8 ± 1.4‡
* All values are means ± SEM. Kv and Kir current amplitudes/densities reported here were determined at +40 mV and -
120mV, respectively. Measured K+ current amplitudes/densities in swim-trained and untrained Akt1-/- LV myocytes were 
compared and K+ currents in icaPI3Kα+Vehicle and icaPI3Kα+TCN LV myocytes were both compared to results from 
WT+Vehicle animals. Values that are significantly (‡ P<0.05, #P<0.01, *P<0.001) different are indicated. Kv indicates 
voltage-gated K+ currents; Kir, inwardly rectifying K+ currents; TCN: triciribine; Cm, cell membrane capacitance; τ, time 
constant of inactivation. 
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3.3.7 Transcriptional upregulation of ion channel subunits with chornic exercise 
training does not require Akt1  
The studies here demonstrate that the increases in ventricular K+ current amplitudes 
with chronic exercise training reflects the upregulation of the transcripts encoding the 
underlying K+ channel pore forming and accessory subunits. Subsequent experiments 
here, therefore, were aimed at determining if the observed increases in K+ current 
amplitudes in Akt1-/- LV myocytes with swim training (Figure 3.11B,C) also reflect 
increased expression of the transcripts encoding the K+ channel subunits.  
 
As illustrated in Figure 3.12, quantitative RT-PCR revealed that the expression levels of 
the transcripts encoding the Ito,f channel pore-forming (α) subunit, Kcnd2 (Kv4.2) (Guo et 
al., 2005), and the Ito,f channel accessory subunit, Kcnip2 (KChIP2) (Kuo et al., 2001; 
Guo et al., 2002), were increased significantly (P<0.05) in the LV of swim-trained, 
compared with untrained Akt1-/-, animals (Figure 3.12A). The expression levels of Kcnb1 
(Kv2.1), which encodes IK,slow2 (Xu et al., 1999a), and of the K2P channel subunit, Kcnk3 
(TASK1), which has been suggested to underlie Iss in rat cardiomyocytes (Putzke et al., 
2007), were also increased significantly (P<0.05) in swim-trained Akt1-/- LV (Figure 
3.12B). Similarly, the expression levels of the IK1 channel subunit, Kcnj12 (Kir2.2) 
(Zaritsky et al., 2001), as well as of Kcnh2 (mERG) (Sanguinetti et al., 1996), the α 
subunits encoding the rapid cardiac delayed rectifiers, IKr, in large mammals, were also 
elevated in Akt1-/- LV following swim training (Figure 3.12C,D). In addition, the 
transcripts encoding depolarizing voltage-gated Na+ and Ca2+ channel pore-forming and 
accessory subunits were also significantly (P<0.05) increased in swim-trained, compared 
with untrained, Akt1-/- LV. These results, which are similar to the results observed in WT 
animals, demonstrate that chronic exercise training leads to the transcriptional 
upregulation of both repolarizing and depolarizing cardiac ion channel subunits, 
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independent of cellular hypertrophy and Akt1. Also similar to above findings in WT mice, 
this parallel upregulation of the subunits encoding depolarizing and repolarizing 
myocardial ion channels in response to exercise training results in the maintenance of 
normal myocardial excitability: ECG waveforms in swim-trained and untrained Akt1-/- 
animals were indistinguishable (Figure 3.12F, G).  
 
Figure 3. 12 Transcriptional upregulation of ion channel subunits with chronic exercise training maintains 
electrical functioning in animals lacking Akt1 
Expression levels of transcripts encoding repolarizing K+ (A-D), as well as depolarizing Na+ and Ca2+ (E) channel subunits 
were measured in individual LV samples from swim-trained (n=6) and untrained (n=6) Akt1-/- LV, normalized to Hprt and 
subsequently to the mean value of the untrained Akt1-/-  LV samples. The mean ± SEM relative expression levels of many 
ion channel subunit transcripts were significantly (‡P<0.05, #P<0.01,*P<0.001) higher in swim-trained, than in untrained, 
Akt1-/- LV. (F) Representative ECG (lead II) waveforms from  anesthetized adult Akt1-/- mice, with and without swim-
training, are illustrated. (G) Mean ± SEM RR, PR, QRS, QT and QTc intervals in Akt1-/- animals with and without swim-
training were not significantly different. 
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3.3.8 Short-term activation of cardiac PI3Kα signaling upregulates repolarizing K+ 
currents independent of Akt 
The results here have shown that cardiac specific expression of constitutively active 
PI3Kα (caPI3Kα) mimicks the effects of exercise training, increasing repolarizing 
ventricular K+ current amplitudes and normalizing K+ current densities to the increase in 
myocyte size (hypertrophy). Also similar to exercise training, cardiac-specific expression 
of caPI3Kα results in transcriptional upregulation of the subunits encoding repolarizing 
K+ and depolarizing (Na+/Ca2+) currents. Additional experiments here, therefore, were 
designed to test the hypothesis that Akt activation is required for the upregulation of 
ventricular K+ currents and ion channel subunits in response to increased PI3Kα 
signaling. 
 
For these experiments, a mouse model previously developed and described by Yano 
and colleagues (Yano et al., 2008) with tetracycline transactivator (tet-off) controlled, 
cardiac-specific expression of caPI3Kα (icaPI3Kα), was utilized. In this transgenic 
mouse line, cardiac PI3Kα activity and Akt phosphorylation are significantly increased 
with transgene induction following the removal of dietary doxycycline for 2 weeks. Short-
term (2-8 weeks), but not chronic (>8 weeks), activation of cadiac PI3Kα in this mouse 
model does not produce significant cardiac hypertrophy, despite the marked increases in 
PI3Kα signaling activities (Yano et al., 2008). Using the protocol schematized in Figure 
3.13A, expression of the caPI3Kα transgene was induced in adult (8-10 weeks) 
icaPI3Kα animals by removing the Dox containing diet. Similar to the findings reported in 
the original description of the icaPI3Kα animals (Yano et al., 2008), removal of the Dox 
diet for 4 weeks and the resultant expression of the caPI3Kα transgene in the adult 
mouse heart did not produce measurable cardiac hypertrophy (Figure 3.13B). 
Significantly (P<0.001) increased PI3Kα signaling, however, was evident in the ~3 fold 
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increase in pAkt and in the pAkt/Akt ratio in icaPI3Kα, compared with WT, LV (Figure 
3.13C,D).  
 
Figure 3. 13 Administration of triciribine (TCN) in icaPI3Kα animals blocked the hyperphorysphorylation of 
cardiac Akt. 
(A) Schematic illustration of the caPI3Kα transgene induction and the pan-Akt inhibitor triciribine (TCN) injection protocol 
in icaPI3Kα animals. (B) LVW/TL ratios were similar in WT+Vehicle, icaPI3Kα+Vehicle and icaPI3Kα+TCN animals. (C) 
Representative Western blots of fractionated LV proteins from WT+Vehicle, icaPI3Kα+Vehicle and icaPI3Kα+TCN 
animals (n=4 in each group) probed with anti-pAkt and anti-total Akt antibodies. The expression level of pAkt in each lane 
on each blot was measured and normalized to the expression of total-Akt in the same lane on the same blot. Mean 
pAkt/Akt ratios in the LV from icaPI3Kα animals, vehicle- or TCN-treated, were expressed relative to the mean value in the 
control (WT+Vehicle) LV samples. (D) Mean ± SEM pAkt/Akt ratio is significantly (*P<0.001) higher in icaPI3Kα+Vehicle, 
compared with WT+Vehicle, LV. In addition, 4 week administration of TCN significantly (*P<0.001) reduced the 
phosphorylation of Akt in icaPI3Kα LV (see text).   
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Voltage-clamp recordings revealed that the amplitudes of IK,peak and IK1, as well as of the 
Kv current components, Ito,f and IK,slow, were increased significantly (P<0.05) in icaPI3Kα, 
compared with WT, LV myocytes (Figure 3.14A, B); the mean ± SEM amplitude of Iss 
was also higher in icaPI3Kα LV myocytes, although this increase was not statistically 
significant. Although the amplitudes were increased, the time- and voltage-dependent 
properties of Ito,f and IK,slow in icaPI3Kα and WT cells were not significantly different 
(Table 3.2). Interestingly, the mean Cm (Figure 3.14C) values determined in icaPI3Kα 
and WT LV myocytes were similar, revealing that cellular hypertrophy is not evident 
following 4 weeks of induced caPI3Kα expression. These observations are consistent 
with the absence of LV hypertrophy in icaPI3Kα animals (Figure 3.13B). The increased 
K+ current amplitudes (Figure 3.14B) in icaPI3Kα LV myocytes, therefore, translate 
directly into increased K+ current densities (Figure 3.14D). With the exception of Iss, 
repolarizing K+ current densities were increased significantly in icaPI3Kα, than in WT, LV 
cells (Figure 3.14D).  
 
To block Akt activation (hyperphosphorylation) in parallel with the induction of caPI3Kα 
transgene expression, a pan-Akt inhibitor triciribine (TCN) was administered (0.5 
mg/kg/day, i.p.) daily to icaPI3Kα animals simultaneous with the removal of Dox diet 
(Figure 3.13A) for four weeks. The hyperphosphorylation of Akt in icaPI3Kα LV was 
completely abrogated with 4 weeks of TCN treatment (Figure 3.13C, D), indicating the 
successful blockade of Akt activation. As illustrated in Figure 5, however, the amplitudes 
of the repolarizing K+ currents, Ito,f, IK,slow, and IK1 were increased significantly (P<0.05) in 
LV myocytes isolated from icaPI3Kα+TCN animals (Figure 3.14A, B). Normalizing the 
current amplitudes to measured Cm revealed that mean ± SEM IK,peak, Ito,f, IK,slow and IK1 
densities were also higher (Figure 3.14D) in icaPI3Kα+TCN, compared to WT, cells.   
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Figure 3. 14 Short-term activation of cardiac PI3Kα signaling upregulates repolarizing K+ currents in an Akt-
independent manner. 
 (A) Representative whole-cell K+ currents were recorded from LV myocytes isolated from WT+Vehicle, icaPI3Kα+Vehicle 
and icaPI3Kα+TCN animals. (B) Mean ± SEM IK,peak, Ito,f and IK,slow amplitudes in icaPI3Kα+Vehicle (n=24) were markedly 
increased compared with WT+Vehicle (n=33) LV myocytes; the increases in K+ current amplitudes (IK,peak, Ito,f, IK,slow and 
IK1) in icaPI3Kα LV myocytes persisted with TCN treatment (n=21). (C) Mean ± SEM Cm values were similar in 
WT+Vehicle, icaPI3Kα+Vehicle and icaPI3Kα+TCN LV myocytes. (D) Normalization of current amplitudes for differences 
in cell size (Cm) revealed that mean ± SEM IK,peak, Ito,f, IK,slow and IK1 densities were significantly (‡P<0.05, #P<0.01, 
*P<0.001) higher in icaPI3Kα+vehicle, than in WT+Vehicle, LV myocytes. The repolarizing K+ current densities in icaPI3Kα 
LV myocytes remained increased despite the inhibition of Akt activation.  
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3.4 Transcriptional Upregulation of Ion Channel Subunits by Enhanced PI3Kα 
Signaling is Akt-Independent 
Quantitative RT-PCR experiments were conducted to examine ion channel subunit 
expression levels in the LV of WT+Vehicle, icaPI3Kα+Vehicle and icaPI3Kα+TCN mice. 
Consistent with the observed increases in K+ current amplitudes, the expression levels 
of the Ito,f channel subunit, Kv4.2, the IK,slow1 pore-forming subunit Kv1.5, the putative Iss 
subunit, TASK1, and the IK1 channel subunit, Kir2.1, were also higher in 
icaPI3Kα+Vehicle, compared to WT+Vehicle, LV (Figures 3.15A-C). In addition, the 
transcript expression of voltage-gated Na+ and Ca2+ channel subunits was increased in 
the LV of icaPI3Kα+Vehicle, than in WT+Vehicle, animals (Figure 3.15D). The 
transcriptional upregulation of these ion channel subunits by enhanced PI3Kα signaling, 
however, was not affected by TCN treatment, revealing that PI3Kα-mediated 
transcriptional upregulatioin of ion channel subunits is independent of Akt activation.  
 Figure 3.15 Transcriptional 
upregulation of ion channel 
subunits with activation of 
PI3Kα signaling is 
independent of Akt. 
Channel subunit transcript 
expression levels were 
measured in individual LV 
samples from WT+Vehicle, 
icaPI3Kα+Vehicle and 
icaPI3Kα+TCN LV (n=6 in 
each group), normalized to 
Hprt in the same sample and 
to the mean value of the WT+Vehicle control LV samples. The expression levels of the transcripts encoding several K+ 
(A,B,C), as well as Na+ and Ca2+ (D), channel subunits were increased significantly (‡P<0.05, *P<0.001) in 
icaPI3Kα+Vehicle, compared with WT+Vehicle, LV. In addition, the increases in the expression of the channel subunit 
transcripts with PI3Kα induction were not affected by inhibition of Akt.   
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3.4 Discussion 
Aerobic exercise training helps to preserve cardiac function, reducing detrimental 
ventricular remodeling and improving survival in animal models of heart failure 
(McMullen et al., 2007) and pressure/volume overload-induced LV hypertrophy 
(McMullen et al., 2003; Lachance et al., 2009). Several mechanisms have been 
proposed to account for the beneficial effects of exercise, including increased myocardial 
perfusion (Hambrecht et al., 2000b), balanced autonomic nervous input (Coats et al., 
1992), improved myocardial energy metabolism (O'Neill et al., 2007), reduced 
myocardial fibrosis (McMullen et al., 2003), and/or calcium handling (Medeiros et al., 
2008). The results here demonstrate that exercise training, as well as the resulting 
increased PI3Kα signaling, also maintain normal electrical function through the 
transcriptional upregulation of ion channels in proportion to the increase in myocyte size.  
 
The phosphoinositide-3-kinases (PI3Ks) are a family of enzymes with both protein and 
lipid kinase activity that are known to be involved in many cellular processes (Cantley, 
2002). PI3Kα is a heterodimeric lipid kinase with a 110 kDa catalytic subunit (p110α) and 
an 85 kDa regulatory subunit (p85) (Cantley, 2002) that is activated upon stimulation of 
insulin or growth factor receptor-coupled tyrosine kinases (Cantley, 2002). Activation of 
PI3Kα catalyzes the conversion of the membrane lipid PIP2 to PIP3, which in turn, 
recruits and activates downstream signaling cascades, most notably those involving Akt 
which link PI3Kα to myocyte growth, hypertrophy, proliferation, survival, metabolism, 
aging and regeneration (Sussman et al., 2011).  The results of the experiments detailed 
here, however, surprisingly revealed that Akt, despite its ubiquitous importance across a 
wide range of cellular processes, is not required for PI3Kα-mediated myocardial 
electrical remodeling. 
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3.4.1 Physiological ventricular hypertrophy in swim-trained and caPI3Kα mice 
Ventricular hypertrophy is clearly evident in swim-trained and in caPI3Kα mice. 
Consistent with the increase in left ventricular mass, membrane capacitance 
measurements demonstrated that LV myocytes from swim-trained and caPI3Kα animals 
are significantly (P<0.001) larger than control LV myocytes. Direct histological 
examination revealed increased LV myocyte cross-sectional area in swim-trained, 
compared with control, animals without interstitial fibrosis (Figure 1B). The expression of 
ANF, a molecular marker of pathological hypertrophy (McMullen & Jennings, 2007), is 
not increased in swim-trained or caPI3Kα LV. Consistent with previous reports 
(McMullen et al., 2003; McMullen et al., 2007), therefore, swim-training and cardiac-
specific activation of PI3Kα signaling result in physiological hypertrophy.  
 
3.4.2 Upregulation of ionic currents in swim-trained and caPI3Kα LV myocytes 
The amplitudes of the repolarizing Kv (Ito,f, IK,slow and Iss) and Kir (IK1) currents are 
markedly increased in LV myocytes from both swim-trained and caPI3Kα mice. 
Importantly, the time and voltage-dependent properties of the currents are 
indistinguishable from control LV myocytes, suggesting that the higher amplitudes of the 
K+ currents in swim-trained and caPI3Kα LV myocytes reflect increases in the numbers 
of functional K+ channels, rather than changes in channel properties. The increases in K+ 
current amplitudes are sufficient to compensate for the cellular hypertrophy, normalizing 
K+ current densities in swim-trained and caPI3Kα myocytes to levels similar to controls. 
In fact, Iss and IK1 densities are actually higher in LV myocytes from both swim-trained 
and caPI3Kα animals. In caPI3Kα LV myocytes, IK,slow densities are also higher than in 
WT cells. The results here clearly suggest that the observed upregulation of K+ currents 
with exercise training is directly related to the activation of PI3Kα signaling pathways. 
Establishment of this direct link warrants further investigation and would be of direct 
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interest to the development of therapeutic strategies aimed at normalizing/increasing K+ 
channel expression in pathological hypertrophy. 
 
Although increased outward K+ current densities can lead to abbreviated myocardial 
action potential durations and shortened QT intervals (Brugada et al., 2004; Priori et al., 
2005), no differences in action potential durations or QT intervals were observed in 
swim-trained or caPI3Kα, compared with control myocytes/animals. The normalization of 
action potential waveform and QT intervals likely reflects the fact that inward Ca2+ 
current densities are also increased in physiological hypertrophy, in parallel with the 
increases in repolarizing K+ currents. 
 
3.4.3 Molecular mechanisms underlying the homeostatic regulation of myocardial 
excitability  
The results presented here demonstrate that the observed increases in myocardial 
membrane currents in physiological hypertrophy primarily reflect increased expression of 
the transcripts encoding the underlying ion channel subunits.  One exception to this 
generality is Kcna5, which encodes Kv1.5, and underlies mouse ventricular IK,slow1 
(London et al., 2001b); Kcna5 transcript expression was not measurably increased in 
swim-trained or caPI3Kα LV. It is possible that increased expression of Kv2.1, which 
underlies IK,slow2  (Xu et al., 1999a), alone is sufficient to account for the increase in IK,slow 
amplitudes in swim-trained and caPI3Kα LV myocytes. It is also possible that Kv1.5 
protein expression is increased by post-transcriptional mechanisms and contributes to 
the observed increases in IK,slow amplitudes. The lack of a reliable anti-Kv1.5 specific 
antibody precludes a direct test of this hypothesis. Finally, additional post-transcriptional 
as well as post-translational mechanisms may contribute to the observed increases in 
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functional channel expression (i.e., increases in current amplitudes and densities) with 
physiological hypertrophy. 
 
3.4.4 Exercise training-induced electrical remodeling is independent of cellular 
hypertrophy and Akt1 
As reported previously, the results here demonstrate that genetic deletion of Akt1 
disrupts hypertrophic growth in response to chronic exercise training (Figure 3.10B,C). 
The observation that repolarizing K+ current amplitudes and the expression of multiple 
ion channel subunits are upregulated in swim-trained Akt1-/- animals suggests that the 
“electrical remodeling” induced by exercise training does not require the presence of 
Akt1 and is, therefore, also completely disconnected from cellular hypertrophy. The 
disconnection between electrical remodeling and the global increases in RNA synthesis 
accompanying exercise training-induced hypertrophy (Hannan et al., 2003) implies a 
unique regulatory mechanism coordinating myocardial ion channel gene expression, 
independent of the general transcriptional machinery that is robustly activated in 
response to hypertrophic stimuli such as exercise training.  
 
Although it would certainly be of interest to utilize a similar experimental strategy to 
determine if Akt2, the only other Akt robustly expressed in the myocardium (Muslin & 
DeBosch, 2006), is required for exercise training-induced ion channel upregulation, it 
has been reported previously that adult Akt2-/- animals have severe hyperglycemia(Cho 
et al., 2001a) and evidence of diabetic cardiomyopathy (Etzion et al., 2010). Several 
previous studies have demonstrated alterations in ionic currents and ion channel subunit 
expression levels in rodent models of diabetic cardiomyopathy (Qin et al., 2001; 
Marionneau et al., 2008a). The diabetic phenotype of the Akt2-/- mice, therefore, seems 
likely to complicate the quantification of ionic currents and ion channel subunit 
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expression levels at baseline and with exercises, compromising the interpretation of 
experimental results. As an alternative approach, we examined the effects of an 
inhibitor, triciribine (TCN), which blocks both Akt1 and Akt2 in parallel with increased 
expression of PI3Kα.  
 
3.4.5 Increased PI3Kα activities upregulates K+ current and ion channel subunit 
expression independent of Akt signaling 
The experiments conducted using the tet-off inducible caPI3Kα mouse model 
demonstrate that short-term activation of cardiac PI3Kα signaling also upregulates K+ 
currents and the expression of ion channel subunit transcripts. Inhibition of cardiac Akt 
(both Akt1 and Akt2) activation in the context of enhanced PI3Kα signaling did not 
prevent the upregulation of myocardial K+ currents and ion channel subunit transcripts, 
suggesting that the impact of PI3Kα signaling on myocardial “electrical remodeling” is 
independent of Akt signaling. These results extend the findings obtained in the Akt1-/- 
exercise training experiments and suggest that both Akt1 and Akt2 are dispensable for 
PI3Kα-mediated electrical remodeling. The pharmacological approach of simultaneously 
blocking both Akt1 and Akt2 avoids several potential caveats in the interpretation of data 
obtained from animals lacking Akt1 or Akt2. First, this approach ruled out the role of Akt2 
in PI3Kα-mediated electrical remodeling without using Akt2-/- animals, for which, as 
discussed above, the quantification of ionic currents and channel subunit expression 
might be complicated by the presence of the diabetic phenotype. Secondly, the 
interpretation of negative results obtained from either Akt1-/- or Akt2-/- animals requires 
taking into consideration the potential functional redundancy between Akt1 and Akt2. 
Theoretically, using animals lacking both Akt1 and Akt2 (Akt1-/-/Akt2-/-) might solve this 
issue. This, however, is not feasible as mice lacking both Akt1 and Akt2 die shortly after 
birth (Peng et al., 2003).  
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Interestingly, it has been shown that PI3Kα activation is also critical in mediating 
myocardial metabolic remodeling in physiological hypertrophy, including increased 
capacity to oxidize fatty acids/glucose and increased mitochondrial biogenesis, and that 
this metabolic remodeling mediated by PI3Kα is also Akt-independent (O'Neill et al., 
2007). Taken together, these results demonstrate that PI3Kα signaling exerts distinct 
biological effects on the myocardium through divergent downstream pathways: Akt1-
dependent physiological cardiac growth, Akt2-dependent insulin-sensitization and 
cellular survival, as well as Akt-independent effects on metabolic and electrical 
remodeling. The signaling mechanisms linking PI3Kα to metabolic and electrical 
remodeling have not been defined, although it has been suggested that PKCλ/ζ could be 
the potential downstream mediator that is required for PI3Kα-dependent metabolic 
remodeling (O'Neill et al., 2007). Interestingly, PI3Kα has also been shown previously to 
modulate the activities of a number of transcription factors, such as FOXO (Philip-
Couderc et al., 2008) or NFκB (Brunet et al., 1999; Panama et al., 2011), that could 
potentially affect cardiac ion channel expression. Further studies are required to explore 
these hypotheses directly and to identify the downstream signaling effectors that 
mediate myocardial electrical remodeling in response to PI3Kα activation.  
 
3.4.6 Conclusions 
Taken together, the results presented here demonstrate that physiological cardiac 
hypertrophy, induced by exercise-training or transgenic activation of PI3Kα (a critical 
regulator of exercise-induced heart growth) signaling, is associated with increased 
expression of myocardial ion channel subunits in proportion to increased myocyte size 
and the global increases in RNA and protein expression. The resulting homeostatic 
regulation of myocardial electrical excitability clearly distinguishes physiological from 
pathological cardiac hypertrophy, which is associated with marked reductions in the 
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densities of repolarizing K+ currents, action potential prolongation and increased risk of 
arrhythmias (McIntyre & Fry, 1997; Haider et al., 1998; Marionneau et al., 2008b). The 
experiments here also demonstrate that the transcriptional upregulation of ion channel 
subunits (the “electrical remodeling”) induced by enhanced PI3Kα signaling, unlike 
hypertrophic growth or insulin sensitization, is Akt-independent. These observations 
suggest a multifaceted role of PI3Kα signaling in regulating myocardial functioning 
through distinct downstream signaling mediators. In addition, the studies here suggest 
that activating PI3Kα signaling pathways might be a useful therapeutic strategy to 
normalize the expression of K+ currents in pathological cardiac hypertrophy and in other 
cardiac diseases associated with reduced K+ current densities and impaired 
repolarization, thereby reducing the risk of life-threatening arrhythmias. Additional 
studies are needed to explore directly the hypothesis that activation of PI3Kα signaling 
pathways will impact the incidence of arrhythmias and the risk of sudden cardiac death 
in pathological hypertrophy.  
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4.1 Abstract  
Aims: Cardiac hypertrophy and heart failure are associated with QT prolongation and 
lethal ventricular arrhythmias, resulting from decreased K+ current densities and 
impaired repolarization. Recent studies in mouse models of physiological cardiac 
hypertrophy revealed that increased phosphoinositide-3-kinase-α (PI3Kα) signaling 
results in the upregulation of K+ channels and the normalization of ventricular 
repolarization. The experiments here were undertaken to test the hypothesis that 
increased PI3Kα signaling will counteract the adverse electrophysiological remodeling 
associated with pathological hypertrophy and heart failure.  
Methods and Results: In contrast to wild-type mice, left ventricular (LV) hypertrophy, 
induced by transverse aortic constriction (TAC), did not result in prolongation of 
ventricular action potentials or QT intervals in mice with cardiac-specific expression of 
constitutively active PI3Kα (caPI3Kα). Indeed, repolarizing K+ currents and K+ channel 
subunit transcripts were increased in caPI3Kα+TAC LV myocytes in proportion to the 
TAC-induced cellular hypertrophy. Congestive heart failure in a transgenic model of 
dilated cardiomyopathy model is accompanied by prolonged QT intervals and ventricular 
action potentials, reduced K+ currents and K+ channel transcripts. Increased PI3Kα 
signaling, but not renin-angiotensin system blockade, in this model also results in 
increased K+ currents and improved ventricular repolarization.  
Conclusion: In the setting of pathological hypertrophy or heart failure, enhanced PI3Kα 
signaling results in the upregulation of K+ channel subunits, normalization of K+ current 
densities and preserved ventricular function. Augmentation of PI3Kα signaling, therefore, 
may be a useful and unique strategy to protect against the increased risk of ventricular 
arrhythmias and sudden death associated with cardiomyopathy.  
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4.2 Introduction  
Left ventricular (LV) dysfunction is associated with increased risk of life-threatening 
arrhythmias (Tomaselli et al., 1994; Haider et al., 1998). Sudden cardiac death, 
presumably due to lethal ventricular arrhythmias, accounts for approximately 50% of 
deaths in individuals with heart failure (Tomaselli et al., 1994). Electrical remodeling in 
cardiac hypertrophy (Mayet et al., 1996; McIntyre & Fry, 1997) and heart failure 
(Beuckelmann et al., 1993) results, at least in part, from reductions in the densities of 
repolarizing K+ currents (Beuckelmann et al., 1993; Marionneau et al., 2008b), which can 
lead to action potential prolongation and increased dispersion of repolarization, both of 
which are arrhythmogenic. Despite advances in pharmacological and device therapies 
for LV dysfunction, none purposefully targets fundamental arrhythmia mechanisms at the 
level of ion channel remodeling (Jessup & Brozena, 2003).  
 
It was recently demonstrated that physiological hypertrophy, induced by exercise training 
or by cardiac-specific expression of constitutively active PI3Kα (caPI3Kα), is associated 
with transcriptional upregulation of the subunits encoding repolarizing K+ channels (Yang 
et al., 2010). This upregulation results in increased repolarizing K+ current amplitudes in 
proportion to the cellular hypertrophy, thereby normalizing ventricular K+ current 
densities, action potential waveforms, and QT intervals. These observations suggest that 
activating the PI3Kα signaling pathway could be a therapeutic strategy in pathological 
cardiac hypertrophy and heart failure to maintain K+ current densities and reduce the risk 
of life-threatening ventricular arrhythmias.  
 
To test this hypothesis, the impact of increased PI3Kα signaling was examined in: (1) a 
mouse model of non-failing, pressure overload-induced pathological left ventricular 
hypertrophy (LVH), produced by transverse aortic constriction (TAC) (Marionneau et al., 
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2008b); and, (2) a transgenic mouse model (TG9) of dilated cardiomyopathy and 
consequent congestive heart failure (Buerger et al., 2006; McMullen et al., 2007). These 
experiments revealed that enhanced PI3Kα signaling results in transcriptional 
upregulation of repolarizing K+ channel subunits, leading to increased K+ current 
amplitudes, thereby normalizing ventricular K+ current densities, action potential 
waveforms and functioning.  
4.3 Results  
4.3.1 Increased PI3Kα signaling prevents the ECG changes associated with 
pressure-overload induced LVH  
Similar to wild-type (WT) mice (Marionneau et al., 2008b), TAC produced LVH in 
caPI3Kα mice (McMullen et al., 2007). The mean ± SEM left ventricular mass to tibia 
length ratio (LVM/TL), for example, was significantly (P<0.001) higher (by 29 ± 6 %) in 
caPI3Kα+TAC, than in control caPI3Kα (Figure 4.1A), animals. In addition, expression 
of ANF, a marker of pathological hypertrophy, was increased significantly (P<0.01) in 
caPI3Kα+TAC, compared with control caPI3Kα, LV (Figure 4.1B). Interestingly, ECG 
recordings (Figure 4.1C) revealed that the morphologies of the QRS complexes, P, J 
and T waves (Figure 4.1C), as well as the durations of the RR, PR, QRS, QT and 
corrected QT (QTc) intervals (Figure 4.1D), were indistinguishable in caPI3Kα control 
and caPI3Kα+TAC animals. These observations contrast markedly with the ECG 
abnormalities (prolonged QTc intervals and flattened J waves) observed in WT mice with 
TAC-induced LVH (Figure 4.1 inset (Marionneau et al., 2008b)). In spite of the marked 
increases in LV mass and ANF expression, the ECG changes were not observed in 
caPI3Kα animals with TAC (Figure 4.1 C,D).  
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Figure 4. 1 Increased PI3Kα 
signaling prevents ECG and 
action potential waveform 
abnormalities associated 
with pressure overload-
induced LVH following 
transverse aortic constriction 
(TAC). 
(A) LV mass/tibia length 
(LVM/TL) ratios were 
determined in caPI3Kα control 
(n=6) and caPI3Kα+TAC (n=6) 
animals; individual and mean ± 
SEM values (*P<0.001) are 
plotted. (B) Mean ± SEM (n=6) 
relative transcript expression 
level of atrial natriuretic factor 
(ANF) is significantly (#P<0.01) 
higher in caPI3Kα+TAC than in 
caPI3Kα control LV. (C) 
Representative ECG (lead II) 
waveforms from caPI3Kα mice 
with and without TAC are 
illustrated; individual beats are 
shown on an expanded 
timescale on the right in each 
panel. (D) Mean ± SEM RR, 
PR, QRS, QT and QTc intervals measured in caPI3Kα+TAC (n=6) and caPI3Kα control (n=6) animals were not 
significantly different. Inset: In contrast to the findings in caPI3Kα animals, and as reported previously,(Marionneau et al., 
2008b) TAC in WT animals results in J point suppression and QT prolongation. (E) Action potential waveforms in LV 
myocytes from caPI3Kα control and caPI3Kα+TAC animals are indistinguishable. (F) No significant differences in mean ± 
SEM resting membrane potentials (Vm), action potential amplitudes (APA) or action potential durations at 50% (APD50) 
and 90% (APD90) repolarization were observed in caPI3Kα control (n=10) and caPI3Kα+TAC (n=9) LV myocytes.  
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4.3.2 Increased PI3Kα signaling prevents TAC-induced action potential 
prolongation 
In WT mice, TAC-induced LVH results in impaired repolarization and prolonged action 
potential durations (Marionneau et al., 2008b). The observation that ECG waveforms in 
caPI3Kα animals were not measurably affected by TAC (Figure 4.1 C,D) suggests that 
augmented PI3Kα signaling abrogates the detrimental effects of pressure overload-
induced LVH on ventricular repolarization. To test this hypothesis directly, current clamp 
recordings were obtained from LV myocytes isolated from caPI3Kα+TAC and caPI3Kα 
control animals. As shown in Figure 4.1E, action potential waveforms in caPI3Kα+TAC 
and caPI3Kα control LV myocytes were indistinguishable. Additionally, no significant 
differences in mean resting membrane potentials, action potential amplitudes or action 
potential durations at 50% (APD50) and 90% (APD90) repolarization in caPI3Kα+TAC and 
caPI3Kα control LV myocytes were observed (Figure 4.1F).  
  
4.3.3 Repolarizing K+ current amplitudes are increased in caPI3Kα+TAC LV 
myocytes  
Studies conducted on experimental models of pressure overload-induced LVH have 
consistently reported reductions in repolarizing LV K+ current densities (Volk et al., 
2001b; Marionneau et al., 2008b), resulting in impaired repolarization (prolonged 
ventricular APDs and QT/QTc intervals) (Marionneau et al., 2008b) and predisposing to 
life-threatening ventricular arrhythmias (McIntyre & Fry, 1997). The finding that no 
electrical abnormalities were evident in caPI3Kα animals with pressure overload-induced 
LVH suggests that increased PI3Kα signaling results in upregulation of K+ currents, in 
parallel with the increase in myocyte size, and the normalization of K+ current densities. 
To explore this hypothesis, voltage-clamp recordings were obtained from LV apex 
myocytes isolated from caPI3Kα control and caPI3Kα+TAC animals. As illustrated in  
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Figure 4. 2 Repolarizing K+ current amplitudes are increased and K+ current densities are normalized in 
caPI3Kα+TAC LV myocytes. 
 (A) Representative whole-cell K+ currents recorded from myocytes isolated from the LV apex of caPI3Kα control and 
caPI3Kα+TAC mice. Currents were evoked in response to (4.5 s) voltage steps to test potentials between -120 and +40 
mV from a holding potential (HP) of -70 mV. (B) The mean ± SEM amplitudes of the K+ currents are significantly (‡P<0.05, 
#P<0.01,*P<0.001) higher in caPI3Kα+TAC, compared with caPI3Kα control, LV myocytes. (C) A significant (#P<0.01) 
increase in mean ± SEM whole-cell membrane capacitance (Cm), consistent with cellular hypertrophy, is also evident in 
caPI3K+TAC LV myocytes. (D) Normalizing current amplitudes for differences in cell size (Cm) revealed that mean ± SEM 
K+ current densities in LV myocytes from caPI3Kα+TAC and caPI3Kα control animals are indistinguishable. Inset: As 
reported previously,(Marionneau et al., 2008b) IK,peak, Ito,f, IK,slow and IK1amplitudes are not increased in WT LV myocytes 
with TAC and current densities are decreased significantly (‡P<0.05, #P<0.01).  
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Supplemental Figure 4. 1 Kv and Kir Currents in caPI3Kα, caPI3Kα+TAC, WT and WT+TAC LV Myocytes. 
LV Cells  Cm  (pF) IK,peak Ito,f IK,slow Iss IK1 
caPI3Kα  198 ± 7      
(n=31) d (ms)  — 115 ± 12 1067 ± 41 — — 
 Amplitude (pA)  12261 ± 668 4841 ± 434 5746 ± 359 1674 ± 122 -2428 ± 152 
 Density (pA/pF)  65.3 ± 4.5 26.2 ± 2.6 30.5 ± 2.3 8.6 ± 0.6 -12.4 ± 0.8 
caPI3Kα 
+TAC 
 230 ± 6#      
(n=45) d (ms)  — 106 ± 10 1003 ± 30 — — 
 Amplitude (pA)  16165 ± 681* 6611 ± 422# 7035 ± 379‡ 2458 ± 125* -2936 ± 160‡ 
 Density (pA/pF)  70.6 ± 3.2 29.4 ± 2.1 30.4 ± 1.7 10.7 ± 0.6 -12.5 ± 0.6 
WT  158 ± 6      
(n=26) d (ms)  — 76 ± 6 996 ± 29 — — 
 Amplitude (pA)  9782 ± 534 4524 ± 304 4202 ± 278 1056 ± 70 -1959 ± 111 
 Density (pA/pF)  63 ± 3.1 29.3 ± 2.0 26.8 ± 1.4 6.8 ± 0.4 -12.2 ± 0.6 
WT+TAC  184 ± 8#      
(n=18) d (ms)  — 94 ± 9 1087 ± 47 — — 
 Amplitude (pA)  8842 ± 794 3549 ± 424 3922 ± 407 1307 ± 58‡ -1717 ± 97 
 Density (pA/pF)  48.5 ± 4.0# 19.6 ± 2.3# 21.3 ± 2.0‡ 7.6 ± 0.5 -9.4 ± 0.5# 
* All values are means ± SEM. Kv and Kir current amplitudes/densities reported here were determined at +40 mV and -
120mV, respectively.  Measured current amplitudes/densities in caPI3Kα+TAC and control caPI3Kα LV myocytes or WT 
and WT+TAC LV myocytes were compared. For each of these comparisons, values that are significantly (‡ P<0.05, 
#P<0.01, *P<0.001) different are indicated. Kv indicates voltage-gated K+ currents; Kir, inwardly rectifying K+ currents; 
TAC, transverse aortic constriction; Cm, cell membrane capacitance. 
Figure 4.2, these experiments revealed that the amplitudes of the peak (IK,peak) outward 
voltage-gated (Kv) and the inwardly rectifying (Kir) K+ currents were significantly higher 
in caPI3Kα+TAC, compared with caPI3Kα control, LV myocytes (P<0.05; Figure 4.2B). 
Kinetic analyses of the decay phases of the outward K+ currents revealed that the 
amplitudes of the individual Kv current components, Ito,f, IK,slow and Iss, were higher in 
caPI3Kα+TAC LV myocytes (Figure 4.2B). There were no measurable differences in the 
time- or the voltage-dependent properties of the Kv currents in cells from caPI3Kα 
control and caPI3Kα+TAC mice (Supplementary Table 4.1). Consistent with TAC-
induced LVH, cellular hypertrophy was clearly evident in caPI3Kα+TAC LV myocytes 
(Figure 4.2C); the mean whole-cell membrane capacitance (Cm) was significantly 
(P<0.01) higher in caPI3Kα+TAC, than in caPI3Kα control, LV cells (Figure 4.2C). 
Normalization of the Kv and Kir (IK1) current amplitudes (Figure 4.2 B) to the measured 
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Cm values (in the same cell) revealed that repolarizing K+ current densities in 
caPI3Kα+TAC and caPI3Kα control LV cells were indistinguishable (Figure 4.2 A,D). 
These results are in striking contrast to observations in WT animals with TAC-induced 
LVH (Marionneau et al., 2008b). Indeed, the amplitudes of the individual K+ currents 
(except for Iss) were not increased in WT cells in response to TAC and, when normalized 
to the increase in cell size (Cm), repolarizing K+ current densities were actually 
decreased significantly in WT LV cells with TAC (Figure 4.2 inset and Supplementary 
Table 4.1).  
 
4.3.4 Transcriptional upregulation of K+ channel subunits in caPI3Kα+TAC LV   
Recent studies demonstrated that the increase in ventricular K+ current amplitudes with 
enhanced myocardial PI3Kα signaling reflects the upregulation of the transcripts 
encoding the underlying K+ channel subunits (Yang et al., 2010). Subsequent 
experiments here, therefore, were aimed at determining if the observed increases in K+ 
current amplitudes in caPI3Kα LV myocytes with TAC (Figure 4.2B) might also reflect 
increased expression of the transcripts encoding the various repolarizing K+ channel 
subunits. As illustrated in Figure 4.3, quantitative RT-PCR revealed that the expression 
levels of the transcripts encoding Ito,f channel pore-forming (α) subunits, Kcnd2 (Kv4.2) 
(Guo et al., 2005) and Kcnd3 (Kv4.3) (Guo et al., 2002), as well as the Ito,f channel 
accessory subunit, Kcnip2 (KChIP2) (Kuo et al., 2001; Guo et al., 2002), were increased 
significantly (P<0.05) in caPI3Kα+TAC, compared with caPI3Kα control, LV (Figure 
4.3A). The expression levels of Kcna5 (Kv1.5) and Kcnb1 (Kv2.1), which encode IK,slow1 
(London et al., 2001b) and IK,slow2 (Xu et al., 1999a), respectively, as well as of the K2P 
channel subunit Kcnk3 (TASK1), which has been suggested to underlie Iss in rat 
cardiomyocytes (Putzke et al., 2007), were also increased significantly (P<0.05) in 
caPI3Kα+TAC LV (Figure 4.3A).  
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Figure 4. 3 Transcriptional 
upregulation of K+ channel 
subunits with TAC-induced 
LVH in caPI3Kα LV. 
K+ channel subunit transcript 
expression levels were 
measured in individual LV 
samples from caPI3Kα+TAC 
(n=6) and caPI3Kα control (n=6) 
LV, normalized to lamin A/C and 
subsequently to the mean value 
of the caPI3Kα control LV 
samples (A-C). The mean ± 
SEM relative expression levels 
of most of the K+ channel subunit transcripts are significantly (‡P<0.05,#P<0.01,*P<0.001) higher in caPI3Kα+TAC, than in 
caPI3Kα control, LV. 
Similarly, expression of the IK1 channel subunits Kcnj2 (Kir2.1) and Kcnj12 (Kir2.2) 
(Zaritsky et al., 2001), as well as of Kcnh2 (mERG) (Sanguinetti et al., 1995) and Kcnq1 
(KvLQT1) (Sanguinetti et al., 1996), the α subunits encoding the rapid and slow cardiac 
delayed rectifiers, IKr and IKs, in large mammals, were also increased in caPI3Kα+TAC 
LV (Figure 4.3B,C). In contrast with WT animals (Marionneau et al., 2008b), therefore, 
the expression levels of a number of K+ channel subunits were actually upregulated in 
caPI3Kα ventricles with TAC (see 4.4 Discussion).  
 
4.3.5 Increased PI3Kα signaling attenuates ECG and action potential abnormalities 
in a mouse model of dilated cardiomyopathy 
To test the hypothesis that increased PI3Kα signaling might also ameliorate the electrical 
abnormalities in failing hearts, additional experiments were conducted using a transgenic 
mouse model of dilated cardiomyopathy (TG9) (Buerger et al., 2006). 
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Figure 4. 4 Increased cardiac PI3Kα signaling attenuates the ECG and action potential abnormalities in a 
transgenic mouse model (TG9) of heart failure. 
 (A) Representative ECG waveforms from WT, TG9, and caPI3KαxTG9 mice. (B) Mean ± SEM PR, QRS, QT and QTc 
intervals are significantly (#P<0.01, *P<0.001) prolonged in TG9 (n=6), compared with WT (n=6), animals. Interestingly, 
mean QT and QTc intervals in caPI3KαxTG9 mice are significantly (‡P<0.05) shorter than in TG9 mice. (C) 
Representative action potential waveforms recorded from LV myocytes isolated from WT, TG9 and caPI3KαxTG9 animals 
are shown. (D) Mean ± SEM APD50 and APD90 were significantly (*P<0.001) longer in TG9 (n=10) than in WT (n=16) LV 
myocytes. Increased PI3Kα signaling significantly (#P<0.01) attenuates the APD prolongation (C,D) seen in TG9 LV 
myocytes. 
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As reported previously (Buerger et al., 2006), TG9 mice develop progressive dilated 
cardiomyopathy, beginning at 6 weeks of age, and die of overt heart failure at 11-13 
weeks. Surface ECG recordings revealed that QT and QTc intervals were significantly 
(P<0.001) prolonged in (10 week) TG9, compared with WT, mice (Figure 4.4A,B), 
indicating impaired ventricular repolarization, reminiscent of the electrical abnormalities 
observed in heart failure patients (Barr et al., 1994) and in animal models of heart failure 
(Adamson & Vanoli, 2001; Rose et al., 2005). Interestingly, PR and QRS intervals were 
prolonged in TG9, compared with WT, animals (Figure 4.4A,B)  suggesting the 
presence of conduction abnormalities, which are also prevalent in patients with 
advanced heart failure (Akar & Tomaselli, 2005). To determine the impact of increased 
PI3Kα signaling on electrical function in heart failure, TG9 and caPI3Kα mice were 
crossed (caPI3KαxTG9). Surface ECG recordings from (10 week) caPI3KαxTG9 mice 
revealed that mean ± SEM QT and QTc intervals were abbreviated significantly (P<0.05) 
compared with TG9 mice (Figure 4.4A,B), albeit not identical to WT. In contrast, PR and 
QRS intervals were prolonged similarly in caPI3KαxTG9 and TG9 animals. (see 4.4 
Discussion). Consistent with the prolonged QT/QTc intervals (Figure 4.4A,B), current 
clamp recordings from LV apex myocytes isolated from TG9 animals revealed 
significantly (P<0.001) prolonged action potential durations (APD50 and APD90), 
compared with recordings from WT LV apex myocytes (Figure 4.4C,D). The action 
potential prolongation evident in TG9 myocytes (Figure 4.4C,D), however, was 
attenuated significantly (P<0.01) in LV cells isolated from (caPI3KαxTG9) animals with 
increased caPI3Kα expression. 
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Figure 4. 5 Increased 
cardiac PI3Kα signaling 
in heart failure 
upregulates repolariz-
ing K+ currents and the 
underlying K+ channel 
subunit transcripts. 
 (A) Representative 
whole-cell K+ currents 
were recorded from LV 
myocytes isolated from 
WT, TG9 and 
caPI3KαxTG9 mice. (B) 
Mean ± SEM Cm values 
are significantly 
(P<0.001) higher in TG9 
(n=21) and in 
caPI3KαxTG9 (n=32), 
than in WT (n=22), LV 
myocytes. (C) Mean ± 
SEM IK,peak, Ito,f and IK,slow 
amplitudes in TG9 (n=21) are markedly reduced compared with WT (n=22) LV myocytes, whereas mean ± SEM K+ 
current amplitudes (IK,peak, Ito,f, IK,slow, Iss and IK1) are higher in caPI3KαxTG9, than in TG9, cells. (D) Normalization for 
differences in cell size (Cm) revealed that mean ± SEM IK,peak, Ito,f, IK,slow and IK1 densities are significantly (‡P<0.05, 
*P<0.001) lower in TG9 (n=21), than in WT (n=22), LV myocytes, and that increasing PI3Kα signaling in TG9 myocytes 
results in significant (#P<0.01,*P<0.001) increases in IK,peak, IK,slow, Iss and IK1 densities. Atrial natriuretic factor (ANF) and K+ 
channel subunit transcript expression levels were determined in individual LV samples from WT, TG9 and caPI3KαxTG9 
LV, normalized to lamin A/C in the same sample and to the mean value of the WT control LV samples. As reported 
previously (Buerger et al., 2006), ANF expression is increased ~10 fold in TG9 LV. The increase in ANF expression is 
blunted in the LV of caPI3KαxTG9 animals (E). The expression levels of the transcripts encoding several K+ channel 
subunits (F,G) are reduced significantly (‡P<0.05) in TG9, compared with WT, LV; the expression levels of many of these 
K+ channel subunits, however, are increased (‡P<0.05, #P<0.01,*P<0.001) in caPI3KαxTG9, compared with TG9, LV.  
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4.3.6 Augmentation of PI3Kα signaling results in increased repolarizing K+ 
currents in failing hearts 
As might be expected based on observations in humans (Beuckelmann et al., 1993) and 
in animal models of heart failure (Rose et al., 2005; Petkova-Kirova et al., 2006), 
voltage-clamp recordings revealed that IK,peak amplitudes were significantly (P<0.001) 
lower in TG9, compared with WT, LV myocytes (Figure 4.5C). The amplitudes of Ito,f and 
IK,slow were also lower (P<0.001) in TG9 myocytes (Figure 4.5C); the time- and voltage-
dependent properties of the (Ito,f and IK,slow) currents in TG9 and WT cells, however, were 
similar (Supplemental Table 4.2). The higher mean Cm (Figure 4.5B) is consistent with 
marked cellular hypertrophy in TG9, compared with WT, LV cells. Normalization of the 
K+ current amplitudes (Figure 4.5C) to myocyte size (Figure 4.5B) revealed that 
repolarizing K+ current densities, with the exception of Iss, were significantly lower in 
TG9, than in WT, LV cells (Figure 4.5A,D). As also illustrated in Figure 4.5C, however, 
increased PI3Kα signaling resulted in significant (P<0.05) increases in the amplitudes of 
all of the repolarizing K+ currents, Ito,f, IK,slow, Iss and IK1, in TG9 LV myocytes. Normalizing 
the current amplitudes to measured Cm revealed that mean ± SEM IK,peak, IK,slow, Iss and 
IK1 densities were actually increased (Figure 4.5A,D) in caPI3KαxTG9, compared to 
TG9, cells.   
 
Additional experiments were carried out in TG9 animals treated with the ACE inhibitor, 
captopril, which has been shown to improve the cardiac function/survival in heart failure 
patients (Pfeffer et al., 1992), as well as the survival of TG9 animals (Buerger et al., 
2006). These experiments, however, did not reveal measurable effects of renin-
angiotensin system blockade on K+ current densities or action potential waveforms 
(Supplemental Figure 4.1) in TG9 LV myocytes (see 4.4 Discussion). 
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Supplemental Table 4. 1  Kv and Kir Currents in WT, TG9, caPI3Kα x TG9 and swim-trained TG9 LV Myocytes.* 
LV Cells  Cm  (pF) IK,peak Ito,f IK,slow Iss IK1 
WT  157 ± 7      
(n=22) d (ms)  — 74 ± 8 1010 ± 31 — — 
 Amplitude (pA)  8651 ± 430 4052 ± 292 3637 ± 214 962 ± 79 -1801 ± 94
 Density (pA/pF)  56.1 ± 3.3 26.5 ± 2.3 23.5 ± 1.4 6.2 ± 0.4 -11.5 ± 0.7
TG9  197 ± 8*      
(n=21) d (ms)  — 81 ± 8 1466 ± 56 — — 
 Amplitude (pA)  5596 ± 357* 2733 ± 319# 1787 ± 86* 1076 ± 63 -1897 ± 132
 Density (pA/pF)  28.9 ± 1.8* 14.1 ± 1.6* 9.3 ± 0.5* 5.5 ± 0.2 -9.5 ± 0.6‡
caPI3Kα 
 x TG9 
 226 ± 13       
(n=32) d (ms)  — 85 ± 5 1175 ± 39 — — 
 Amplitude (pA)  10174 ± 557* 3892 ± 333‡ 4028 ± 164* 2011 ± 112* -3176 ± 156
 Density (pA/pF)  48.1 ± 3.9* 18.5 ± 2.2 18.3 ± 1.2* 9.6 ± 0.8* -15.5 ± 1.4#
TG9 with 
swim training 
 184 ± 11      
(n=15) d (ms)  — 75 ±12 1563 ± 127 — — 
 Amplitude (pA)  9031 ± 960* 3568 ± 820 2477 ± 219# 2986 ± 198* -3395 ± 294
 Density (pA/pF)  53.5 ± 4.7* 20.6 ± 4.5 14.8 ± 1.1# 18.1 ± 1.3* -20.3 ± 1.7*
* All values are means ± SEM. Kv and Kir current amplitudes/densities reported here were determined at +40 mV and -
120mV, respectively.  Measured current amplitudes/densities in WT and TG9 LV myocytes, TG9 and caPI3Kα x TG9 
LV myocytes or TG9 and swim-trained TG9 LV myocytes, were compared. For each of these comparisons, values that 
are significantly (‡ P<0.05, #P<0.01, *P<0.001) different are indicated. Kv indicates voltage-gated K+ currents; Kir, 
inwardly rectifying K+ currents; Cm, cell membrane capacitance. 
 
Quantitative RT-PCR experiments were also conducted to examine K+ channel subunit 
and ANF transcript expression levels in the LV of WT, TG9 and caPI3KαxTG9 mice. 
ANF expression was significantly (P<0.01) increased in TG9, compared to WT, LV, but 
this increase was attenuated in caPI3KαxTG9 LV (Figure 4.5E). Consistent with the 
observed decreases in K+ current amplitudes, the expression levels of Ito,f subunits, 
Kv4.2, Kv4.3 and KChIP2, IK,slow subunits Kv1.5 and Kv2.1, the putative Iss subunit, 
TASK1, and both Kir2.1 and Kir2.2 (IK1 subunits) were also lower in TG9, compared to 
WT, (Figures 4.5F,G) LV. Increased PI3Kα signaling in TG9 LV, however, resulted in 
marked increases in the expression levels of all of these K+ channel subunit transcripts 
(Figure 4.5F,G).  
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Supplemental Figure 4. 2 
Captopril treatment does 
not measurably affect action 
potential waveforms or 
ventricular K+ currents in 
heart failure. 
Four weeks of captopril 
treatment (Sigma, 50mg/L in 
drinking water from 6 weeks of 
age), which has been reported 
to improve the survival of TG9 
animals,(Buerger et al., 2006) 
attenuated the increase of 
ANF expression in the TG9 
LV (A), suggesting delayed 
deterioration of cardiac function. Mean ± SEM APD50 and APD90, however, were prolonged similarly in TG9 animals with 
(n=15) and without (n=10) captopril treatment (B). In contrast to the finding that repolarizing K+ current densities are 
increased in TG9 LV with enhanced PI3Kα activity (C), K+ current densities were not increased in LV myocytes from TG9 
animals treated with captopril; indeed, K+ current densities in LV myocytes from TG9 animals with (n=25) and without 
(n=21) captopril treatment were not significantly different.  
 
4.3.7 Exercise training also upregulates repolarizing K+ currents in heart failure 
It was recently demonstrated that chronic exercise (swim training)-induced physiological 
hypertrophy, which results in increased PI3Kα activation (McMullen et al., 2003; Yang et 
al., 2010), leads to the upregulation of repolarizing ventricular K+ currents in parallel with 
the cellular hypertrophy (increase in myocyte size) (Yang et al., 2010). Additional 
experiments here, therefore, were designed to determine if chronic exercise training also 
results in K+ current upregulation in the context of heart failure. 
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Figure 4. 6 Exercise training also results in K+ current upregulation in heart failure. 
 (A) Representative whole-cell K+ currents in myocytes isolated from the LV of TG9 mice with and without swim training 
are illustrated. (B-D) Mean ± SEM IK,peak, IK,slow, Iss and IK1 amplitudes and densities are significantly (#P<0.01,*P<0.001) 
higher in LV myocytes from swim-trained (n=15), compared with untrained (n=21), TG9 animals. Although mean Ito,f 
amplitudes/densities are also higher in swim-trained TG9 LV myocytes, the differences did not reach statistical 
significance. 
Following 4 week chronic swim training, voltage-clamp experiments were performed on 
LV myocytes isolated from (10 week) trained and untrained TG9 mice. Mean ± SEM 
citrate synthase activity was increased significantly (P<0.05) in the gastrocnemius 
muscles from swim-trained (0.92±0.11 µmol/mg protein/min; n=4), compared with 
untrained (0.49±0.09 µmol/mg protein/min; n=4), TG9 animals, indicating the robustness 
of aerobic exercise training (Allen et al., 2001). The amplitudes of IK,peak and IK1 
(P<0.001), as well as of the Kv current components, IK,slow (P<0.01) and Iss (P<0.001), 
were significantly higher in TG9 LV myocytes from the swim-trained, compared with the 
untrained, TG9 animals (Figure 4.6B). The mean ± SEM Cm determined in LV myocytes 
from trained and untrained animals were similar (Figure 4.6C). Repolarizing K+ current 
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(IK,peak, IK,slow, Iss and IK1) densities, therefore, were significantly (P<0.01) higher in TG9 
LV myocytes following swim training (Figure 4.6A,D). Indeed IK,peak and IK1 densities 
were normalized to the levels found in WT cells (compare values in Supplemental 
Table 4.2).  
4.4 Discussion  
The increased incidence of life-threatening ventricular arrhythmias in patients with LV 
dysfunction is a consequence of complex pathological remodeling in cardiac structural 
(Akar et al., 2004), neurohumoral (Vaseghi & Shivkumar, 2008) and electrophysiological 
properties (Beuckelmann et al., 1993; Marionneau et al., 2008b). Advances in the clinical 
management of heart failure, specifically pharmacologic (Kober et al., 1995; Pitt et al., 
1999) and device therapies (Moss et al., 2009) which are aimed at treating 
neurohumoral and structural abnormalities, have improved patient outcomes (Kober et 
al., 1995; Pitt et al., 1999; Moss et al., 2009). Targeting the electrophysiological 
derangements using anti-arrhythmic agents has proven to be much more problematic 
and, indeed, has been associated with increased, rather than decreased, mortality 
(CAST, 1989). The results presented here demonstrate that increased PI3Kα signaling 
in pathological hypertrophy and heart failure helps to normalize ventricular repolarization 
and maintain electrical functioning through the transcriptional upregulation of repolarizing 
K+ channels, a mechanism of action distinct from classic heart failure therapeutics. 
 
Interestingly, PI3Kα signaling has been shown to modulate a number of transcription 
factors that could potentially affect the expression of cardiac K+ channels. The Forkhead 
(FOXO) family of transcriptional factors, for example, which are direct targets of the 
downstream target of PI3Kα, Akt, has been shown to regulate the promoter activity of 
several K+ channel genes such as Kcnj8 (Kir6.1), Kcnj11 (Kir6.2) and Abcc8 (SUR1) 
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(Philip-Couderc et al., 2008). Promoter analyses (using web-based program rVista 2.0, 
http://rvista.decode.org) (Loots & Ovcharenko, 2004) also reveal multiple FOXO 
transcription factor binding sites in Kcnd2 (Kv4.2), Kcnip2 (KChIP2), Kcnb1 (Kv2.1) and 
Kcnk3 (TASK1). Glycogen synthase kinase 3 beta (GSK3β), another important 
downstream target of PI3Kα, also modulates the activity of several transcriptional 
factors, including NFAT, GATA4, myocardin, c-Myc, c-Jun and β-catenin, many of which 
have putative binding sites in the promoter regions of several K+ channel subunit genes 
and could potentially contribute to the transcriptional regulation of K+ channel expression 
mediated by increased PI3Kα. Further experiments are needed to explore these 
hypotheses and delineate PI3Kα-mediated transcriptional regulatory mechanisms 
directly.  
 
4.4.1 Increased PI3Kα signaling mitigates impaired repolarization in hypertrophied 
and failing hearts 
Chronic cardiac-specific increases in PI3Kα signaling produce physiological hypertrophy 
characterized by normal electrical and mechanical function (Shioi et al., 2000; McMullen 
et al., 2003; Yang et al., 2010). The results here demonstrate that increased myocardial 
PI3Kα signaling also eliminates the effects of pressure overload-induced LV 
(pathological) hypertrophy on ventricular action potential durations. In addition, in 
caPI3Kα+TAC LV myocytes, the transcripts encoding the subunits that underlie the 
generation of several repolarizing K+ channels were increased significantly and in 
parallel with the TAC-induced increase in myocyte size, resulting in normalized K+ 
current densities. These results contrast strikingly with the effects of TAC-induced LVH 
in WT animals, in which K+  channel subunit expression levels are not increased in 
parallel with the cellular hypertrophy, resulting in decreased K+ current densities and 
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impaired repolarization (Marionneau et al., 2008b). Augmented PI3Kα signaling, 
therefore, has a clear beneficial effect in the context of pathological LVH. 
 
The experiments here also demonstrated that repolarizing K+ channel subunit transcript 
expression levels are upregulated and K+ current amplitudes are increased in failing TG9 
hearts with increased PI3Kα signaling. Although the treatment with the ACE inhibitor 
captopril also improves the survival of TG9 animals (Buerger et al., 2006), there were no 
detectable effects of captopril treatment on ventricular K+ currents or action potentials in 
TG9 hearts (Supplemental Figure 4.1). Enhanced PI3Kα signaling in the setting of 
heart failure, therefore, has unique beneficial effects on electrical functioning that are not 
observed with renin-angiotensin system blockade.  
 
QRS complexes were widened in TG9, compared with WT, mice, suggesting the 
presence of intracardiac conduction slowing, which is also commonly observed in heart 
failure patients (Hombach, 2002) and in animal models of non-ischemic dilated 
cardiomyopathy (Akar et al., 2004). In contrast with the effects on QT intervals, however, 
increased PI3Kα activity does not normalize the widened QRS complexes in TG9 mice. 
These observations may reflect low expression of the caPI3Kα transgene in the 
specialized conduction system, as previous reports suggest that transgenes driven by 
the α-MHC promoter may not be expressed consistently in nodal and His-Purkinje 
tissues (Dobrzynski et al., 2006). It is also possible, however, that increased PI3Kα 
signaling is not sufficient to reverse the structural and molecular changes that underlie 
the abnormal conduction. Further experiments focused on the conduction system 
directly are needed to explore these possibilities directly.  
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4.4.2 Chronic Swim-Training Normalizes K+ Current Densities in Heart Failure 
The observation that increased PI3Kα signaling in failing hearts provides beneficial 
effects in maintaining physiological K+ current expression levels suggests an attractive 
strategy for alleviating arrhythmogenic electrical remodeling in heart failure 
(Beuckelmann et al., 1993). A simple and practical approach to increasing cardiac PI3Kα 
signaling is aerobic exercise training (McMullen et al., 2003; Yang et al., 2010). Indeed, 
aerobic exercise training has been shown to improve LV function and prolong survival in 
heart failure patients (Coats, 2011), as well as in animal models of heart failure 
(McMullen et al., 2007; Lachance et al., 2009). Various mechanisms have been 
proposed to explain the beneficial effects of exercise, including improved endothelial 
function (Hambrecht et al., 2000a), reduced myocardial fibrosis (McMullen et al., 2007), 
and balanced sympathovagal input (Coats et al., 1992). The results here demonstrate 
that chronic exercise training also upregulates repolarizing K+ currents in the setting of 
heart failure, an effect that normalizes ventricular repolarizing K+ current densities and 
action potential durations and reduce arrhythmia susceptibility. In spite of the benefits of 
exercise, however, it is also clear that adherence to, or compliance with, prescribed 
exercise regimens can be very difficult for heart failure patients (O'Connor et al., 2009). 
Importantly, the results here suggests the potential of a therapeutic strategy focused on 
enhancing PI3Kα signaling directly. 
 
4.4.3 Conclusion  
In summary, enhanced cardiac PI3Kα activity is associated with increased expression of 
myocardial K+ channel subunits in pressure overload-induced LVH and heart failure. The 
transcriptional upregulation of K+ channel subunits produced by increased PI3Kα activity 
leads to increased K+ current amplitudes in proportion to the increase in cell size, 
thereby normalizing K+ current densities, action potential waveforms, and QT intervals. 
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The experiments here also demonstrate that chronic exercise training, a physiological 
means to enhance PI3Kα signaling leads to K+ channel upregulation in the failing heart, 
whereas the ACE inhibitor captopril does not. These observations suggest that 
increased PI3Kα signaling, either by exercise or by direct pharmacological intervention, 
could directly address the electrophysiological basis of life-threatening arrhythmias 
associated with pathological LVH and heart failure. These results argue for further 
research focused on developing practical methods to activate PI3Kα signaling in the 
human heart, as well as on detailing the effects of these manipulations on arrhythmia 
vulnerability and sudden cardiac death.  
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Chapter 5: Combined Deep microRNA and 
mRNA Sequencing Identifies Protective 
Transcriptomal Signature of Enhanced PI3Kα 
Signaling in Cardiac Hypertrophy 
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5.1 Abstract  
Rationale: The perturbation of myocardial transcriptome homeostasis is the hallmark of 
pathological hypertrophy, underlying the maladaptive structural and functional 
remodeling of the heart in response to pathological stresses. Classic and novel 
therapeutics that provide beneficial effects against pathological remodeling likely impact 
myocardial transcriptome architecture, including miRNA and mRNA expression profiles. 
Microarray and PCR-based technologies, although employed extensively, cannot 
provide adequate sequence coverage or quantitative accuracy to test this hypothesis 
directly. 
Objective: To develop and exploit next-generation sequencing approaches for 
comprehensive and quantitative analyses of myocardial miRNAs and mRNAs to test the 
hypothesis that augmented phosphoinositide-3-kinase-p110α (PI3Kα) signaling in the 
setting of pathological hypertrophy provides beneficial effects through remodeling of the 
myocardial transcriptome signature. 
Methods and Results: A molecular and bioinformatic pipeline permitting 
comprehensive analysis and quantification of myocardial miRNA and mRNA expression 
with next-generation sequencing was developed and the impact of enhanced PI3Kα 
signaling on the myocardial transcriptome signature of pressure overload-induced 
pathological hypertrophy was explored. These analyses identified multiple miRNAs and 
mRNAs that were abnormally expressed in pathological hypertrophy and partially or 
completely normalized with increased PI3Kα signaling. Additionally, several novel 
miRNAs potentially linked to remodeling in cardiac hypertrophy were identified. 
Additional experiments revealed that increased PI3Kα signaling reduces cardiac fibrosis 
in pathological hypertrophy through modulating TGF-β signaling and miR-21 expression. 
Conclusion: These studies demonstrate that combined deep miRNA- and mRNA-
sequencing analyses can be exploited to provide sensitive, accurate and comprehensive 
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quantification of the cardiac transcriptome, the potential to uncover novel miRNAs, and 
insights into the molecular mechanisms involved in the pathophysiology of cardiac 
remodeling. 
 
* Chapter 5 contains large datasets that can be accessed through the following link: 
 
Online Table S5.3, S5.4, S5.5, S5.7, S5.8 
https://docs.google.com/open?id=0B2YE75Fy4fPpZjViZTYwZjEtNGVmZi00MWMxLThkNzItM2Fj
YzZkYTFmNmU0 
 
Online Table S5.6 
https://docs.google.com/open?id=0B2YE75Fy4fPpZWNhOWM3N2YtYzBiZC00ODdiLWEzMDctN
jU5NjBhNWRlZjkz 
 
Online Table S5.9, S5.10, S5.11, S5.12 
https://docs.google.com/open?id=0B2YE75Fy4fPpMzA3ZDYwMTYtZjYxZi00ZGRkLWJmNmYtM
TVmMDdiZGVlNDM1 
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5.2 Introduction 
 
Comparative transcriptional profiling has been used extensively to explore disease 
mechanisms and to improve the accuracy of clinical diagnosis and outcome predictions 
(Golub et al., 1999; Heidecker et al., 2008). Although standard hybridization 
technologies (microarrays)- and PCR-based profiling have been employed extensively, 
the sensitivity and the sequence coverage provided by these assays are quite limited. As 
high-throughput sequencing technologies have evolved over the past few years, deep 
sequencing has proven superior to microarray- or PCR-based methods of transcriptional 
profiling, owing to its capacity to provide comprehensive and quantitative transcript 
expression data over a wide dynamic range (Marguerat & Bahler, 2010; Matkovich et al., 
2010). The high sensitivity of deep sequencing is particularly useful in miRNA research 
because of the wide range over which miRNAs are expressed, from tens of thousands of 
copies to a single copy per cell (Matkovich et al., 2010; van Rooij, 2011). Moreover, 
deep sequencing, unlike microarrays, is not limited by the number of probes, allowing 
the discovery of novel miRNAs. With the evolution of next-generation sequencing 
technologies, the amount and speed of data output have reached unprecedented levels, 
yet the overall cost is decreasing. Despite the potential and the decreasing costs, there 
have to date, been remarkably few studies applying deep sequencing in cardiovascular 
miRNA research (Rao et al., 2009), likely reflecting the considerable bioinformatic 
challenges involved in the analyses of such large datasets. Here, we developed a 
molecular and bioinformatic pipeline using state-of-the-art next-generation sequencing to 
provide a comprehensive miRNA and mRNA expression profiling in the mouse heart, 
and used this approach to study remodeling in pathological and physiological cardiac 
hypertrophy. 
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Pathological cardiac hypertrophy, a maladaptive response of the myocardium to 
increased biomechanical stresses, is associated with increased propensity to develop 
interstitial fibrosis, heart failure, life-threatening arrhythmias and sudden cardiac death 
(Levy et al., 1990; McMullen & Jennings, 2007). Physiological hypertrophy in response 
to exercise training, in contrast, is characterized by normal cardiac structure and 
maintained cardiac function, and is not associated with increased risk of heart failure, 
arrhythmias or sudden cardiac death (McMullen et al., 2003; McMullen & Jennings, 
2007). Two distinct signaling mechanisms, G-protein coupled receptor (GPCR) signaling 
(D'Angelo et al., 1997; Mende et al., 1998; McMullen & Jennings, 2007) and 
phosphoinositide-3-kinase-p110α (PI3Kα) signaling (McMullen et al., 2003), have been 
linked to the development of pathological and physiological hypertrophy, respectively. In 
addition, it has been demonstrated that augmentation of PI3Kα signaling is beneficial in 
the setting of pathological hypertrophy and heart failure (McMullen et al., 2007; Yang et 
al., 2012), resulting in improved cardiac function and survival. The mechanisms through 
which enhanced PI3Kα signaling is protective, however, have not been delineated.  
 
A hallmark of pathological hypertrophy is that the myocardial transcriptome landscape, 
including mRNAs, miRNAs, long noncoding RNAs and other RNA species, is 
dramatically altered (Matkovich et al., 2010; Lee et al., 2011), suggesting that 
perturbation of transcriptome homeostasis is critically coupled to the disease process. 
We hypothesized that augmented PI3Kα signaling provides protective effects by 
preventing or reversing the changes in myocardial miRNA and mRNA expression 
associated with pathological hypertrophy. Exploiting a molecular and bioinformatic 
pipeline optimized for transcriptome profiling with next-generation high-throughput 
sequencing, we examined directly the impact of increased PI3Kα signaling on 
myocardial transcriptome structure in the setting of pathological hypertrophy. The results 
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presented here demonstrate that combining miRNA- and mRNA-Seq analyses allows 
quantitative in-depth profiling of myocardial miRNA and mRNA expression, identification 
of novel miRNA species, and the potential to explore the detailed molecular mechanisms 
contributing both to the pathophysiology associated with cardiac hypertrophy and the 
beneficial effects of potential therapeutic interventions. 
5.3 Results 
 
5.3.1 Enhanced PI3Kα signaling mitigates pressure overload-induced pathological 
remodeling  
 Transverse aortic constriction (TAC) in WT animals, as expected, resulted in marked 
pressure overload-induced LV hypertrophy, evident in the ~30% increase in LVW/TL 
ratio (Figure 5.1A and Supplemental Table 5.1) and a significantly (~12 fold, P<0.001) 
increased expression (Figure 5.1B) in ANF, a molecular marker of pathological 
hypertrophy (McMullen & Jennings, 2007). Although cardiac specific expression of 
constitutively active PI3Kα (caPI3Kα) also produces marked LV hypertrophy (Figure 
5.1A and Supplemental Table 5.1), in this case, without increased ANF expression 
(Figure 5.1B), consistent with the development of physiological hypertrophy (Shioi et al., 
2000).  
Supplemental Table 5. 1 Demographic and echocardiographic measurements in experimental animals 
Data Measure WT Sham 
(n=6) 
WT+TAC 
(n=6) 
caPI3Kα Sham 
(n=6) 
caPI3Kα+TAC 
(n=6) 
Body weight (g) 27.9±0.4 26.6±0.4 29.7±1.1 30.0±0.9 
Tibia length (mm) 21.9±0.2 21.6±0.2 21.7±0.2 21.6±0.1 
Heart weight (g) 122.5±3.8 145.9±2.7* 149.1±4.5 169.1±9.3‡ 
LV weight (g) 68.1±2.6 85.8±3.4# 84.7±2.9 98.3±4.8‡ 
LVW/TL ratio (mg/mm) 3.1±0.1 4.1±0.2* 3.9±0.1 4.5±0.2‡ 
Fractional shortening (%) 55.7±1.5 54.0±7.1 51.1±3.1 53.1±2.9 
VTI ratio (Ao/LVOT) 0.9±0.1 5.8±0.4* 0.9±0.0 5.9±0.8# 
LVMI: LV mass index; VTI: velocity time integral; Ao: aorta; LVOT: LV outflow tract; all values are means ± SEM. Values in 
WT+TAC or in caPI3Kα+TAC that are significantly (‡P<0.05, #P<0.01 , *P<0.001) different from the values in WT sham or 
caPI3Kα sham animals, respectively, are indicated. 
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Figure 5. 1 Functional 
impact of enhanced PI3Kα 
signaling on pressure 
overload-induced LVH 
and the LV miRNA 
abundance. 
(A) LV weight/tibia length 
(LVW/TL) ratios were 
determined in WT sham, 
WT+TAC, caPI3Kα sham 
and caPI3Kα+TAC (n=6 in 
each group) animals; 
individual and mean ± SEM 
values (*P<0.001, ‡P<0.05) 
are plotted. (B) Transcript 
expression of ANF, the 
molecular marker of 
pathological hypertrophy is 
increased ~12 fold with 
TAC in WT LV. The 
increase in ANF expression 
in response to TAC is 
significantly (P<0.01) 
blunted in the LV of 
caPI3Kα animals. (C) 
Expression of the 20 most 
abundant miRNAs in WT sham, WT+TAC, caPI3Kα sham and caPI3Kα+TAC LV are compared. The abundances of the 
individual miRNAs were expressed as percentages of individual miRNA read counts contributing to the total read counts 
of known miRNAs in a cDNA library. (D)The 10 most abundant miRNAs account for >70% of the total miRNA reads in 
mouse LV.  
Enhanced PI3Kα signaling, however, significantly (P<0.001) attenuated the TAC-
induced increase in ANF expression (~5 fold, Figure 5.1B), consistent with previous 
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reports suggesting that enhanced PI3Kα signaling is protective and mitigates the 
maladaptive, pathological myocardial remodeling secondary to pressure overload 
(McMullen et al., 2007; Yang et al., 2012). 
 
5.3.2 Deep sequencing of microRNAs in Sham-operated and TAC- WT and 
caPI3Kα LV 
Using the 15 barcoded small RNA libraries prepared from the (4 WT sham, 5 WT+TAC, 
3 caPI3Kα sham and 3 caPI3Kα+TAC) mouse LV samples, a total of 165,496,374 reads 
were generated from 2 flow cell lanes on the HiSeq2000 sequencer (Table 5.1), on 
average producing >10 million reads per library. The read lengths obtained from the 
libraries showed a Gaussian distribution with a peak at 22 nucleotides (Supplemental 
Figure 5.1), consistent with the enrichment of miRNAs. More than 152 million of the 
sequence reads (92.2%) were aligned to the mouse genome (mm9), ~88 million (53.3%) 
mapped to known miRNAs, and ~11 million (6.7%) to RNA species other than miRNA. 
Approximately 53 million (32.3%) of the remaining reads mapped to unannotated 
genomic regions, and ~10 million of these were subsequently re-classified to be putative 
miRNAs (see below). In each sample, the read counts of each of the known miRNAs 
were then normalized to the total counts of sequences mapped to the miRbase v.18 
database and presented as PMMR (sequences per million mapped reads). Scatter plots 
of the normalized read counts of all known miRNAs showed high degrees of correlation 
(β=0.95, R2=0.99, Supplemental Figure 5.2A) between biological replicates, indicating 
high levels of reproducibility for these miRNA-Seq experiments. The expression levels of 
several of the miRNAs identified in WT sham LV were also examined with qRT-PCR and 
the relative abundances (in CT) of the individual miRNAs were found to be well 
correlated with the results from miRNA-Seq (Supplemental Figure 5.2B).  
  
104 
Table 5. 1 Summary of miRNA- and mRNA-Seq read counts and mapping results 
miRNA-Seq            
Read Counts 
WT Sham      
(n=4) 
WT TAC        
(n=5) 
caPI3Kα 
Sham (n=3) 
caPI3Kα TAC   
(n=3) 
Total 
Total 45901044 49701319 37441052 32452959 165496374 
Mapped  41986529      
(91.5) 
45593199     
(91.7%) 
34304088      
(91.6%) 
30735651    
(94.7%) 
152619467  
(92.2%) 
Unmapped  3914515      
(8.5%) 
4108120  
(8.3%) 
3136964 
(8.4%) 
1717308 
(5.3%) 
12876907 
(7.8%) 
Known miRNAs 22981918  
(50.1%) 
27443912 
(55.2%) 
18360999 
(49.0%) 
19354436  
(59.6%) 
88141265 
(53.3%) 
Putative miRNAs 2514756      
(5.5%) 
2564454 
(5.2%) 
2696651 
(7.2%) 
2444635      
(7.5%) 
10220496 
(6.2%) 
Mapped to other 
RNA species 
2968104      
(6.5%) 
2942701 
(5.9%) 
2950463 
(7.9%) 
2282158      
(7.0%) 
11143426 
(6.7%) 
Mapped to genome, 
unannotated 
13521751    
(29.5%) 
12642132 
(25.4%) 
10295975 
(27.5%) 
6654422    
(20.5%) 
43114280 
(26.1%) 
mRNA-Seq                 
Read Counts 
WT Sham 
(n=4) 
WT+TAC  
(n=3) 
caPI3Kα Sham 
(n=2) 
caPI3Kα+TAC 
(n=2) 
Total 
Total 47913934 45178741 84373729 65384703 242851107 
Mapped  40884751 
(85.3%) 
38297928 
(84.8%) 
70954141 
(84.1%) 
55108361 
(84.3%) 
205245181 
(84.5%) 
Unmapped  7029183 
(14.7%) 
6880813 
(15.2%) 
13419588 
(15.9%) 
10276342 
(15.7%) 
37605926   
(15.5%) 
Mapped to exon 
regions 
26279745 
(54.8%) 
26838716 
(59.4%) 
48917894 
(58.0%) 
37761525 
(57.8%) 
139797880 
(57.6%) 
TAC: trans-thoracic aortic constriction 
 
 
Supplemental Figure 5. 1 Read 
length distribution of miRNA 
sequencing experiments. 
The read lengths obtained from the 
small RNA libraries showed a 
Gaussian pattern distribution with a 
peak at a length of 22 nucleotides 
(ranging from 16 to 37 nt), consistent 
with the expected miRNA lengths and 
the enrichment of miRNAs in the 
libraries 
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Supplemental Figure 5. 2 Scatter plot of normalized read counts between biological replicates and correlation 
with qPCR results confirms the reproducibility and accuracy of miRNA-Seq experiments 
 (A) Scatter plot of the normalized read counts of all known miRNAs shows high degree of correlation (β=0.95, R2=0.99) 
between biological replicates (WT sham heart 1 and 2), documenting the reproducibility of the miRNA-Seq experiments. 
(B) Representative qRT-PCR amplication plots of selected miRs (indicated with colored squares in Supplemental Figure 
2A) in WT sham LV. The relative abundances (CT values) of the individual miRs were accurately reflected in the results of 
miRNA-seq experiments. 
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Using the criterion that a miRNA sequence must be detected in at least 2 small RNA 
libraries, the sequence reads were mapped to 393 mature miRNAs reported in miRbase 
v.18 (Online Supplemental Table S5.3). A wide range of miRNA expression levels, 
ranging from 0.1 to 222655.7 PMMR, was observed. MiR-22 was the most abundant 
mature miRNA expressed in mouse LV, corresponding to 18-20% of all of the miRNA 
sequence reads. The relative expression levels of the 20 most abundant mature miRNAs 
are shown in Figure 5.1C. Interestingly, 13 out of these 20 miRNAs, including muscle-
specific miR-1 and miR-133a (Rao et al., 2006), and endothelial cell-specific miR-126-5p 
(Wang et al., 2008), have been reported previously to be highly abundant in the mouse 
heart (Rao et al., 2009). The 10 most abundant miRNAs accounted for >70% of all 
miRNA sequence reads in all LV samples (Figure 5.1D). In addition to known mature 
miRNAs, 13 novel miRNA* (mature-star miRNA, mature miRNAs derived from the less-
expressed, opposite arm) sequences were identified for known miRNA genes without 
prior annotation in miRBase v.18 (Table 5.2 and Online Supplemental Table S5.4).  
Table 5. 2 Novel miRNA* identified in mouse LV 
Novel miRNA* 
WT Sham Mean 
PMMR 
WT TAC/    WT 
Sham 
caPI3Kα Sham/ WT 
Sham 
caPI3Kα TAC/ WT 
Sham 
mmu-mir-145* 287.96 0.75 0.87 0.67 
mmu-mir-322* 54.41 1.16 0.90 0.91 
mmu-mir-425* 5.97 1.72 1.36 1.7 
mmu-mir-1960* 1.55 0.94 1.03 0.81 
mmu-mir-503* 1.31 1.36 0.79 1.94 
mmu-mir-28* 1.26 1.46 1.12 0.53 
mmu-mir-30d* 1.18 0.13 0.50 0.14 
mmu-mir-382* 0.81 1.73 1.00 1.45 
mmu-mir-153* 0.39 0.14 0.61 1.74 
mmu-mir-3068* 0.22 0.97 0.48 0.00 
mmu-mir-486* 0.20 0.00 3.96 0.69 
mmu-mir-455* 0.19 1.23 0.00 0.00 
mmu-mir-140* 0.08 3.26 2.87 0.00 
mmu-mir-143* 0.00 N.A. N.A. N.A. 
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Comparative analyses revealed that 78 miRNAs were differentially expressed in the 4 
sets of LV samples analyzed (P<0.01 at a false-discovery rate of 0.05). A complete list of 
the differentially expressed miRNAs, with mean PMMR values, fold differences 
(compared to WT sham LV) and P values, is presented in Online Supplemental Table 
S5.5. Consistent with previous studies demonstrating normal cardiac structure and 
function in the caPI3Kα mouse model of physiological hypertrophy (Shioi et al., 2000), 
unsupervised hierarchical clustering analyses revealed that the miRNA expression 
profiles in WT sham and caPI3Kα sham LV samples were similar (Supplemental Figure 
5.3). 
Supplemental Figure 5. 3 
Differentially regulated 
miRNAs in WT sham, 
WT+TAC, caPI3Kα sham and 
caPI3Kα+TAC LV. 
 Heat map and hierarchical 
clustering of the differentially 
regulated miRNAs in WT sham, 
WT+TAC, caPI3Kα sham and 
caPI3Kα+TAC LV samples.  The 
miRNA expression signatures of 
WT sham and caPI3Kα sham LV 
were similar. The WT+TAC LV 
miRNA expression profile, 
however, was distinct; increased 
PI3Kα signaling attenuated the 
abnormal miRNA expression 
pattern observed in response 
with TAC.  
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In contrast, the miRNA expression signature of WT+TAC LV was dramatically different 
from both WT sham and caPI3Kα sham LV, segregating the WT+TAC from the WT 
sham and caPI3Kα sham LV samples (Supplemental Figure 5.3). Consistent with 
previous miRNA studies in murine models of pressure overload-induced pathological 
hypertrophy, the expression levels of the miR-146 family (Cheng et al., 2007), as well as 
miR-199a-5p (van Rooij et al., 2006; Sayed et al., 2007), miR-21 (van Rooij et al., 2006; 
Cheng et al., 2007; Sayed et al., 2007), miR-212 (Jentzsch et al., 2011) and miR-214 
(van Rooij et al., 2006; Cheng et al., 2007; Sayed et al., 2007) were upregulated, 
whereas miR-133a (van Rooij et al., 2006; Cheng et al., 2007) was downregulated in 
WT+TAC, compared with WT sham, LV. Interestingly, when comparing the miRNA 
expression profiles of WT+TAC and caPI3Kα+TAC LV, it is clear that the aberrant 
expression pattern of miRNAs observed with TAC-induced LVH was blunted 
substantially with increased PI3Kα signaling (Supplemental Figure 5.3 and Online 
Supplemental Table S5.5).  
 
To identify miRNAs that were abnormally expressed in pathological hypertrophy but 
partially or completely normalized with increased PI3Kα signaling, an unsupervised, self-
organized tree analysis for the differentially expressed miRNAs (in Online 
Supplemental Table S5.5) was conducted (Supplemental Figure 5.4). A total of 23 
miRNAs fitting this “protective PI3Kα microRNome” expression pattern were identified 
and clustered (Figure 5.2). Most of these miRNAs were upregulated ≥ 2 fold in 
WT+TAC, compared with WT sham, LV, and were normalized or markedly reduced with 
increased PI3Kα signaling. A number of the miRNAs identified in the “protective PI3Kα 
microRNome” have been shown to cause or to contribute to various myocardial 
pathologies, including cardiac hypertrophy (miR-146b, miR199a-5p, miR-21, miR-212, 
miR-214), heart failure (miR-146b, miR199a-5p, miR-21, miR-212, miR-214), myocardial 
109 
ischemia (miR-134, miR-199a-5p, miR-21, miR-214, miR-379), cardiac fibrosis (miR-21) 
and fetal gene program activation (miR-21, miR-212). A complete list of the 23 miRNAs 
identified and references to the identified cardiac and extra-cardiac functions of these 
miRNAs is provided in Online Supplemental Table S5.6. Taken together, these data 
indicate that enhanced PI3Kα signaling ameliorates the adverse effects of pathological 
stress on multiple disease-linked miRNAs, normalizing their expression in the 
myocardium.  
 
Supplemental Figure 5. 4 miRNA clustering using self organizing tree algorithm. 
Differentially regulated miRNAs in the four groups of LV samples were clustered using Self Organizing Tree Algorithm 
(SOTA). Only the clusters showing aberrant regulation of miRNAs in response to TAC that were also normalized with 
increased myocardial PI3Kα signaling were selected (cluster 2, 3, 4, 5, 6 and 7). Two additional miRNAs fitting the 
expected expression pattern were found in cluster 10.  
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Figure 5. 2 MicroRNAs aberrantly expressed in pathological hypertrophy are normalized with enhanced PI3Kα 
signaling. 
(A) Heat map and hierarchical clustering of miRNAs found to be aberrantly expressed in TAC-induced pathological 
hypertrophy and normalized with augmented myocardial PI3Kα signaling. Green denotes low expression; red, high 
expression. (B)The average PMMR, fold change (compared to WT sham) and P values (ANOVA) of each miRNA 
identified are listed. 
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5.3.3 Identification of novel miRNAs expressed in mouse ventricular tissue 
One advantage of miRNA-Seq is the opportunity to discover novel miRNAs. Using a 
computational algorithm on the basis of miRNA biogenesis (Hackenberg et al., 2009), 
we identified ~10 million unannotated mapped sequence reads that share characteristics 
of microRNAs. These sequence reads generated 896 alignment clusters. Of these, 543 
had read counts ≥10 and these clusters were further filtered to exclude contamination 
from repetitive sequences and mRNA or noncoding RNA degradation products. Clusters 
with a read depths ≥100 were chosen for further analyses. A total of 246 of these 
identified clusters were subjected to subsequent analyses for miRNA precursor 
characteristics, including predicted folding structures and negative ∆G criteria (see 
Methods). Using the combined read depth and precursor characteristics criteria, we 
identified 26 putative miRNAs that were not in miRBase v.16. Interestingly, 15 of these 
putative miRNAs (Online Supplemental Table S5.7) were reported in miRBase v.18, 
which was updated in Nov 2011, validating the analytical approaches used. Among the 
remaining 11 novel miRNAs (Online Supplemental Table S5.8) identified in mouse LV, 
3 were differentially regulated in WT+TAC, compared with WT sham, LV (Figure 5.3A). 
The predicted secondary structure and precursor sequence of one of these novel 
miRNAs (miR-cluster 16) are illustrated in Figure 5.3B. The expression of miR-cluster 
16 and the two other novel miRNAs in WT sham and WT+TAC LV were also confirmed 
using qRT-PCR (Figures 5.3C and 5.3D). 
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Figure 5. 3 Novel miRNAs identified in mouse ventricles are differentially expressed. 
(A) Three novel miRNAs (miR-cluster 16, 4 and 54), identified by miRNA-seq, were differentially expressed in WT+TAC, 
compared with WT sham, LV. (B) Sequence and predicted secondary structure of the miR-cluster 16 precursor. The linear 
sequence with the mature miRNA sequence in red and miRNA star sequence in blue is also illustrated. (C) 
Representative qRT-PCR amplication plots for miR-cluster 16, 4 and 54 in WT sham and WT+TAC LV. Dotted line 
indicates fluorescence threshold for determining CT values. (D) qRT-PCR confirmed the differential expression of miR-
cluster 16, 4 and 54 in WT sham (n=6) and WT+TAC (n=6) LV. (*P<0.001, ‡P<0.05)   
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5.3.4 Parallel messenger RNA expression profiling in mouse LV with mRNA 
sequencing  
To complete the functional transcriptome profiling, mRNA sequencing (mRNA-Seq) 
experiments were conducted in parallel to the miRNA-Seq. Eleven barcoded mRNA 
libraries were prepared from mouse LV samples (4 WT sham, 3 WT+TAC, 2 caPI3Kα 
sham and 2 caPI3Kα+TAC). A total of 242,851,107 sequence reads were generated 
from 2 HiSeq2000 flow cell lanes (Table 5.1), with an average sequencing depth of > 22 
million reads per library. Among the 242 million sequence reads obtained, 84.5% (~205 
million reads) were aligned to mm9 mouse genome, among which ~140 million reads 
(57.6% of total reads) were mapped within exon regions (Table 5.1). Read counts 
mapped to different isoforms of individual genes were pooled together to calculate the 
RPKM (reads per kilobase of exon per million mapped reads) value of each gene. These 
mRNA-Seq experiments were highly reproducible among biological replicates 
(Supplemental Figure 5.5). 
 
Supplemental Figure 5. 5 Scatter plot of normalized read counts between biological replicates reveals the 
reproducibility of mRNA-Seq experiments. 
Scatter plot of the normalized mapped read counts annotated in the RefSeq database showed high degree of correlation 
(β=0.99, R2=0.99) between biological replicates (WT sham heart 1 and 2), consistent with high reproducibility of the RNA-
Seq experiments.  
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Using the cutoff value of 3 RPKM, which corresponds to expression level ≈1 copy per 
cell (Mortazavi et al., 2008), we identified a total of 8989 genes that were expressed at ≥ 
3 RPKM in at least one LV sample (Online Supplemental Table S5.9); 2638 genes 
were found to be differentially expressed (P<0.05, FDR of 0.05) among the four groups 
of LV samples (Online Supplemental Table S5.10). As an internal control, the 
expression level of the pik3ca gene was increased by 15-20 fold in every caPI3Kα, 
compared to WT, LV sample, consistent with the overexpression of the caPI3Kα 
transgene in these animals. The caPI3Kα sham LV share similar transcriptome 
signatures with WT sham LV, whereas the transcriptional signature of WT+TAC LV was 
distinct (Figure 5.4) from WT and caPI3Kα sham LV. In WT+TAC LV, for example, the   
activation of fetal gene program (nppa, nppb and acta1) (Hoshijima & Chien, 2002; 
Olson & Schneider, 2003) and increased expression of cardiac fibrosis genes (col3a1, 
col5a2, col8a1, col15a1, col6a1) were evident. Interestingly, consistent with the notion 
that enhancing PI3Kα signaling in pathological hypertrophy is protective, the expression 
levels of many of the genes identified as abnormally expressed in (compared with WT 
sham) WT+TAC LV were attenuated or normalized (in caPI3Kα+TAC LV) with increased 
myocardial PI3Kα signaling (Figure 5.4).  
 
The self-organizing tree algorithm was applied to identify genes that were downregulated 
or upregulated in pathological hypertrophy, and normalized or reversed with increased 
PI3Kα signaling, i.e., the “protective PI3Kα mRNome”. These genes are presented in 
Online Supplemental Table S5.11 and S5.12. A total of 249 genes were found to be 
down-regulated in pathological LVH and normalized with increased PI3Kα signaling 
(Figure 5.5A).   
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Figure 5. 4 Distinct mRNA expression profiles in pathological and physiological hypertrophy. 
Heat map and hierarchical clustering of the top 50 differentially regulated mRNAs (ranked by P value) in WT sham, 
WT+TAC, caPI3Kα sham and caPI3Kα+TAC LV.  
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Gene ontology analysis of these 249 genes revealed an enrichment in mitochondrial, 
cellular catabolism, oxidation-reduction and lipid metabolism genes (Figure 5.5B), 
consistent with previous reports suggesting the critical role of PI3Kα signaling in 
maintaining homeostatic mitochondria biogenesis and lipid metabolism.(O'Neill et al., 
2007) The expression levels of 156 other genes, however, were found to be upregulated 
in WT+TAC LV, and reversed with enhanced PI3Kα signaling (Figure 5.5C); in this 
case, many genes linked to development, stress responses and the extracellular matrix 
were identified (Figure 5.5D), consistent with previous suggestions that PI3Kα signaling 
attenuates the activation of the fetal gene program and the fibrotic changes associated 
with pressure overload-induced LVH (McMullen et al., 2007; Yang et al., 2012). 
Interestingly, a number of genes involved in immune and inflammatory responses 
including Il6, Il6st, Nfkb1,Tlr4, Vcam1, Icam2, Tnfrsf1a and Tnfrsf1b, were also 
upregulated with TAC-induced pathological hypertrophy (Supplemental Figure 5.6), 
consistent with previous reports linking innate immunity/inflammatory responses and 
cardiac hypertrophy/LV dysfunction.(Mann, 2011; Valen, 2011; Masiha et al., 2012) 
Interestingly, the upregulation of these nflammatory markers by TAC was also markedly 
blunted with increased PI3Kα signaling (Supplemental Figure 5.6). 
Supplemental Figure 5. 6 
Enhanced PI3Kα 
signaling normalizes 
inflammatory markers 
that are increased with 
TAC-induced pathological 
hypertrophy. 
Averaged normalized read count of genes involved in inflammatory responses (Il6, Il6st, Nfkb1,Tlr4, Vcam1, Icam2, 
Tnfrsf1a and Tnfrsf1b). Normalized read count data were expressed relative to the mean WT sham value. 
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Figure 5. 5 Transcripts 
increased/decreased with 
pathological hypertrophy 
and normalized with 
enhanced PI3Kα signaling 
are segregated to distinct 
functional groups. 
 (A) Unsupervised hierarchi-
cal clustering of the 
transcripts that were 
downregulated in 
pathological hypertrophy 
and normalized with 
enhanced PI3Kα signaling. 
(B)Gene ontology analysis 
revealed enrichment of 
genes that are required for 
normal myocardial 
functioning, including 
mitochondrial regulation, 
cellular catabolism, 
oxidation/reduction, electron 
transport, and lipid 
metabolism. (C) 
Unsupervised hierarchical 
clustering of the genes that 
were upregulated in 
pathological hypertrophy 
and normalized with 
enhanced PI3Kα signaling; 
gene ontology analysis 
revealed enrichment of genes involved in maladaptive myocardial responses to pathological stimuli, including genes 
involved in development, stress responses and extracellular matrix formation (D).    
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5.3.5 MicroRNA-21 involved in the inhibition of cardiac fibrosis by enhanced PI3Kα 
signaling  
Enhanced PI3Kα signaling has been shown to reduce cardiac fibrosis in pathological 
LVH induced by pressure overload (McMullen et al., 2007). Indeed, the upregulation of 
fibrosis genes, including collagens, fibronectin (fbn1), fibrillin (fn1) and connective tissue 
growth factor (ctgf), in TAC-induced LVH was largely abrogated with enhanced 
myocardial PI3Kα signaling (Figure 5.6A). Interestingly, miR-21, which has been shown 
to promote tissue fibrosis in pulmonary (Liu et al.) and cardiac (Thum et al., 2008) 
disease, was highly upregulated in response to TAC, and this upregulation was 
significantly attenuated with increased PI3Kα signaling (Figure 5.2A,B).  It has been 
shown that miR-21 promotes cardiac fibrosis through translational suppression of 
Sprouty-1, which inhibits the pro-fibrotic ERK-MAPK signaling pathway (Thum et al., 
2008). Consistent with this, Sprouty-1 protein expression was significantly (P<0.05) 
decreased in WT+TAC, compared with WT sham, LV. The downregulation of Sprouty-1 
protein in response to TAC, however, was reversed with increased PI3Kα signaling 
(Figure 5.6B). In addition, components of the TGF-β pathway, a potent miR-21 activator 
(Davis et al., 2008; Cottonham et al., 2010), including tgfb2, tgfbr1 and tgfbr2, were 
upregulated with TAC, and suppressed with increased PI3Kα activity (Figure 5.6A). 
These results suggest that enhanced PI3Kα signaling inhibits cardiac fibrosis through 
reducing TGF-β signaling and the repression of the pro-fibrotic miR-21.   
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Figure 5. 6 Enhanced PI3Kα signaling in pathological hypertrophy attenuates TGF-β and miR-21 expression, in 
pathological hypertrophy, maintaining Sprouty-1 protein expression and reducing fibrosis. 
 (A) Averaged normalized read count of genes linked to fibrosis (Ctgf, Col15a1, Col1a1, Col1a2, Col3a1, Col8a1, Fn1 and 
Fbn1) or the TGF-β pathway (Tgfb1, Tgfb2, Tgfbr1 and Tgfbr2) in WT sham, WT+TAC, caPI3Kα sham and caPI3Kα+TAC 
LV. Normalized read count data were expressed relative to the mean WT sham value. (B) Representative Western blot of 
fractionated LV proteins from WT sham, WT+TAC, caPI3Kα sham and caPI3Kα+TAC LV (n=4-5 in each group) probed 
with anti-sprouty1 and anti-GAPDH antibodies. The expression levels of each protein on each blot were measured and 
normalized to the expression of GAPDH of the same sample on the same blot. Protein expression data were expressed 
relative to the mean value of WT sham LV samples. The mean ± SEM relative expression level of Sprouty-1 was 
significantly (‡P<0.05) lower in WT+TAC than in WT sham, LV. The downregulation of the Sprouty-1 protein with TAC, 
however, was abrogated with enhanced PI3Kα signaling. (D) Schematic of proposed mechanism underlying PI3Kα-
mediated suppression of cardiac fibrosis in pathological hypertrophy induced by pressure-overload. 
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5.4 Discussion 
 
5.4.1 MicroRNA sequencing revealed protective mirna expression signature of 
enhaned PI3Kα signaling 
The comparative analyses of miRNA expression in WT sham, WT+TAC, caPI3Kα sham 
and caPI3Kα+TAC LV samples allowed the identification of the “protective PI3Kα 
microRNome” in the setting of pathological hypertrophy. As described above and 
detailed in Online Supplemental Table S5.6, the increased expression of many of 
these miRNAs have been shown to contribute to various myocardial pathologies. For 
example, miR-199a-5p, miR-214 and miR-212 have all been shown to be upregulated in 
murine models of pathological hypertrophy (van Rooij et al., 2006; Cheng et al., 2007; 
Sayed et al., 2007) and in human failing hearts (van Rooij et al., 2006; Thum et al., 
2007; van Rooij et al., 2008), and overexpression of miR-199a-5p, miR-214 or miR-212 
in murine myocytes led to hypertrophic growth and activation of fetal gene program (van 
Rooij et al., 2006; Jentzsch et al., 2011). The observation that enhanced PI3Kα signaling 
suppresses the expression of these disease-causing miRNAs suggests that the anti-
pathological-hypertrophy effects of PI3Kα signaling are mediated, at least in part, by 
normalizing the expression of these “pathological miRNAs”. Previous attempts to 
modulate the pathological expression of these miRNAs have consisted largely of 
eliminating or reducing them, one or two miRNAs at a time. Interestingly, however, this 
approach seems to have only very small to moderate beneficial effects likely reflecting 
the inherent complexity of the signaling networks involved (Matkovich et al.; van Rooij, 
2011). The observation that enhanced PI3Kα signaling results in the marked and 
simultaneous suppression of multiple “pathological miRNAs” suggests a novel 
therapeutic approach: modulating  the expression of multiple disease-causing miRNAs 
concurrently. This strategy has the potential of impacting multiple signaling pathways 
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which would be expected to have a greater effect on disease progression and severity 
than knocking down individual miRNAs.  
 
The analytical approach developed and used here allowed the identification of 13 novel 
miRNA* of known mature miRNA genes and 11 novel miRNAs. Importantly, of the >10 
million sequence reads analyzed, up to 896 clusters were predicted to be putative 
mouse miRNAs. Of these, 246 clusters were detected at >100 reads, and 26 putative 
miRNAs met all the criteria of “novel miRNA”, of these, 15 were updated in the most 
recent (November 2011) miRNAbase, leaving 11 truely novel miRNAs. The low yield of 
novel miRNAs identified in these experiments has two interpretations. First, a large 
fraction of the “putative miRNA” reads may represent low-abundance hairpin species 
that were occasionally processed by the Drosha-Dicer miRNA biogenesis machinery. 
Secondly, it is possible that most mouse miRNAs have already been identified and 
annotated, as recent studies using large-scale cloning approaches to identify novel 
mammalian miRNAs yielded only a few uncharacterized, low-abundance miRNAs 
(Landgraf et al., 2007; Basso et al., 2009). Importantly, however, we cannot exclude the 
possibility that the stringent criteria used might have filtered out some miRNAs 
expressed at very low levels but that, nevertheless, are of biological significance. 
Regardleess, additional experiments are needed to determine the functional roles of the 
novel miRNAs identified in the studies here.   
 
In the miRNA sequencing experiments detailed here, a small number (~10-20) of highly 
abundant miRNAs were identified that account for the majority of the mature miRNA 
species expressed in the adult mouse LV (Figure 5.1C,D). Although this observation is 
similar to previously published miRNA-Seq findings in the mouse heart (Rao et al., 
2009), the relative abundances of the highly expressed miRs in the previous report by 
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Rao et al were different than those determined here. The most abundant miRNA in Rao 
et al (Rao et al., 2009), which accounted for ~40% of the total miRNA reads, was miR-1. 
Here, however, miR-1 ranked #20 in abundance and accounted for only ~1% of the total 
miRNA reads (Figure 5.1C and Online Supplemental Table S5.3). Although the use of 
different sequencing platforms or library construction approaches might be expected to 
cause minor read count differences (Fehniger et al., 2010), it is unlikely that either could 
contribute significantly to the differences observed in these two studies. It seems more 
likely the apparent discrepancy in the findings may reflect the fact that whole heart 
samples were used by Rao et al (Rao et al., 2009), whereas only LV was used in the 
studies here. Because of the highly sensitive and quantitative nature of deep sequencing 
experiments (Pais et al., 2011), regional differences in relative miRNA expression levels 
will impact quantitative analyses.  
 
5.4.2 Combined miRNA-Seq and mRNA-Seq analyses provide a transcriptome 
framework to explore novel mechanisms underlying the pathobiology of cardiac 
hypertrophy 
The mechanisms through which miRNAs regulate biological process are translational 
inhibition or mRNA degradation of the miRNA targets (Ambros, 2004; van Rooij, 2011). It 
has been argued recently that mRNA destabilization accounts for most of miRNA-
mediated gene modulation (Baek et al., 2008; Selbach et al., 2008), and that up to 84% 
of the protein level changes caused by miRNA regulation can be attributed to altered 
mRNA expression (Guo et al., 2010).  To understand the functional impact of miRNA 
regulation, therefore, it is pivotal to examine the target mRNA expression levels 
concomitantly in the same biological context.  
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Combining miRNA-Seq and mRNA-Seq datasets allows direct assessment of the 
reciprocal expression of a given miRNA and its known/predicted target transcripts. Using 
this approach, miR-21 was identified as a potential candidate through which increased 
PI3Kα signaling protects against cardiac fibrosis induced by TAC. A mechanistic model 
was proposed on the basis of these findings (Figure 5.6C): upon pressure-overload, the 
TGF-β signaling pathway is activated and promotes the expression of miR-21 in cardiac 
fibroblasts, resulting in the translational suppression of the protein, Sprouty-1, which 
tonically suppresses the activation of pro-fibrotic ERK-MAPK signaling; ERK-MAPK 
signaling, therefore, is released from tonic inhibition by Sprouty-1, resulting in increased 
cardiac fibrosis. The augmentation of cardiac PI3Kα signaling, however, abrogates the 
activation of TGF-β signaling, leading to blunted miR-21 expression and the 
maintenance of Sprouty-1 expression, keeping the ERK-MAPK signaling inhibited and 
preventing the development of cardiac fibrosis. Additional in vitro and in vivo 
experiments are needed to test this hypothesis directly. 
 
In addition, the mRNA-seq experiments also uncovered functional transcriptome 
changes that suggest possible mechanisms underlying the protective effects of PI3Kα 
signaling against pathological hypertrophy (Figure 5.5). On the transcriptional level, 
pressure-overload impairs cardiac functioning through: (1) suppressing the expression of 
genes required for normal cardiac functioning, including genes involved in regulating 
mitochondrial function, oxidative-reduction, and lipid metabolism; and, (2) maladaptively 
upregulating the fetal gene program, inflammation, stress-response and extracellular 
matrix genes. The results here demonstrate that increased PI3Kα signaling ameliorates 
the aberrant expression of genes that are upregulated and genes that are 
downregulated, thereby providing multiple cardioprotective effects.  
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In conclusion, the studies presented here utilized next-generation sequencing 
technologies for comprehensive cardiac miRNA and mRNA expression profiling in 
mouse LV and identified multiple miRNAs and mRNAs that were abnormally expressed 
in pathological hypertrophy and normalized with enhanced PI3Kα signaling. Several 
novel miRNAs of potential significance in cardiac hypertrophy were also identified. 
Combined miRNA and mRNA analyses revealed that increased PI3Kα signaling reduces 
cardiac fibrosis in pathological hypertrophy through modulating TGF-β signaling and 
attenuating miR-21 expression. In addition, the TAC-induced maladaptive remodeling 
were ameliorated with increased PI3Kα signaling and were associated with the 
normalization of the pathological, disease-causing miRNAs including miR-199a-5p, miR-
214 and miR-212. These results demonstrate not only the strength and robustness of 
next-generation sequencing in exploring the cardiac transcriptome architecture and 
dynamics in physiological and pathological contexts, but also the potential molecular 
mechanisms underlying the cardioprotective effects of increased PI3Kα signaling in the 
setting of pathological hypertrophy.  
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Chapter 6: Conclusions 
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6.1 Overview 
 
Repolarizing K+ currents, including voltage-gated K+ (Kv) and inwardly rectifying (Kir) 
currents, are the major determinants of myocardial action potential repolarization. 
Alterations in the expression of myocardial repolarizing K+ currents can lead to changes 
in resting membrane properties, in the shapes and durations of action potentials, as well 
as the myocardial excitability. Considerable evidence has shown that electrical 
remodeling, particularly the reductions in densities of repolarizing K+ currents, occurs in 
LV dysfunction, including pathological cardiac hypertrophy (Mayet et al., 1996; McIntyre 
& Fry, 1997) and heart failure (Beuckelmann et al., 1993), leading to arrhythmogenic 
ventricular action potential prolongation, increased dispersion of repolarization, and 
subsequently increased propensity for life-threatening arrhythmias and sudden cardiac 
death (Tomaselli et al., 1994; Haider et al., 1998). Despite advances in pharmacological 
and device therapies for LV dysfunction to inhibit the maladaptive, pathological changes, 
ion channel remodeling, one of the fundamental mechanisms underlying the increased 
arrhythmogenecity with various myocardial diseases, has not been successfully targeted 
(Jessup & Brozena, 2003).  
 
Exercise training-induced physiological hypertrophy, in contrast to pathological LVH or 
heart failure, is not associated with electrical abnormalities or increased arrhythmia risk 
(Mayet et al., 1999; Biffi et al., 2008). In fact, aerobic exercise training has been shown 
to reduce repolarization abnormalities and sudden-death rate in heart failure patients (Ali 
et al., 1999), as well as in animal models of LV dysfunction (Lachance et al., 2009). 
These observations clearly suggest that electrical remodeling occurs in response to 
exercise training to maintain the normal myocardial function. Considerable evidence 
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suggests that aerobic exercise provides multiple beneficial effects on the myocardium, 
including increased myocardial perfusion (Hambrecht et al., 2000b), improved 
myocardial energy metabolism (O'Neill et al., 2007), reduced myocardial fibrosis 
(McMullen et al., 2003), and/or maintained calcium handling (Medeiros et al., 2008), 
many of which have been attributed to increased PI3Kα signaling in response to 
exercise training.  
 
The studies here were conducted to test directly the hypothesis that beneficial ion 
channel remodeling occurs with exercise training and enhanced PI3Kα activity, and to 
explore the signaling mechanisms underlying this exercise training- (PI3Kα-) mediated 
electrical remodeling. The hypothesis that increased PI3Kα signaling will counteract the 
adverse electrophysiological remodeling, including decreased K+ current densities, 
impaired repolarization, and increased risk of lethal ventricular arrhythmias, associated 
with pathological hypertrophy and heart failure, was also tested. Finally, combined 
miRNA- and mRNA-sequencing analyses were applied to explore the mechanisms by 
which enhanced PI3Kα signaling provides cardioprotective effects, minimizing 
pathological remodeling, in a mouse model of TAC-induced pathological hypertrophy.  
 
6.2 Exercise training and PI3Kα activation lead to transcriptional upregulation of 
myocardial ion channel subunits independent of cellular hypertrophy and Akt 
The results presented here demonstrate that physiological hypertrophy, induced by 
chronic exercise (swim) training or transgenic increases in PI3Kα signaling, is associated 
with increases in myocardial repolarizing K+, as well as depolarizing Na+ and Ca2+, 
currents, reflecting increased expression of the transcripts encoding the underlying ion 
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channel subunits. The transcriptional upregulation of ion channel subunits with 
physiological hypertrophy is in proportion to increased myocyte size and the global 
increases in RNA and protein expression, resulting in the maintenance of ionic current 
densities and myocardial electrical excitability. Further experiments revealed that 
exercise training and enhanced PI3Kα signaling-mediated transcriptional upregulation of 
myocardial ion channel subunits is independent of cellular hypertrophy and Akt 
signaling. 
 
 
Interestingly, recent studies in a mouse model of TAC-induced pathological hypertrophy 
have shown repolarizing K+ channel subunit expression levels are not increased in 
proportion to the increased total RNA synthesis and the hypertrophic growth and, as a 
result, K+ current densities are decreased (Marionneau et al., 2008b). The disconnect 
between the global increases in RNA synthesis and the transcriptional regulationof ion 
channel subunits in TAC-induced  hypertrophy (Hannan et al., 2003), together with the 
hypertrophy-independent transcriptional upregulation of channel subunits in response to 
exercise training or increased PI3Kα signaling imply a unique regulatory mechanism 
coordinating myocardial ion channel gene expression, that is independent of the general 
transcriptional machinery that is robustly activated in response to hypertrophic stimuli, 
such as pressure overload or exercise training.  
 
In addition, it has been recently shown that PI3Kα activation is critical in mediating 
myocardial metabolic remodeling in physiological hypertrophy, including increased 
capacity to oxidize fatty acids/glucose and increased mitochondrial biogenesis, and that 
these metabolic remodeling effects are also Akt-independent (O'Neill et al., 2007). Taken 
together, these results demonstrate that PI3Kα signaling exerts distinct biological effects 
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on the myocardium through divergent downstream pathways: Akt1-dependent 
physiological cardiac growth, Akt2-dependent insulin-sensitization and cellular survival, 
as well as Akt-independent metabolic and electrical remodeling. The signaling 
mechanisms of how PI3Kα mediates the Akt-independent metabolic and electrical 
effects are not well-understood; although it has been suggested that PKCλ/ζ could be 
the potential downstream effecter that is required for PI3Kα-mediated metabolic 
remodeling (O'Neill et al., 2007). Further studies are required to identify the downstream 
signaling effectors that mediate myocardial electrical remodeling in response to PI3Kα 
activation. 
 
6.3 Enhancing myocardial PI3Kα activity as a novel therapeutic approach to 
ameliorate arrhythmogenic LV dysfunction 
The increased incidence of life-threatening ventricular arrhythmias in patients with 
pathological hypertrophy and heart failure is a consequence of complex pathological 
remodeling in cardiac structural (Akar et al., 2004), neurohumoral (Vaseghi & 
Shivkumar, 2008) and electrophysiological properties (Beuckelmann et al., 1993; Kaab 
et al., 1998; Li et al., 2002; Akar et al., 2005; Marionneau et al., 2008b). Traditional 
approaches used in the clinical management of heart failure, specifically 
pharmacological (Kober et al., 1995; Pitt et al., 1999) and device therapies (Moss et al., 
2009), are largely aimed at inhibiting the maladaptive neurohumoral signaling and 
structural abnormalities accompanying LV dysfunction. Targeting the 
electrophysiological derangements using anti-arrhythmic agents has proven to be 
ineffective and, indeed, has been associated with increased, rather than decreased, 
mortality (CAST, 1989). The results presented here demonstrate that increased PI3Kα 
signaling in pathological hypertrophy and heart failure helps to normalize ventricular 
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repolarization and maintain electrical functioning through the transcriptional upregulation 
of repolarizing K+ channels, a mechanism of action distinct from classic heart failure 
therapeutics.  
A simple and practical approach to increasing cardiac PI3Kα signaling is aerobic 
exercise training (McMullen et al., 2003; Yang et al., 2010). Indeed, aerobic exercise 
training has been shown to improve LV function and prolong survival in heart failure 
patients (Coats, 2011), as well as in animal models of heart failure (McMullen et al., 
2007; Lachance et al., 2009). These results suggest a novel proactive, physiologic 
therapeutic approach against the increased arrhythmogenecity with LV dysfunction, 
which may synergize with traditional heart failure therapeutics and improve patient 
outcomes.  
6.4 Deep sequencing revealed mechanisms underlying the protective effects of 
increased PI3Kα signaling in pathological hypertrophy/heart failure 
PI3Kα signaling plays multiple roles in the myocardium, including the regulatioin of 
myocyte growth, hypertrophy, proliferation, survival, metabolism, aging and regeneration 
(Cantley, 2002; Sussman et al., 2011). Accumulating evidence suggests that 
augmentation of PI3Kα signaling is beneficial in various cardiac diseases, including 
pathological hypertrophy (McMullen et al., 2007; Yang et al., 2012), myocardial infarction 
(Lin et al., 2010), diabetic cardiomyopathy (Huynh et al.), atrial fibrillation (Pretorius et 
al., 2009), and heart failure (McMullen et al., 2007; Yang et al., 2012), normalizing the 
detrimental molecular and structural remodeling resulting from pathological stimuli. The 
mechanisms underlying the cardioprotective effects provided by increased PI3Kα 
signaling, however, remain poorly understood. 
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The studies presented here utilized next-generation sequencing technologies for a 
comprehensive cardiac miRNA and mRNA expression profiling in pathological and 
physiological hypertrophy. These analyses identified multiple miRNAs and mRNAs that 
were aberrantly expressed in pathological hypertrophy but normalized with enhanced 
PI3Kα signaling, revealing the “protective PI3Kα microRNome and mRNome”. The 
combined miRNA and mRNA analyses, for example, revealed that increased PI3Kα 
signaling reduces cardiac fibrosis in pathological hypertrophy through modulating TGF-β 
signaling and miR-21 expression. In addition, TAC-induced pathological remodeling is 
blunted with enhanced PI3Kα signaling and is associated with the repression of 
pathological, disease-causing miRNAs including miR-199a-5p, miR-214 and miR-212. 
Several novel miRNAs of potential significance in cardiac hypertrophy were also 
identified.  
 
6.5 Impact of studies 
The studies completed and presented here have revealed that electrical remodeling 
distinguishes exercise training-induced physiological, from stress-induced pathological, 
cardiac hypertrophy. While pathological hypertrophy is associated with abnormal 
electrical functioning, including arrhythmogenic action potential prolongation and 
increased repolarization dispersion (Mayet et al., 1996; McIntyre & Fry, 1997), 
physiological hypertrophy is not associated with electrical abnormalities or increased 
arrhythmia risk. The experiments here revealed that the electrophysiological differences 
between pathological and physiological hypertrophy resulted from the differences in the 
transcriptional regulation of repolarizing K+ channel subunits: transcripts encoding K+ 
channel subunits fail to upregulate in proportion to cellular hypertrophy with pathological 
hypertrophy, resulting in reduced K+ current densities and subsequent arrhythmogenic 
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changes. In contrast, K+ channel subunit transcripts are upregulated in parallel with the 
increase in myocyte size with physiological hypertrophy, maintaining K+ current densities 
and electrical functioning. The results here also demonstrate that PI3Kα signaling plays 
a critical role in mediating the electrical remodeling observed with physiological 
hypertrophy, and that PI3Kα signaling-mediated electrical remodeling is actually 
independent of cellular hypertrophy and Akt. These studies provide novel insights in the 
role of PI3Kα signaling pathway in the transcriptional regulation of myocardial ion 
channels.  
 
The results presented here also demonstrate that increased PI3Kα signaling in 
pathological hypertrophy and heart failure can normalize ventricular repolarization and 
maintain electrical functioning through the transcriptional upregulation of repolarizing 
 K+ channels. These results suggest that enhancing myocardial PI3Kα signaling, either 
through exercise training or pharmacologic agents, could directly address the 
electrophysiological basis of life-threatening arrhythmias associated with pathological 
LVH and heart failure. These observations, therefore, could lead to the development of 
novel heart failure treatments via a mechanism of action distinct from classic heart 
failure therapeutics. 
 
Finally, the studies here established a molecular and bioinformatic pipeline that permits 
comprehensive quantification and analyses of myocardial miRNA and mRNA expression 
with next-generation sequencing, and applied this approach to define the impact of 
enhanced PI3Kα signaling on myocardial transcriptome structure in the setting of 
pressure overload-induced pathological hypertrophy. The results from these studies not 
only demonstrate the strength and robustness of next-generation sequencing in efforts 
to define the cardiac transcriptome architecture and dynamics in physiological and 
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pathological contexts, but also reveal the protective transcriptome signature of enhanced 
PI3Kα signaling in pathological hypertrophy, as well as the potential molecular 
mechanisms underlying the cardioprotective effects of increased PI3Kα signaling. The 
approach described provides a comprehensive yet straightforward set of methods to 
quantify and analyze myocardial transcritpome, methods that could be exploited in 
studies on normal and disease human hearts to provide important new insights into 
disease mechanisms and novel therapeutic targets.   
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6.6 Future directions 
Increasing evidence suggests that myocardial Kv and Kir channels function in 
macromolecular complexes, comprising pore-forming α subunits, a number of cytosolic 
and transmembrane accessory subunits, as well as regulatory, cytoskeletal, and 
signaling proteins (Sanguinetti et al., 1996; Shi et al., 1996; Manganas & Trimmer, 2000; 
Aimond et al., 2005; Nerbonne & Kass, 2005; Radicke et al., 2005; Radicke et al., 2006; 
Niwa & Nerbonne, 2010; Pongs & Schwarz, 2010). Various signaling molecules have 
been shown to modulate functional K+ current expression through regulating channel 
activity, channel subunit stability or trafficking, including calmodulin kinase II (CaMKII) (Li 
et al., 2006), cAMP-dependent protein kinase (PKA) (Anderson et al., 2000; Gallego et 
al., 2005), protein kinase C (PKC) (Schrader et al., 2009), and extracellular signal 
regulated kinase (ERK) (Schrader et al., 2006; Schrader et al., 2009). Interestingly, 
many of these signaling molecules also play critical roles in regulating the development 
of cardiac hypertrophy (Frey & Olson, 2003; Dorn & Force, 2005) and, like PI3Kα, have 
been shown to modulate K+ channel subunit expression transcriptionally. For example, 
in neonatal rat ventricle, activation of PKC negatively regulates Kcnip2 (KChIP2) 
expression , and this PKC-dependent transcriptional suppression of KChIP2 was shown 
to be mediated by the ERK pathway (Jia & Takimoto, 2006). In addition, calcineurin 
(Rossow et al., 2006)  and NFAT (Amberg et al., 2004; Rossow et al., 2004), two 
downstream targets of Gq/11 protein kinase, the signaling nexus mediating pathological 
hypertrophy, have been shown to negatively regulate K+ channel (Kv1.5, Kv2.1, Kv4.2 
and Kv4.3) transcript expression. The links between these hypertrophy-related signaling 
pathways and the transcriptional networks regulating the expression of K+ channel 
subunit genes, however, have not been defined. Future studies focused on determining 
how the signaling pathways activated on pathological hypertrophy prevent the 
transcriptional upregulation of the transcripts encoding ion channels subunits in 
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proportion to the global increase in mRNA/protein expression. The studies completed 
here demonstrate that transcriptional upregulation of K+ channel subunits induced by 
enhanced PI3Kα signaling is Akt-independent. These results argue for further research 
focused on dissecting the downstream signaling mechanisms through which enhanced 
PI3Kα activities mediates electrical remodeling. Further studies aimed at delineating the 
links between cellular signaling pathways and the transcriptional (and post-
transcriptional) regulation of K+ channel (and other ion channel) genes are also needed. 
Insights gained from these studies could provide more direct and specific strategies to 
reverse ion channel dysregulation, and the resulting generation of arrhythmogenic 
substrates, in cardiomyopathy and heart failure.  
 
The studies completed here also demonstrate that enhancing cardiac PI3Kα signaling 
mitigates the increased arrhythmogenicity associated with pathological hypertrophy and 
heart failure, observations which suggest that possible therapeutic potential of 
pharmacological agents that activate PI3Kα signaling in human failing hearts. Clearly, 
studies aimed at exploring this hypothesis directly are needed. Interestingly, growth 
hormone (GH) and IGF-1 , two endogenous neurohumoral agonists that can activate 
cellular PI3Kα signaling, have been tested as experimental heart failure therapeutics in 
animal models (Yang et al., 1995; Duerr et al., 1996; Cittadini et al., 1997) and human 
patients (Fazio et al., 1996; Osterziel et al., 1998; Genth-Zotz et al., 1999). Animal 
studies have demonstrated that the administration of GH or IGF-1 confers beneficial 
effects on cardiac structural remodeling, contractile function and survival in heart failure 
(Yang et al., 1995; Duerr et al., 1996; Cittadini et al., 1997). Initial human studies also 
showed that recombinant GH therapy resulted in improvements in LV performance, 
hemodynamics, exercise capacity and clinical symptoms in patients with moderate to 
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advanced heart failure (Fazio et al., 1996; Osterziel et al., 1998; Genth-Zotz et al., 
1999). Subsequent randomized, placebo-controlled trials, however, failed to confirm 
significant beneficial effects of chronic GH therapy in heart failure patients (Isgaard et al., 
1998; Smit et al., 2001; Acevedo et al., 2003). The lack of beneficial effects of GH 
administration in these larger studies may reflect the development of GH resistance, 
which has been described in patients with heart failure and other chronic illnesses 
(Anker et al., 1997; Van den Berghe et al., 1999). Using IGF-1, instead of GH, would 
avoid the issue of GH resistance, although, to date, there have been no studies that 
have investigated the impact of direct IGF-1 administration in patients with heart failure. 
Importantly, none of the studies conducted to date have investigated the effects of 
increased GH/IGF-1 on cardiac electrical functioning in the setting of LV dysfunction 
(Fazio et al., 1996; Osterziel et al., 1998; Genth-Zotz et al., 1999). Future studies, 
therefore, should also include an emphasis on investigating the effect(s) of increasing 
IGF-1 signaling on electrical remodeling and arrhythmia risk in animal models and 
patients with LV dysfunction. The results presented here also argue for further research 
focused on developing pharmacological agents or biological approaches to activate 
PI3Kα signaling directly in the human heart, as well as on detailing the effects of these 
manipulations on arrhythmia vulnerability and sudden cardiac death. 
 
Additional studies here applied next-generation sequencing technologies in myocardial 
transcriptome profiling. These analyses identified miRNAs and mRNAs that are 
implicated in the molecular mechanisms underlying PI3Kα-mediated cardioprotective 
effects. Future studies should focus on investigating the mechanisms through which 
PI3Kα signaling modulates the aberrantly expressed miRNAs and mRNAs involved in 
pathological myocardial remodeling. It was also recently reported that deep sequencing 
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can be exploited for in-depth, genome-wide, analyses of the expression of cardiac 
transcript isoforms, as well as for the identification of novel spliced exons, alternative 
terminal exons, novel genes, long noncoding RNAs (lncRNAs) and long intergenic 
noncoding RNAs (lincRNAs) (Lee et al., 2011), further demonstrating the power and 
feasibility of applying deep sequencing methods to detail the complex cardiac 
transcriptome at individual exon and transcript levels. Taken together, these results 
argue that next-gen sequencing approaches could be used to re-evaluate cardiac 
transcriptome remodeling in human cardiovascular diseases, such as heart failure and 
cardiomyopathy, to advance our understanding of the mechanisms underlying disease 
processes, as well as to identify novel therapeutic targets.       
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